id	sid	tid	token	lemma	pos
bam-5962	1	1	clinical	clinical	ADJ
bam-5962	1	2	features	feature	NOUN
bam-5962	1	3	of	of	ADP
bam-5962	1	4	n	n	CCONJ
bam-5962	1	5	-	-	PUNCT
bam-5962	1	6	type	type	NOUN
bam-5962	1	7	vgcc	vgcc	NOUN
bam-5962	1	8	neuromuscular	neuromuscular	ADJ
bam-5962	1	9	syndromes	syndrome	NOUN
bam-5962	1	10	eur	eur	PROPN
bam-5962	1	11	j	j	PROPN
bam-5962	1	12	transl	transl	PROPN
bam-5962	1	13	myol	myol	NOUN
bam-5962	1	14	26	26	NUM
bam-5962	1	15	(	(	PUNCT
bam-5962	1	16	4	4	NUM
bam-5962	1	17	):	):	PUNCT
bam-5962	1	18	301	301	NUM
bam-5962	1	19	-	-	SYM
bam-5962	1	20	306	306	NUM
bam-5962	1	21	301	301	NUM
bam-5962	1	22	clinical	clinical	ADJ
bam-5962	1	23	features	feature	NOUN
bam-5962	1	24	of	of	ADP
bam-5962	1	25	neuromuscular	neuromuscular	ADJ
bam-5962	1	26	disorders	disorder	NOUN
bam-5962	1	27	in	in	ADP
bam-5962	1	28	patients	patient	NOUN
bam-5962	1	29	with	with	ADP
bam-5962	1	30	n	n	CCONJ
bam-5962	1	31	-	-	PUNCT
bam-5962	1	32	type	type	NOUN
bam-5962	1	33	voltage	voltage	NOUN
bam-5962	1	34	-	-	PUNCT
bam-5962	1	35	gated	gate	VERB
bam-5962	1	36	calcium	calcium	NOUN
bam-5962	1	37	channel	channel	NOUN
bam-5962	1	38	antibodies	antibodie	VERB
bam-5962	1	39	andreas	andreas	PROPN
bam-5962	1	40	totzeck	totzeck	PROPN
bam-5962	1	41	,	,	PUNCT
bam-5962	1	42	petra	petra	PROPN
bam-5962	1	43	mummel	mummel	PROPN
bam-5962	1	44	,	,	PUNCT
bam-5962	1	45	oliver	oliver	PROPN
bam-5962	1	46	kastrup	kastrup	PROPN
bam-5962	1	47	,	,	PUNCT
bam-5962	1	48	tim	tim	PROPN
bam-5962	1	49	hagenacker	hagenacker	PROPN
bam-5962	1	50	department	department	PROPN
bam-5962	1	51	of	of	ADP
bam-5962	1	52	neurology	neurology	NOUN
bam-5962	1	53	,	,	PUNCT
bam-5962	1	54	university	university	NOUN
bam-5962	1	55	duisburg	duisburg	PROPN
bam-5962	1	56	-	-	PUNCT
bam-5962	1	57	essen	essen	PROPN
bam-5962	1	58	,	,	PUNCT
bam-5962	1	59	germany	germany	PROPN
bam-5962	1	60	this	this	DET
bam-5962	1	61	article	article	NOUN
bam-5962	1	62	is	be	AUX
bam-5962	1	63	distributed	distribute	VERB
bam-5962	1	64	under	under	ADP
bam-5962	1	65	the	the	DET
bam-5962	1	66	terms	term	NOUN
bam-5962	1	67	of	of	ADP
bam-5962	1	68	the	the	DET
bam-5962	1	69	creative	creative	ADJ
bam-5962	1	70	commons	common	NOUN
bam-5962	1	71	attribution	attribution	NOUN
bam-5962	1	72	noncommercial	noncommercial	ADJ
bam-5962	1	73	license	license	NOUN
bam-5962	1	74	(	(	PUNCT
bam-5962	1	75	cc	cc	NOUN
bam-5962	1	76	by	by	ADP
bam-5962	1	77	-	-	PUNCT
bam-5962	1	78	nc	nc	PROPN
bam-5962	1	79	4.0	4.0	NUM
bam-5962	1	80	)	)	PUNCT
bam-5962	1	81	which	which	PRON
bam-5962	1	82	permits	permit	VERB
bam-5962	1	83	any	any	DET
bam-5962	1	84	noncommercial	noncommercial	ADJ
bam-5962	1	85	use	use	NOUN
bam-5962	1	86	,	,	PUNCT
bam-5962	1	87	distribution	distribution	NOUN
bam-5962	1	88	,	,	PUNCT
bam-5962	1	89	and	and	CCONJ
bam-5962	1	90	reproduction	reproduction	NOUN
bam-5962	1	91	in	in	ADP
bam-5962	1	92	any	any	DET
bam-5962	1	93	medium	medium	NOUN
bam-5962	1	94	,	,	PUNCT
bam-5962	1	95	provided	provide	VERB
bam-5962	1	96	the	the	DET
bam-5962	1	97	original	original	ADJ
bam-5962	1	98	author(s	author(s	NOUN
bam-5962	1	99	)	)	PUNCT
bam-5962	1	100	and	and	CCONJ
bam-5962	1	101	source	source	NOUN
bam-5962	1	102	are	be	AUX
bam-5962	1	103	credited	credit	VERB
bam-5962	1	104	.	.	PUNCT
bam-5962	2	1	abstract	abstract	ADJ
bam-5962	2	2	neuromuscular	neuromuscular	ADJ
bam-5962	2	3	junction	junction	NOUN
bam-5962	2	4	disorders	disorder	NOUN
bam-5962	2	5	affect	affect	VERB
bam-5962	2	6	the	the	DET
bam-5962	2	7	preor	preor	ADJ
bam-5962	2	8	postsynaptic	postsynaptic	ADJ
bam-5962	2	9	nerve	nerve	NOUN
bam-5962	2	10	to	to	PART
bam-5962	2	11	muscle	muscle	VERB
bam-5962	2	12	transmission	transmission	NOUN
bam-5962	2	13	due	due	ADP
bam-5962	2	14	to	to	ADP
bam-5962	2	15	autoimmune	autoimmune	ADJ
bam-5962	2	16	antibodies	antibodie	VERB
bam-5962	2	17	.	.	PUNCT
bam-5962	3	1	members	member	NOUN
bam-5962	3	2	of	of	ADP
bam-5962	3	3	the	the	DET
bam-5962	3	4	group	group	NOUN
bam-5962	3	5	like	like	ADP
bam-5962	3	6	myasthenia	myasthenia	NOUN
bam-5962	3	7	gravis	gravis	PROPN
bam-5962	3	8	and	and	CCONJ
bam-5962	3	9	lamberteaton	lamberteaton	NOUN
bam-5962	3	10	syndrome	syndrome	NOUN
bam-5962	3	11	have	have	VERB
bam-5962	3	12	pathophysiologically	pathophysiologically	ADV
bam-5962	3	13	distinct	distinct	ADJ
bam-5962	3	14	characteristics	characteristic	NOUN
bam-5962	3	15	.	.	PUNCT
bam-5962	4	1	however	however	ADV
bam-5962	4	2	,	,	PUNCT
bam-5962	4	3	in	in	ADP
bam-5962	4	4	practice	practice	NOUN
bam-5962	4	5	,	,	PUNCT
bam-5962	4	6	distinction	distinction	NOUN
bam-5962	4	7	may	may	AUX
bam-5962	4	8	be	be	AUX
bam-5962	4	9	difficult	difficult	ADJ
bam-5962	4	10	.	.	PUNCT
bam-5962	5	1	we	we	PRON
bam-5962	5	2	present	present	VERB
bam-5962	5	3	a	a	DET
bam-5962	5	4	series	series	NOUN
bam-5962	5	5	of	of	ADP
bam-5962	5	6	three	three	NUM
bam-5962	5	7	patients	patient	NOUN
bam-5962	5	8	with	with	ADP
bam-5962	5	9	a	a	DET
bam-5962	5	10	myasthenic	myasthenic	ADJ
bam-5962	5	11	syndrome	syndrome	NOUN
bam-5962	5	12	,	,	PUNCT
bam-5962	5	13	dropped	drop	VERB
bam-5962	5	14	-	-	PUNCT
bam-5962	5	15	head	head	NOUN
bam-5962	5	16	syndrome	syndrome	NOUN
bam-5962	5	17	,	,	PUNCT
bam-5962	5	18	bulbar	bulbar	NOUN
bam-5962	5	19	and	and	CCONJ
bam-5962	5	20	respiratory	respiratory	ADJ
bam-5962	5	21	muscle	muscle	NOUN
bam-5962	5	22	weakness	weakness	NOUN
bam-5962	5	23	and	and	CCONJ
bam-5962	5	24	positive	positive	ADJ
bam-5962	5	25	testing	testing	NOUN
bam-5962	5	26	for	for	ADP
bam-5962	5	27	antin	antin	NOUN
bam-5962	5	28	-	-	PUNCT
bam-5962	5	29	type	type	NOUN
bam-5962	5	30	voltage	voltage	NOUN
bam-5962	5	31	-	-	PUNCT
bam-5962	5	32	gated	gate	VERB
bam-5962	5	33	calcium	calcium	NOUN
bam-5962	5	34	channel	channel	NOUN
bam-5962	5	35	antibodies	antibodie	VERB
bam-5962	5	36	.	.	PUNCT
bam-5962	6	1	in	in	ADP
bam-5962	6	2	two	two	NUM
bam-5962	6	3	cases	case	NOUN
bam-5962	6	4	anti	anti	ADJ
bam-5962	6	5	-	-	ADJ
bam-5962	6	6	acetylcholin	acetylcholin	ADJ
bam-5962	6	7	receptor	receptor	NOUN
bam-5962	6	8	antibodies	antibody	NOUN
bam-5962	6	9	were	be	AUX
bam-5962	6	10	elevated	elevate	VERB
bam-5962	6	11	,	,	PUNCT
bam-5962	6	12	anti	anti	ADJ
bam-5962	6	13	-	-	ADJ
bam-5962	6	14	p	p	ADJ
bam-5962	6	15	/	/	SYM
bam-5962	6	16	q	q	ADJ
bam-5962	6	17	-	-	PUNCT
bam-5962	6	18	type	type	NOUN
bam-5962	6	19	voltage	voltage	NOUN
bam-5962	6	20	-	-	PUNCT
bam-5962	6	21	gated	gate	VERB
bam-5962	6	22	calcium	calcium	NOUN
bam-5962	6	23	channel	channel	NOUN
bam-5962	6	24	antibodies	antibody	NOUN
bam-5962	6	25	were	be	AUX
bam-5962	6	26	negative	negative	ADJ
bam-5962	6	27	.	.	PUNCT
bam-5962	7	1	all	all	DET
bam-5962	7	2	patients	patient	NOUN
bam-5962	7	3	initially	initially	ADV
bam-5962	7	4	responded	respond	VERB
bam-5962	7	5	to	to	ADP
bam-5962	7	6	pyridostigmine	pyridostigmine	NOUN
bam-5962	7	7	with	with	ADP
bam-5962	7	8	a	a	DET
bam-5962	7	9	non	non	ADJ
bam-5962	7	10	-	-	NOUN
bam-5962	7	11	response	response	NOUN
bam-5962	7	12	in	in	ADP
bam-5962	7	13	the	the	DET
bam-5962	7	14	course	course	NOUN
bam-5962	7	15	of	of	ADP
bam-5962	7	16	the	the	DET
bam-5962	7	17	disease	disease	NOUN
bam-5962	7	18	.	.	PUNCT
bam-5962	8	1	while	while	SCONJ
bam-5962	8	2	one	one	NUM
bam-5962	8	3	patient	patient	NOUN
bam-5962	8	4	recovered	recover	VERB
bam-5962	8	5	well	well	ADV
bam-5962	8	6	after	after	ADP
bam-5962	8	7	treatment	treatment	NOUN
bam-5962	8	8	with	with	ADP
bam-5962	8	9	intravenous	intravenous	ADJ
bam-5962	8	10	immunoglobulins	immunoglobulin	NOUN
bam-5962	8	11	,	,	PUNCT
bam-5962	8	12	3,4	3,4	NUM
bam-5962	8	13	-	-	PUNCT
bam-5962	8	14	diaminopyridine	diaminopyridine	NOUN
bam-5962	8	15	,	,	PUNCT
bam-5962	8	16	steroids	steroid	NOUN
bam-5962	8	17	and	and	CCONJ
bam-5962	8	18	later	later	ADV
bam-5962	8	19	on	on	ADP
bam-5962	8	20	immunosuppression	immunosuppression	NOUN
bam-5962	8	21	with	with	ADP
bam-5962	8	22	mycophenolate	mycophenolate	PROPN
bam-5962	8	23	mofetil	mofetil	PROPN
bam-5962	8	24	,	,	PUNCT
bam-5962	8	25	a	a	DET
bam-5962	8	26	second	second	NOUN
bam-5962	8	27	died	die	VERB
bam-5962	8	28	after	after	ADP
bam-5962	8	29	restriction	restriction	NOUN
bam-5962	8	30	of	of	ADP
bam-5962	8	31	treatment	treatment	NOUN
bam-5962	8	32	due	due	ADP
bam-5962	8	33	to	to	ADP
bam-5962	8	34	unfavorable	unfavorable	ADJ
bam-5962	8	35	cancer	cancer	NOUN
bam-5962	8	36	diagnosis	diagnosis	NOUN
bam-5962	8	37	,	,	PUNCT
bam-5962	8	38	the	the	DET
bam-5962	8	39	third	third	ADJ
bam-5962	8	40	patient	patient	NOUN
bam-5962	8	41	declined	decline	VERB
bam-5962	8	42	treatment	treatment	NOUN
bam-5962	8	43	.	.	PUNCT
bam-5962	9	1	although	although	SCONJ
bam-5962	9	2	new	new	ADJ
bam-5962	9	3	antibodies	antibody	NOUN
bam-5962	9	4	causing	cause	VERB
bam-5962	9	5	neuromuscular	neuromuscular	ADJ
bam-5962	9	6	disorders	disorder	NOUN
bam-5962	9	7	were	be	AUX
bam-5962	9	8	discovered	discover	VERB
bam-5962	9	9	,	,	PUNCT
bam-5962	9	10	clinical	clinical	ADJ
bam-5962	9	11	distinction	distinction	NOUN
bam-5962	9	12	has	have	AUX
bam-5962	9	13	not	not	PART
bam-5962	9	14	yet	yet	ADV
bam-5962	9	15	been	be	AUX
bam-5962	9	16	made	make	VERB
bam-5962	9	17	.	.	PUNCT
bam-5962	10	1	our	our	PRON
bam-5962	10	2	patients	patient	NOUN
bam-5962	10	3	showed	show	VERB
bam-5962	10	4	features	feature	NOUN
bam-5962	10	5	of	of	ADP
bam-5962	10	6	preand	preand	NOUN
bam-5962	10	7	postsynaptic	postsynaptic	ADJ
bam-5962	10	8	myasthenic	myasthenic	ADJ
bam-5962	10	9	syndrome	syndrome	NOUN
bam-5962	10	10	as	as	ADV
bam-5962	10	11	well	well	ADV
bam-5962	10	12	as	as	ADP
bam-5962	10	13	severe	severe	ADJ
bam-5962	10	14	dropped	drop	VERB
bam-5962	10	15	-	-	PUNCT
bam-5962	10	16	head	head	NOUN
bam-5962	10	17	syndrome	syndrome	NOUN
bam-5962	10	18	and	and	CCONJ
bam-5962	10	19	bulbar	bulbar	NOUN
bam-5962	10	20	and	and	CCONJ
bam-5962	10	21	axial	axial	ADJ
bam-5962	10	22	muscle	muscle	NOUN
bam-5962	10	23	weakness	weakness	NOUN
bam-5962	10	24	,	,	PUNCT
bam-5962	10	25	but	but	CCONJ
bam-5962	10	26	only	only	ADV
bam-5962	10	27	anti	anti	ADJ
bam-5962	10	28	-	-	ADJ
bam-5962	10	29	n	n	CCONJ
bam-5962	10	30	-	-	PUNCT
bam-5962	10	31	type	type	NOUN
bam-5962	10	32	voltagegated	voltagegate	VERB
bam-5962	10	33	calcium	calcium	NOUN
bam-5962	10	34	channel	channel	NOUN
bam-5962	10	35	antibodies	antibody	NOUN
bam-5962	10	36	were	be	AUX
bam-5962	10	37	positive	positive	ADJ
bam-5962	10	38	.	.	PUNCT
bam-5962	11	1	when	when	SCONJ
bam-5962	11	2	administered	administer	VERB
bam-5962	11	3	,	,	PUNCT
bam-5962	11	4	one	one	NUM
bam-5962	11	5	patient	patient	NOUN
bam-5962	11	6	benefited	benefit	VERB
bam-5962	11	7	from	from	ADP
bam-5962	11	8	3,4	3,4	NUM
bam-5962	11	9	-	-	PUNCT
bam-5962	11	10	diaminopyridine	diaminopyridine	NOUN
bam-5962	11	11	.	.	PUNCT
bam-5962	12	1	we	we	PRON
bam-5962	12	2	suggest	suggest	VERB
bam-5962	12	3	that	that	SCONJ
bam-5962	12	4	this	this	DET
bam-5962	12	5	overlap	overlap	NOUN
bam-5962	12	6	-	-	PUNCT
bam-5962	12	7	syndrome	syndrome	NOUN
bam-5962	12	8	should	should	AUX
bam-5962	12	9	be	be	AUX
bam-5962	12	10	considered	consider	VERB
bam-5962	12	11	especially	especially	ADV
bam-5962	12	12	in	in	ADP
bam-5962	12	13	patients	patient	NOUN
bam-5962	12	14	with	with	ADP
bam-5962	12	15	assumed	assume	VERB
bam-5962	12	16	seronegative	seronegative	ADJ
bam-5962	12	17	myasthenia	myasthenia	NOUN
bam-5962	12	18	gravis	gravis	NOUN
bam-5962	12	19	and	and	CCONJ
bam-5962	12	20	lack	lack	NOUN
bam-5962	12	21	of	of	ADP
bam-5962	12	22	improvement	improvement	NOUN
bam-5962	12	23	under	under	ADP
bam-5962	12	24	standard	standard	ADJ
bam-5962	12	25	therapy	therapy	NOUN
bam-5962	12	26	.	.	PUNCT
bam-5962	13	1	key	key	ADJ
bam-5962	13	2	words	word	NOUN
bam-5962	13	3	:	:	PUNCT
bam-5962	13	4	neuromuscular	neuromuscular	ADJ
bam-5962	13	5	junction	junction	NOUN
bam-5962	13	6	disorders	disorder	NOUN
bam-5962	13	7	,	,	PUNCT
bam-5962	13	8	voltage	voltage	NOUN
bam-5962	13	9	gated	gate	VERB
bam-5962	13	10	calcium	calcium	NOUN
bam-5962	13	11	channels	channel	NOUN
bam-5962	13	12	,	,	PUNCT
bam-5962	13	13	myasthenia	myasthenia	NOUN
bam-5962	13	14	gravis	gravis	NOUN
bam-5962	13	15	,	,	PUNCT
bam-5962	13	16	3,4	3,4	NUM
bam-5962	13	17	-	-	PUNCT
bam-5962	13	18	diaminopyridin	diaminopyridin	NOUN
bam-5962	13	19	,	,	PUNCT
bam-5962	13	20	dropped	drop	VERB
bam-5962	13	21	-	-	PUNCT
bam-5962	13	22	head	head	NOUN
bam-5962	13	23	syndrome	syndrome	NOUN
bam-5962	13	24	eur	eur	PROPN
bam-5962	13	25	j	j	PROPN
bam-5962	13	26	transl	transl	PROPN
bam-5962	13	27	myol	myol	NOUN
bam-5962	13	28	26	26	NUM
bam-5962	13	29	(	(	PUNCT
bam-5962	13	30	4	4	NUM
bam-5962	13	31	):	):	PUNCT
bam-5962	13	32	301	301	NUM
bam-5962	13	33	-	-	SYM
bam-5962	13	34	306	306	NUM
bam-5962	13	35	neuromuscular	neuromuscular	ADJ
bam-5962	13	36	junction	junction	NOUN
bam-5962	13	37	disorders	disorder	NOUN
bam-5962	13	38	are	be	AUX
bam-5962	13	39	a	a	DET
bam-5962	13	40	heterogeneous	heterogeneous	ADJ
bam-5962	13	41	group	group	NOUN
bam-5962	13	42	of	of	ADP
bam-5962	13	43	predominantly	predominantly	ADV
bam-5962	13	44	autoimmune	autoimmune	ADJ
bam-5962	13	45	diseases	disease	NOUN
bam-5962	13	46	that	that	PRON
bam-5962	13	47	affect	affect	VERB
bam-5962	13	48	the	the	DET
bam-5962	13	49	neuromuscular	neuromuscular	ADJ
bam-5962	13	50	transmission	transmission	NOUN
bam-5962	13	51	.	.	PUNCT
bam-5962	14	1	myasthenia	myasthenia	PROPN
bam-5962	14	2	gravis	gravis	PROPN
bam-5962	14	3	(	(	PUNCT
bam-5962	14	4	mg	mg	PROPN
bam-5962	14	5	)	)	PUNCT
bam-5962	14	6	is	be	AUX
bam-5962	14	7	the	the	DET
bam-5962	14	8	most	most	ADV
bam-5962	14	9	known	know	VERB
bam-5962	14	10	member	member	NOUN
bam-5962	14	11	of	of	ADP
bam-5962	14	12	the	the	DET
bam-5962	14	13	group	group	NOUN
bam-5962	14	14	with	with	ADP
bam-5962	14	15	a	a	DET
bam-5962	14	16	prevalence	prevalence	NOUN
bam-5962	14	17	of	of	ADP
bam-5962	14	18	150	150	NUM
bam-5962	14	19	-	-	SYM
bam-5962	14	20	300	300	NUM
bam-5962	14	21	per	per	ADP
bam-5962	14	22	1,000,000	1,000,000	NUM
bam-5962	14	23	individuals	individual	NOUN
bam-5962	14	24	.	.	PUNCT
bam-5962	15	1	1,2	1,2	NUM
bam-5962	15	2	mg	mg	NOUN
bam-5962	15	3	has	have	VERB
bam-5962	15	4	a	a	DET
bam-5962	15	5	postsynaptic	postsynaptic	ADJ
bam-5962	15	6	defect	defect	NOUN
bam-5962	15	7	of	of	ADP
bam-5962	15	8	neuromuscular	neuromuscular	ADJ
bam-5962	15	9	transmission	transmission	NOUN
bam-5962	15	10	as	as	ADP
bam-5962	15	11	the	the	DET
bam-5962	15	12	common	common	ADJ
bam-5962	15	13	feature	feature	NOUN
bam-5962	15	14	.	.	PUNCT
bam-5962	16	1	the	the	DET
bam-5962	16	2	characteristic	characteristic	ADJ
bam-5962	16	3	symptoms	symptom	NOUN
bam-5962	16	4	are	be	AUX
bam-5962	16	5	fatigability	fatigability	NOUN
bam-5962	16	6	and	and	CCONJ
bam-5962	16	7	focal	focal	ADJ
bam-5962	16	8	or	or	CCONJ
bam-5962	16	9	generalized	generalized	ADJ
bam-5962	16	10	muscle	muscle	NOUN
bam-5962	16	11	weakness	weakness	NOUN
bam-5962	16	12	that	that	SCONJ
bam-5962	16	13	usually	usually	ADV
bam-5962	16	14	effects	effect	VERB
bam-5962	16	15	the	the	DET
bam-5962	16	16	ocular	ocular	ADJ
bam-5962	16	17	,	,	PUNCT
bam-5962	16	18	bulbar	bulbar	NOUN
bam-5962	16	19	and	and	CCONJ
bam-5962	16	20	proximal	proximal	ADJ
bam-5962	16	21	extremity	extremity	NOUN
bam-5962	16	22	muscles	muscle	NOUN
bam-5962	16	23	.	.	PUNCT
bam-5962	17	1	3	3	NUM
bam-5962	17	2	-	-	SYM
bam-5962	17	3	6	6	NUM
bam-5962	17	4	anti	anti	ADJ
bam-5962	17	5	-	-	ADJ
bam-5962	17	6	acetylcholine	acetylcholine	ADJ
bam-5962	17	7	receptor	receptor	NOUN
bam-5962	17	8	(	(	PUNCT
bam-5962	17	9	achr	achr	NOUN
bam-5962	17	10	)	)	PUNCT
bam-5962	17	11	antibodies	antibodie	VERB
bam-5962	17	12	can	can	AUX
bam-5962	17	13	be	be	AUX
bam-5962	17	14	detected	detect	VERB
bam-5962	17	15	in	in	ADP
bam-5962	17	16	70	70	NUM
bam-5962	17	17	%	%	NOUN
bam-5962	17	18	of	of	ADP
bam-5962	17	19	all	all	PRON
bam-5962	17	20	mg	mg	NOUN
bam-5962	17	21	patients.3	patients.3	VERB
bam-5962	17	22	-	-	PUNCT
bam-5962	17	23	6	6	NUM
bam-5962	17	24	autoantibodies	autoantibody	NOUN
bam-5962	17	25	against	against	ADP
bam-5962	17	26	the	the	DET
bam-5962	17	27	muscle	muscle	NOUN
bam-5962	17	28	specific	specific	ADJ
bam-5962	17	29	kinase	kinase	NOUN
bam-5962	17	30	(	(	PUNCT
bam-5962	17	31	musk	musk	ADJ
bam-5962	17	32	)	)	PUNCT
bam-5962	17	33	or	or	CCONJ
bam-5962	17	34	against	against	ADP
bam-5962	17	35	the	the	DET
bam-5962	17	36	low	low	ADJ
bam-5962	17	37	-	-	PUNCT
bam-5962	17	38	density	density	NOUN
bam-5962	17	39	lipoprotein	lipoprotein	ADJ
bam-5962	17	40	receptor	receptor	NOUN
bam-5962	17	41	-	-	PUNCT
bam-5962	17	42	related	relate	VERB
bam-5962	17	43	protein	protein	NOUN
bam-5962	17	44	4	4	NUM
bam-5962	17	45	(	(	PUNCT
bam-5962	17	46	lrp4	lrp4	PROPN
bam-5962	17	47	)	)	PUNCT
bam-5962	17	48	are	be	AUX
bam-5962	17	49	less	less	ADV
bam-5962	17	50	common	common	ADJ
bam-5962	17	51	.	.	PUNCT
bam-5962	18	1	patients	patient	NOUN
bam-5962	18	2	with	with	ADP
bam-5962	18	3	mg	mg	PROPN
bam-5962	19	1	but	but	CCONJ
bam-5962	19	2	no	no	DET
bam-5962	19	3	positive	positive	ADJ
bam-5962	19	4	test	test	NOUN
bam-5962	19	5	results	result	NOUN
bam-5962	19	6	for	for	ADP
bam-5962	19	7	antiachr	antiachr	NOUN
bam-5962	19	8	,	,	PUNCT
bam-5962	19	9	anti	anti	ADJ
bam-5962	19	10	-	-	ADJ
bam-5962	19	11	musk	musk	ADJ
bam-5962	19	12	or	or	CCONJ
bam-5962	19	13	anti	anti	ADJ
bam-5962	19	14	-	-	ADJ
bam-5962	19	15	lrp4	lrp4	ADJ
bam-5962	19	16	antibodies	antibody	NOUN
bam-5962	19	17	are	be	AUX
bam-5962	19	18	characterized	characterize	VERB
bam-5962	19	19	as	as	ADP
bam-5962	19	20	having	have	VERB
bam-5962	19	21	seronegative	seronegative	ADJ
bam-5962	19	22	mg	mg	ADP
bam-5962	19	23	,	,	PUNCT
bam-5962	19	24	although	although	SCONJ
bam-5962	19	25	a	a	DET
bam-5962	19	26	still	still	ADV
bam-5962	19	27	growing	grow	VERB
bam-5962	19	28	number	number	NOUN
bam-5962	19	29	of	of	ADP
bam-5962	19	30	autoantibodies	autoantibody	NOUN
bam-5962	19	31	are	be	AUX
bam-5962	19	32	detected	detect	VERB
bam-5962	19	33	in	in	ADP
bam-5962	19	34	patients	patient	NOUN
bam-5962	19	35	with	with	ADP
bam-5962	19	36	mg	mg	PROPN
bam-5962	19	37	,	,	PUNCT
bam-5962	19	38	for	for	ADP
bam-5962	19	39	example	example	NOUN
bam-5962	19	40	anti	anti	ADJ
bam-5962	19	41	-	-	ADJ
bam-5962	19	42	titin	titin	ADJ
bam-5962	19	43	,	,	PUNCT
bam-5962	19	44	anti	anti	ADJ
bam-5962	19	45	-	-	ADJ
bam-5962	19	46	agrin	agrin	ADJ
bam-5962	19	47	or	or	CCONJ
bam-5962	19	48	anti	anti	ADJ
bam-5962	19	49	voltage	voltage	NOUN
bam-5962	19	50	-	-	PUNCT
bam-5962	19	51	gated	gate	VERB
bam-5962	19	52	potassium	potassium	NOUN
bam-5962	19	53	channel	channel	NOUN
bam-5962	19	54	antibodies	antibodie	VERB
bam-5962	19	55	(	(	PUNCT
bam-5962	19	56	kv1.4	kv1.4	PROPN
bam-5962	19	57	)	)	PUNCT
bam-5962	19	58	.	.	PUNCT
bam-5962	20	1	7	7	NUM
bam-5962	20	2	therapeutic	therapeutic	ADJ
bam-5962	20	3	strategies	strategy	NOUN
bam-5962	20	4	include	include	VERB
bam-5962	20	5	symptomatic	symptomatic	ADJ
bam-5962	20	6	pharmacological	pharmacological	ADJ
bam-5962	20	7	treatment	treatment	NOUN
bam-5962	20	8	(	(	PUNCT
bam-5962	20	9	i.e.	i.e.	X
bam-5962	20	10	acetylcholinesterase	acetylcholinesterase	NOUN
bam-5962	20	11	inhibitor	inhibitor	PROPN
bam-5962	20	12	pyridostigmine	pyridostigmine	PROPN
bam-5962	20	13	)	)	PUNCT
bam-5962	20	14	,	,	PUNCT
bam-5962	20	15	immunomodulatory	immunomodulatory	ADJ
bam-5962	20	16	pharmacological	pharmacological	NOUN
bam-5962	20	17	treatment	treatment	NOUN
bam-5962	20	18	(	(	PUNCT
bam-5962	20	19	i.e.	i.e.	X
bam-5962	20	20	prednisolone	prednisolone	PROPN
bam-5962	20	21	,	,	PUNCT
bam-5962	20	22	azathioprine	azathioprine	NOUN
bam-5962	20	23	,	,	PUNCT
bam-5962	20	24	mycophenolate	mycophenolate	PROPN
bam-5962	20	25	mofetil	mofetil	PROPN
bam-5962	20	26	)	)	PUNCT
bam-5962	20	27	,	,	PUNCT
bam-5962	20	28	thymectomy	thymectomy	NOUN
bam-5962	20	29	,	,	PUNCT
bam-5962	20	30	plasma	plasma	NOUN
bam-5962	20	31	exchange	exchange	NOUN
bam-5962	20	32	and	and	CCONJ
bam-5962	20	33	supportive	supportive	ADJ
bam-5962	20	34	treatment	treatment	NOUN
bam-5962	20	35	.	.	PUNCT
bam-5962	21	1	4,8	4,8	NUM
bam-5962	21	2	presynaptic	presynaptic	ADJ
bam-5962	21	3	affection	affection	NOUN
bam-5962	21	4	by	by	ADP
bam-5962	21	5	autoimmune	autoimmune	ADJ
bam-5962	21	6	ion	ion	NOUN
bam-5962	21	7	channel	channel	NOUN
bam-5962	21	8	blockade	blockade	NOUN
bam-5962	21	9	defines	define	VERB
bam-5962	21	10	lambert	lambert	PROPN
bam-5962	21	11	-	-	PUNCT
bam-5962	21	12	eaton	eaton	PROPN
bam-5962	21	13	myasthenic	myasthenic	PROPN
bam-5962	21	14	syndrome	syndrome	NOUN
bam-5962	21	15	(	(	PUNCT
bam-5962	21	16	lems	lem	NOUN
bam-5962	21	17	)	)	PUNCT
bam-5962	21	18	.	.	PUNCT
bam-5962	22	1	9	9	NUM
bam-5962	22	2	antibodies	antibodie	VERB
bam-5962	22	3	against	against	ADP
bam-5962	22	4	the	the	DET
bam-5962	22	5	p	p	NOUN
bam-5962	22	6	/	/	SYM
bam-5962	22	7	q	q	ADJ
bam-5962	22	8	-	-	PUNCT
bam-5962	22	9	type	type	NOUN
bam-5962	22	10	voltage	voltage	NOUN
bam-5962	22	11	-	-	PUNCT
bam-5962	22	12	gated	gate	VERB
bam-5962	22	13	calcium	calcium	NOUN
bam-5962	22	14	channel	channel	NOUN
bam-5962	22	15	(	(	PUNCT
bam-5962	22	16	vgcc	vgcc	PROPN
bam-5962	22	17	)	)	PUNCT
bam-5962	22	18	are	be	AUX
bam-5962	22	19	detectable	detectable	ADJ
bam-5962	22	20	in	in	ADP
bam-5962	22	21	85	85	NUM
bam-5962	22	22	%	%	NOUN
bam-5962	22	23	of	of	ADP
bam-5962	22	24	the	the	DET
bam-5962	22	25	patients	patient	NOUN
bam-5962	22	26	with	with	ADP
bam-5962	22	27	lems.10	lems.10	VERB
bam-5962	22	28	characteristic	characteristic	ADJ
bam-5962	22	29	symptoms	symptom	NOUN
bam-5962	22	30	of	of	ADP
bam-5962	22	31	lems	lem	NOUN
bam-5962	22	32	are	be	AUX
bam-5962	22	33	an	an	DET
bam-5962	22	34	ascending	ascend	VERB
bam-5962	22	35	muscle	muscle	NOUN
bam-5962	22	36	weakness	weakness	NOUN
bam-5962	22	37	starting	start	VERB
bam-5962	22	38	with	with	ADP
bam-5962	22	39	the	the	DET
bam-5962	22	40	lower	low	ADJ
bam-5962	22	41	proximal	proximal	ADJ
bam-5962	22	42	limb	limb	NOUN
bam-5962	22	43	muscles	muscle	NOUN
bam-5962	22	44	and	and	CCONJ
bam-5962	22	45	autonomic	autonomic	ADJ
bam-5962	22	46	dysfunction	dysfunction	NOUN
bam-5962	22	47	.	.	PUNCT
bam-5962	23	1	ptosis	ptosis	NOUN
bam-5962	23	2	and	and	CCONJ
bam-5962	23	3	ophthalmoplegia	ophthalmoplegia	NOUN
bam-5962	23	4	are	be	AUX
bam-5962	23	5	less	less	ADV
bam-5962	23	6	common	common	ADJ
bam-5962	23	7	compared	compare	VERB
bam-5962	23	8	to	to	ADP
bam-5962	23	9	mg	mg	PROPN
bam-5962	23	10	,	,	PUNCT
bam-5962	23	11	and	and	CCONJ
bam-5962	23	12	respiratory	respiratory	ADJ
bam-5962	23	13	muscle	muscle	NOUN
bam-5962	23	14	failure	failure	NOUN
bam-5962	23	15	is	be	AUX
bam-5962	23	16	not	not	PART
bam-5962	23	17	typical	typical	ADJ
bam-5962	23	18	.	.	PUNCT
bam-5962	24	1	11	11	NUM
bam-5962	24	2	first	first	ADJ
bam-5962	24	3	-	-	PUNCT
bam-5962	24	4	line	line	NOUN
bam-5962	24	5	treatment	treatment	NOUN
bam-5962	24	6	of	of	ADP
bam-5962	24	7	lems	lem	NOUN
bam-5962	24	8	is	be	AUX
bam-5962	24	9	3,4	3,4	NUM
bam-5962	24	10	-	-	PUNCT
bam-5962	24	11	diaminopyridine,12	diaminopyridine,12	NOUN
bam-5962	24	12	which	which	PRON
bam-5962	24	13	inhibits	inhibit	VERB
bam-5962	24	14	presynaptic	presynaptic	ADJ
bam-5962	24	15	potassium	potassium	NOUN
bam-5962	24	16	channels	channel	NOUN
bam-5962	24	17	and	and	CCONJ
bam-5962	24	18	,	,	PUNCT
bam-5962	24	19	thus	thus	ADV
bam-5962	24	20	,	,	PUNCT
bam-5962	24	21	increases	increase	VERB
bam-5962	24	22	levels	level	NOUN
bam-5962	24	23	of	of	ADP
bam-5962	24	24	non	non	ADJ
bam-5962	24	25	co	co	PROPN
bam-5962	24	26	mmerc	mmerc	PROPN
bam-5962	24	27	ial	ial	PROPN
bam-5962	24	28	us	us	PROPN
bam-5962	24	29	e	e	NOUN
bam-5962	24	30	o	o	NOUN
bam-5962	24	31	nly	nly	ADV
bam-5962	24	32	clinical	clinical	ADJ
bam-5962	24	33	features	feature	NOUN
bam-5962	24	34	of	of	ADP
bam-5962	24	35	n	n	CCONJ
bam-5962	24	36	-	-	PUNCT
bam-5962	24	37	type	type	NOUN
bam-5962	24	38	vgcc	vgcc	NOUN
bam-5962	24	39	neuromuscular	neuromuscular	ADJ
bam-5962	24	40	syndromes	syndrome	NOUN
bam-5962	25	1	eur	eur	PROPN
bam-5962	25	2	j	j	PROPN
bam-5962	25	3	transl	transl	PROPN
bam-5962	25	4	myol	myol	NOUN
bam-5962	25	5	26	26	NUM
bam-5962	25	6	(	(	PUNCT
bam-5962	25	7	4	4	NUM
bam-5962	25	8	):	):	PUNCT
bam-5962	25	9	301	301	NUM
bam-5962	25	10	-	-	SYM
bam-5962	25	11	306	306	NUM
bam-5962	25	12	302	302	NUM
bam-5962	25	13	acetylcholine	acetylcholine	NOUN
bam-5962	25	14	.	.	PUNCT
bam-5962	26	1	pyridostigmine	pyridostigmine	NOUN
bam-5962	26	2	and	and	CCONJ
bam-5962	26	3	intravenous	intravenous	ADJ
bam-5962	26	4	immunoglobulins	immunoglobulin	NOUN
bam-5962	26	5	have	have	VERB
bam-5962	26	6	less	less	ADJ
bam-5962	26	7	effect	effect	NOUN
bam-5962	26	8	.	.	PUNCT
bam-5962	27	1	in	in	ADP
bam-5962	27	2	the	the	DET
bam-5962	27	3	last	last	ADJ
bam-5962	27	4	decades	decade	NOUN
bam-5962	27	5	,	,	PUNCT
bam-5962	27	6	several	several	ADJ
bam-5962	27	7	autoimmune	autoimmune	ADJ
bam-5962	27	8	antibodies	antibody	NOUN
bam-5962	27	9	were	be	AUX
bam-5962	27	10	detected	detect	VERB
bam-5962	27	11	in	in	ADP
bam-5962	27	12	patients	patient	NOUN
bam-5962	27	13	with	with	ADP
bam-5962	27	14	mg	mg	NOUN
bam-5962	27	15	and	and	CCONJ
bam-5962	27	16	lems	lem	NOUN
bam-5962	27	17	although	although	SCONJ
bam-5962	27	18	clinical	clinical	ADJ
bam-5962	27	19	distinction	distinction	NOUN
bam-5962	27	20	has	have	AUX
bam-5962	27	21	not	not	PART
bam-5962	27	22	yet	yet	ADV
bam-5962	27	23	been	be	AUX
bam-5962	27	24	made	make	VERB
bam-5962	27	25	.	.	PUNCT
bam-5962	28	1	7,13,14	7,13,14	NUM
bam-5962	28	2	recently	recently	ADV
bam-5962	28	3	the	the	DET
bam-5962	28	4	existence	existence	NOUN
bam-5962	28	5	of	of	ADP
bam-5962	28	6	a	a	DET
bam-5962	28	7	myasthenia	myasthenia	NOUN
bam-5962	28	8	gravis	gravis	PROPN
bam-5962	28	9	lambert	lambert	PROPN
bam-5962	28	10	-	-	PUNCT
bam-5962	28	11	eaton	eaton	PROPN
bam-5962	28	12	overlap	overlap	PROPN
bam-5962	28	13	syndrome	syndrome	NOUN
bam-5962	28	14	(	(	PUNCT
bam-5962	28	15	mlos	mlo	NOUN
bam-5962	28	16	)	)	PUNCT
bam-5962	28	17	was	be	AUX
bam-5962	28	18	reported	report	VERB
bam-5962	28	19	.	.	PUNCT
bam-5962	29	1	15	15	NUM
bam-5962	29	2	we	we	PRON
bam-5962	29	3	present	present	VERB
bam-5962	29	4	a	a	DET
bam-5962	29	5	case	case	NOUN
bam-5962	29	6	series	series	NOUN
bam-5962	29	7	with	with	ADP
bam-5962	29	8	myasthenic	myasthenic	ADJ
bam-5962	29	9	syndrome	syndrome	NOUN
bam-5962	29	10	with	with	ADP
bam-5962	29	11	marked	mark	VERB
bam-5962	29	12	dropped	drop	VERB
bam-5962	29	13	head	head	NOUN
bam-5962	29	14	syndrome	syndrome	NOUN
bam-5962	29	15	,	,	PUNCT
bam-5962	29	16	dysphagia	dysphagia	NOUN
bam-5962	29	17	and	and	CCONJ
bam-5962	29	18	dysarthria	dysarthria	NOUN
bam-5962	29	19	as	as	ADP
bam-5962	29	20	a	a	DET
bam-5962	29	21	common	common	ADJ
bam-5962	29	22	feature	feature	NOUN
bam-5962	29	23	.	.	PUNCT
bam-5962	30	1	all	all	DET
bam-5962	30	2	patients	patient	NOUN
bam-5962	30	3	have	have	VERB
bam-5962	30	4	electrophysiological	electrophysiological	ADJ
bam-5962	30	5	features	feature	NOUN
bam-5962	30	6	of	of	ADP
bam-5962	30	7	mg	mg	PRON
bam-5962	30	8	and	and	CCONJ
bam-5962	30	9	were	be	AUX
bam-5962	30	10	tested	test	VERB
bam-5962	30	11	positive	positive	ADJ
bam-5962	30	12	for	for	ADP
bam-5962	30	13	anti	anti	ADJ
bam-5962	30	14	-	-	ADJ
bam-5962	30	15	vgcc	vgcc	ADJ
bam-5962	30	16	n	n	NOUN
bam-5962	30	17	-	-	PUNCT
bam-5962	30	18	type	type	NOUN
bam-5962	30	19	but	but	CCONJ
bam-5962	30	20	not	not	PART
bam-5962	30	21	p	p	X
bam-5962	30	22	/	/	SYM
bam-5962	30	23	q	q	ADJ
bam-5962	30	24	-	-	PUNCT
bam-5962	30	25	type	type	NOUN
bam-5962	30	26	antibodies	antibody	NOUN
bam-5962	30	27	.	.	PUNCT
bam-5962	31	1	case	case	NOUN
bam-5962	31	2	reports	report	VERB
bam-5962	31	3	patients	patient	NOUN
bam-5962	31	4	,	,	PUNCT
bam-5962	31	5	methods	method	NOUN
bam-5962	31	6	,	,	PUNCT
bam-5962	31	7	results	result	VERB
bam-5962	31	8	patient	patient	ADJ
bam-5962	31	9	#	#	SYM
bam-5962	31	10	1	1	NUM
bam-5962	31	11	a	a	DET
bam-5962	31	12	71	71	NUM
bam-5962	31	13	-	-	PUNCT
bam-5962	31	14	year	year	NOUN
bam-5962	31	15	old	old	ADJ
bam-5962	31	16	male	male	ADJ
bam-5962	31	17	caucasian	caucasian	NOUN
bam-5962	31	18	presented	present	VERB
bam-5962	31	19	in	in	ADP
bam-5962	31	20	2013	2013	NUM
bam-5962	31	21	with	with	ADP
bam-5962	31	22	myasthenic	myasthenic	ADJ
bam-5962	31	23	syndrome	syndrome	NOUN
bam-5962	31	24	and	and	CCONJ
bam-5962	31	25	rapidly	rapidly	ADV
bam-5962	31	26	progressive	progressive	ADJ
bam-5962	31	27	proximal	proximal	ADJ
bam-5962	31	28	tetraparesis	tetraparesis	NOUN
bam-5962	31	29	,	,	PUNCT
bam-5962	31	30	dropped	drop	VERB
bam-5962	31	31	head	head	NOUN
bam-5962	31	32	syndrome	syndrome	NOUN
bam-5962	31	33	and	and	CCONJ
bam-5962	31	34	dysphagia	dysphagia	NOUN
bam-5962	31	35	.	.	PUNCT
bam-5962	32	1	weeks	week	NOUN
bam-5962	32	2	before	before	ADV
bam-5962	32	3	,	,	PUNCT
bam-5962	32	4	a	a	DET
bam-5962	32	5	neurological	neurological	ADJ
bam-5962	32	6	outpatient	outpatient	NOUN
bam-5962	32	7	clinic	clinic	NOUN
bam-5962	32	8	reported	report	VERB
bam-5962	32	9	beginning	begin	VERB
bam-5962	32	10	dysphagia	dysphagia	NOUN
bam-5962	32	11	and	and	CCONJ
bam-5962	32	12	slight	slight	ADJ
bam-5962	32	13	proximal	proximal	ADJ
bam-5962	32	14	paraparesis	paraparesis	NOUN
bam-5962	32	15	.	.	PUNCT
bam-5962	33	1	anti	anti	ADJ
bam-5962	33	2	-	-	ADJ
bam-5962	33	3	achr	achr	ADJ
bam-5962	33	4	antibodies	antibody	NOUN
bam-5962	33	5	were	be	AUX
bam-5962	33	6	elevated	elevate	VERB
bam-5962	33	7	(	(	PUNCT
bam-5962	33	8	0.53nmol	0.53nmol	PROPN
bam-5962	33	9	/	/	SYM
bam-5962	33	10	l	l	NOUN
bam-5962	33	11	,	,	PUNCT
bam-5962	33	12	reference	reference	NOUN
bam-5962	33	13	value	value	NOUN
bam-5962	33	14	<	<	X
bam-5962	33	15	0.40nmol	0.40nmol	PROPN
bam-5962	33	16	/	/	SYM
bam-5962	33	17	l	l	NOUN
bam-5962	33	18	)	)	PUNCT
bam-5962	33	19	but	but	CCONJ
bam-5962	33	20	no	no	DET
bam-5962	33	21	pathological	pathological	ADJ
bam-5962	33	22	decrement	decrement	NOUN
bam-5962	33	23	of	of	ADP
bam-5962	33	24	the	the	DET
bam-5962	33	25	orbicular	orbicular	ADJ
bam-5962	33	26	and	and	CCONJ
bam-5962	33	27	trapezius	trapezius	ADJ
bam-5962	33	28	muscle	muscle	NOUN
bam-5962	33	29	was	be	AUX
bam-5962	33	30	measured	measure	VERB
bam-5962	33	31	and	and	CCONJ
bam-5962	33	32	no	no	PRON
bam-5962	33	33	diurnal	diurnal	ADJ
bam-5962	33	34	or	or	CCONJ
bam-5962	33	35	exercise	exercise	VERB
bam-5962	33	36	dependent	dependent	ADJ
bam-5962	33	37	weakness	weakness	NOUN
bam-5962	33	38	was	be	AUX
bam-5962	33	39	noted	note	VERB
bam-5962	33	40	in	in	ADP
bam-5962	33	41	the	the	DET
bam-5962	33	42	repetitive	repetitive	ADJ
bam-5962	33	43	nerve	nerve	NOUN
bam-5962	33	44	stimulation	stimulation	NOUN
bam-5962	33	45	test	test	NOUN
bam-5962	33	46	.	.	PUNCT
bam-5962	34	1	the	the	DET
bam-5962	34	2	electromyography	electromyography	NOUN
bam-5962	34	3	(	(	PUNCT
bam-5962	34	4	emg	emg	NOUN
bam-5962	34	5	)	)	PUNCT
bam-5962	34	6	and	and	CCONJ
bam-5962	34	7	nerve	nerve	NOUN
bam-5962	34	8	conduction	conduction	NOUN
bam-5962	34	9	studies	study	NOUN
bam-5962	34	10	(	(	PUNCT
bam-5962	34	11	ncs	ncs	PROPN
bam-5962	34	12	)	)	PUNCT
bam-5962	34	13	were	be	AUX
bam-5962	34	14	normal	normal	ADJ
bam-5962	34	15	.	.	PUNCT
bam-5962	35	1	the	the	DET
bam-5962	35	2	patient	patient	NOUN
bam-5962	35	3	was	be	AUX
bam-5962	35	4	admitted	admit	VERB
bam-5962	35	5	to	to	ADP
bam-5962	35	6	the	the	DET
bam-5962	35	7	department	department	NOUN
bam-5962	35	8	of	of	ADP
bam-5962	35	9	gastroenterology	gastroenterology	NOUN
bam-5962	35	10	for	for	ADP
bam-5962	35	11	diagnosis	diagnosis	NOUN
bam-5962	35	12	and	and	CCONJ
bam-5962	35	13	treatment	treatment	NOUN
bam-5962	35	14	of	of	ADP
bam-5962	35	15	recurrent	recurrent	ADJ
bam-5962	35	16	diarrhea	diarrhea	NOUN
bam-5962	35	17	and	and	CCONJ
bam-5962	35	18	thrombocytopenia	thrombocytopenia	NOUN
bam-5962	35	19	and	and	CCONJ
bam-5962	35	20	a	a	DET
bam-5962	35	21	weight	weight	NOUN
bam-5962	35	22	loss	loss	NOUN
bam-5962	35	23	(	(	PUNCT
bam-5962	35	24	20	20	NUM
bam-5962	35	25	kg	kg	NOUN
bam-5962	35	26	)	)	PUNCT
bam-5962	35	27	.	.	PUNCT
bam-5962	36	1	at	at	ADP
bam-5962	36	2	this	this	DET
bam-5962	36	3	point	point	NOUN
bam-5962	36	4	,	,	PUNCT
bam-5962	36	5	the	the	DET
bam-5962	36	6	patient	patient	NOUN
bam-5962	36	7	developed	develop	VERB
bam-5962	36	8	a	a	DET
bam-5962	36	9	rapidly	rapidly	ADV
bam-5962	36	10	progressive	progressive	ADJ
bam-5962	36	11	severe	severe	ADJ
bam-5962	36	12	tetraparesis	tetraparesis	NOUN
bam-5962	36	13	with	with	ADP
bam-5962	36	14	affection	affection	NOUN
bam-5962	36	15	of	of	ADP
bam-5962	36	16	the	the	DET
bam-5962	36	17	upper	upper	ADJ
bam-5962	36	18	limbs	limb	NOUN
bam-5962	36	19	more	more	ADJ
bam-5962	36	20	than	than	ADP
bam-5962	36	21	the	the	DET
bam-5962	36	22	lower	low	ADJ
bam-5962	36	23	limbs	limb	NOUN
bam-5962	36	24	,	,	PUNCT
bam-5962	36	25	with	with	ADP
bam-5962	36	26	dropped	drop	VERB
bam-5962	36	27	-	-	PUNCT
bam-5962	36	28	head	head	NOUN
bam-5962	36	29	syndrome	syndrome	NOUN
bam-5962	36	30	and	and	CCONJ
bam-5962	36	31	dysphagia	dysphagia	NOUN
bam-5962	36	32	.	.	PUNCT
bam-5962	37	1	deep	deep	ADJ
bam-5962	37	2	tendon	tendon	NOUN
bam-5962	37	3	reflexes	reflex	NOUN
bam-5962	37	4	were	be	AUX
bam-5962	37	5	slightly	slightly	ADV
bam-5962	37	6	reduced	reduce	VERB
bam-5962	37	7	.	.	PUNCT
bam-5962	38	1	the	the	DET
bam-5962	38	2	origin	origin	NOUN
bam-5962	38	3	of	of	ADP
bam-5962	38	4	the	the	DET
bam-5962	38	5	diarrhea	diarrhea	NOUN
bam-5962	38	6	could	could	AUX
bam-5962	38	7	not	not	PART
bam-5962	38	8	be	be	AUX
bam-5962	38	9	clarified	clarify	VERB
bam-5962	38	10	.	.	PUNCT
bam-5962	39	1	he	he	PRON
bam-5962	39	2	was	be	AUX
bam-5962	39	3	transferred	transfer	VERB
bam-5962	39	4	to	to	ADP
bam-5962	39	5	our	our	PRON
bam-5962	39	6	intensive	intensive	ADJ
bam-5962	39	7	care	care	NOUN
bam-5962	39	8	unit	unit	NOUN
bam-5962	39	9	with	with	ADP
bam-5962	39	10	aspiration	aspiration	NOUN
bam-5962	39	11	pneumonia	pneumonia	NOUN
bam-5962	39	12	and	and	CCONJ
bam-5962	39	13	acute	acute	ADJ
bam-5962	39	14	respiratory	respiratory	ADJ
bam-5962	39	15	insufficiency	insufficiency	NOUN
bam-5962	39	16	due	due	ADP
bam-5962	39	17	to	to	ADP
bam-5962	39	18	respiratory	respiratory	ADJ
bam-5962	39	19	muscle	muscle	NOUN
bam-5962	39	20	weakness	weakness	NOUN
bam-5962	39	21	.	.	PUNCT
bam-5962	40	1	the	the	DET
bam-5962	40	2	patient	patient	NOUN
bam-5962	40	3	was	be	AUX
bam-5962	40	4	intubated	intubate	VERB
bam-5962	40	5	,	,	PUNCT
bam-5962	40	6	later	later	ADV
bam-5962	40	7	on	on	ADP
bam-5962	40	8	tracheostomized	tracheostomize	VERB
bam-5962	40	9	,	,	PUNCT
bam-5962	40	10	and	and	CCONJ
bam-5962	40	11	sepsis	sepsis	NOUN
bam-5962	40	12	was	be	AUX
bam-5962	40	13	treated	treat	VERB
bam-5962	40	14	with	with	ADP
bam-5962	40	15	empirical	empirical	ADJ
bam-5962	40	16	antibiotics	antibiotic	NOUN
bam-5962	40	17	.	.	PUNCT
bam-5962	41	1	a	a	DET
bam-5962	41	2	retest	retest	NOUN
bam-5962	41	3	of	of	ADP
bam-5962	41	4	the	the	DET
bam-5962	41	5	repetitive	repetitive	ADJ
bam-5962	41	6	nerve	nerve	NOUN
bam-5962	41	7	stimulation	stimulation	NOUN
bam-5962	41	8	of	of	ADP
bam-5962	41	9	the	the	DET
bam-5962	41	10	n.	n.	PROPN
bam-5962	41	11	accessories	accessory	NOUN
bam-5962	41	12	now	now	ADV
bam-5962	41	13	showed	show	VERB
bam-5962	41	14	a	a	DET
bam-5962	41	15	pathological	pathological	ADJ
bam-5962	41	16	decrement	decrement	NOUN
bam-5962	41	17	(	(	PUNCT
bam-5962	41	18	>	>	SYM
bam-5962	41	19	50	50	NUM
bam-5962	41	20	%	%	NOUN
bam-5962	41	21	reduction	reduction	NOUN
bam-5962	41	22	of	of	ADP
bam-5962	41	23	amplitude	amplitude	NOUN
bam-5962	41	24	)	)	PUNCT
bam-5962	41	25	using	use	VERB
bam-5962	41	26	the	the	DET
bam-5962	41	27	3hz	3hz	ADJ
bam-5962	41	28	-	-	PUNCT
bam-5962	41	29	stimulation	stimulation	NOUN
bam-5962	41	30	and	and	CCONJ
bam-5962	41	31	an	an	DET
bam-5962	41	32	increment	increment	NOUN
bam-5962	41	33	using	use	VERB
bam-5962	41	34	a	a	DET
bam-5962	41	35	fig	fig	NOUN
bam-5962	41	36	1	1	NUM
bam-5962	41	37	.	.	PUNCT
bam-5962	41	38	muscle	muscle	NOUN
bam-5962	41	39	biopsy	biopsy	NOUN
bam-5962	41	40	of	of	ADP
bam-5962	41	41	patient	patient	NOUN
bam-5962	41	42	#	#	SYM
bam-5962	41	43	1	1	NUM
bam-5962	41	44	with	with	ADP
bam-5962	41	45	unspecific	unspecific	ADJ
bam-5962	41	46	signs	sign	NOUN
bam-5962	41	47	of	of	ADP
bam-5962	41	48	mild	mild	ADJ
bam-5962	41	49	to	to	ADP
bam-5962	41	50	moderate	moderate	ADJ
bam-5962	41	51	myopathy	myopathy	ADJ
bam-5962	41	52	.	.	PUNCT
bam-5962	42	1	no	no	DET
bam-5962	42	2	significant	significant	ADJ
bam-5962	42	3	inflammatory	inflammatory	ADJ
bam-5962	42	4	infiltrates	infiltrate	NOUN
bam-5962	42	5	are	be	AUX
bam-5962	42	6	detectable	detectable	ADJ
bam-5962	42	7	.	.	PUNCT
bam-5962	43	1	non	non	PROPN
bam-5962	43	2	co	co	PROPN
bam-5962	43	3	mmerc	mmerc	PROPN
bam-5962	43	4	ial	ial	PROPN
bam-5962	43	5	us	us	PROPN
bam-5962	43	6	e	e	NOUN
bam-5962	43	7	o	o	NOUN
bam-5962	43	8	nly	nly	ADV
bam-5962	43	9	clinical	clinical	ADJ
bam-5962	43	10	features	feature	NOUN
bam-5962	43	11	of	of	ADP
bam-5962	43	12	n	n	CCONJ
bam-5962	43	13	-	-	PUNCT
bam-5962	43	14	type	type	NOUN
bam-5962	43	15	vgcc	vgcc	NOUN
bam-5962	43	16	neuromuscular	neuromuscular	ADJ
bam-5962	43	17	syndromes	syndrome	NOUN
bam-5962	43	18	eur	eur	PROPN
bam-5962	43	19	j	j	PROPN
bam-5962	43	20	transl	transl	PROPN
bam-5962	43	21	myol	myol	NOUN
bam-5962	43	22	26	26	NUM
bam-5962	43	23	(	(	PUNCT
bam-5962	43	24	4	4	NUM
bam-5962	43	25	):	):	PUNCT
bam-5962	43	26	301	301	NUM
bam-5962	43	27	-	-	SYM
bam-5962	43	28	306	306	NUM
bam-5962	43	29	303	303	NUM
bam-5962	43	30	30hz	30hz	NOUN
bam-5962	43	31	(	(	PUNCT
bam-5962	43	32	>	>	SYM
bam-5962	43	33	60	60	NUM
bam-5962	43	34	%	%	NOUN
bam-5962	43	35	increase	increase	NOUN
bam-5962	43	36	of	of	ADP
bam-5962	43	37	the	the	DET
bam-5962	43	38	amplitude	amplitude	NOUN
bam-5962	43	39	)	)	PUNCT
bam-5962	43	40	.	.	PUNCT
bam-5962	44	1	muscle	muscle	NOUN
bam-5962	44	2	biopsy	biopsy	PROPN
bam-5962	44	3	found	find	VERB
bam-5962	44	4	unspecific	unspecific	ADJ
bam-5962	44	5	diffuse	diffuse	ADJ
bam-5962	44	6	atrophy	atrophy	NOUN
bam-5962	44	7	of	of	ADP
bam-5962	44	8	the	the	DET
bam-5962	44	9	muscle	muscle	NOUN
bam-5962	44	10	fibers	fiber	NOUN
bam-5962	44	11	but	but	CCONJ
bam-5962	44	12	no	no	DET
bam-5962	44	13	inflammatory	inflammatory	ADJ
bam-5962	44	14	infiltrates	infiltrate	NOUN
bam-5962	44	15	(	(	PUNCT
bam-5962	44	16	figure	figure	NOUN
bam-5962	44	17	1	1	NUM
bam-5962	44	18	)	)	PUNCT
bam-5962	44	19	.	.	PUNCT
bam-5962	45	1	immunohistochemical	immunohistochemical	ADJ
bam-5962	45	2	workup	workup	PROPN
bam-5962	45	3	was	be	AUX
bam-5962	45	4	negative	negative	ADJ
bam-5962	45	5	.	.	PUNCT
bam-5962	46	1	the	the	DET
bam-5962	46	2	patient	patient	NOUN
bam-5962	46	3	was	be	AUX
bam-5962	46	4	unsuccessfully	unsuccessfully	ADV
bam-5962	46	5	treated	treat	VERB
bam-5962	46	6	with	with	ADP
bam-5962	46	7	steroids	steroid	NOUN
bam-5962	46	8	(	(	PUNCT
bam-5962	46	9	500	500	NUM
bam-5962	46	10	mg	mg	NOUN
bam-5962	46	11	prednisolone	prednisolone	NOUN
bam-5962	46	12	per	per	ADP
bam-5962	46	13	day	day	NOUN
bam-5962	46	14	over	over	ADP
bam-5962	46	15	5	5	NUM
bam-5962	46	16	days	day	NOUN
bam-5962	46	17	)	)	PUNCT
bam-5962	46	18	.	.	PUNCT
bam-5962	47	1	anti	anti	ADJ
bam-5962	47	2	-	-	ADJ
bam-5962	47	3	vgcc	vgcc	ADJ
bam-5962	47	4	n	n	NOUN
bam-5962	47	5	-	-	PUNCT
bam-5962	47	6	type	type	NOUN
bam-5962	47	7	(	(	PUNCT
bam-5962	47	8	antibody	antibody	NOUN
bam-5962	47	9	ratio	ratio	NOUN
bam-5962	47	10	41.3	41.3	NUM
bam-5962	47	11	,	,	PUNCT
bam-5962	47	12	reference	reference	NOUN
bam-5962	47	13	ratio	ratio	NOUN
bam-5962	47	14	<	<	X
bam-5962	47	15	15.0	15.0	NUM
bam-5962	47	16	;	;	PUNCT
bam-5962	47	17	radioreceptor	radioreceptor	NOUN
bam-5962	47	18	assay	assay	PROPN
bam-5962	47	19	,	,	PUNCT
bam-5962	47	20	a	a	DET
bam-5962	47	21	commercially	commercially	ADV
bam-5962	47	22	used	use	VERB
bam-5962	47	23	statistically	statistically	ADV
bam-5962	47	24	defined	define	VERB
bam-5962	47	25	endpoint	endpoint	NOUN
bam-5962	47	26	titer	titer	NOUN
bam-5962	47	27	determination	determination	NOUN
bam-5962	47	28	method	method	NOUN
bam-5962	47	29	for	for	ADP
bam-5962	47	30	immunoassays	immunoassay	NOUN
bam-5962	47	31	was	be	AUX
bam-5962	47	32	used	use	VERB
bam-5962	47	33	according	accord	VERB
bam-5962	47	34	to	to	ADP
bam-5962	47	35	frey	frey	PROPN
bam-5962	47	36	et	et	NOUN
bam-5962	47	37	al.)16	al.)16	PROPN
bam-5962	47	38	but	but	CCONJ
bam-5962	47	39	not	not	PART
bam-5962	47	40	p	p	X
bam-5962	47	41	/	/	SYM
bam-5962	47	42	q	q	NOUN
bam-5962	47	43	-	-	PUNCT
bam-5962	47	44	type	type	NOUN
bam-5962	47	45	were	be	AUX
bam-5962	47	46	detected	detect	VERB
bam-5962	47	47	.	.	PUNCT
bam-5962	48	1	anti	anti	ADJ
bam-5962	48	2	-	-	ADJ
bam-5962	48	3	titin	titin	ADJ
bam-5962	48	4	and	and	CCONJ
bam-5962	48	5	antimusk	antimusk	PROPN
bam-5962	48	6	antibodies	antibody	NOUN
bam-5962	48	7	were	be	AUX
bam-5962	48	8	negative	negative	ADJ
bam-5962	48	9	.	.	PUNCT
bam-5962	49	1	the	the	DET
bam-5962	49	2	titer	titer	NOUN
bam-5962	49	3	of	of	ADP
bam-5962	49	4	antinuclear	antinuclear	ADJ
bam-5962	49	5	antibody	antibody	NOUN
bam-5962	49	6	(	(	PUNCT
bam-5962	49	7	ana	ana	PROPN
bam-5962	49	8	)	)	PUNCT
bam-5962	49	9	was	be	AUX
bam-5962	49	10	elevated	elevate	VERB
bam-5962	49	11	(	(	PUNCT
bam-5962	49	12	>	>	X
bam-5962	49	13	1:2.000	1:2.000	NUM
bam-5962	49	14	)	)	PUNCT
bam-5962	49	15	,	,	PUNCT
bam-5962	49	16	and	and	CCONJ
bam-5962	49	17	differentiation	differentiation	NOUN
bam-5962	49	18	only	only	ADV
bam-5962	49	19	positive	positive	ADJ
bam-5962	49	20	for	for	ADP
bam-5962	49	21	anti	anti	ADJ
bam-5962	49	22	-	-	ADJ
bam-5962	49	23	sm	sm	ADJ
bam-5962	49	24	-	-	PUNCT
bam-5962	49	25	d	d	NOUN
bam-5962	49	26	-	-	NOUN
bam-5962	49	27	antibodies	antibodie	VERB
bam-5962	49	28	.	.	PUNCT
bam-5962	50	1	further	further	ADJ
bam-5962	50	2	autoantibodies	autoantibody	NOUN
bam-5962	50	3	including	include	VERB
bam-5962	50	4	myositis	myositis	NOUN
bam-5962	50	5	antibodies	antibody	NOUN
bam-5962	50	6	and	and	CCONJ
bam-5962	50	7	onconeural	onconeural	ADJ
bam-5962	50	8	antibodies	antibody	NOUN
bam-5962	50	9	were	be	AUX
bam-5962	50	10	negative	negative	ADJ
bam-5962	50	11	.	.	PUNCT
bam-5962	51	1	the	the	DET
bam-5962	51	2	patient	patient	NOUN
bam-5962	51	3	had	have	VERB
bam-5962	51	4	a	a	DET
bam-5962	51	5	history	history	NOUN
bam-5962	51	6	of	of	ADP
bam-5962	51	7	pulmonary	pulmonary	ADJ
bam-5962	51	8	sarcoidosis	sarcoidosis	NOUN
bam-5962	51	9	.	.	PUNCT
bam-5962	52	1	extended	extend	VERB
bam-5962	52	2	tumor	tumor	NOUN
bam-5962	52	3	screening	screening	NOUN
bam-5962	52	4	including	include	VERB
bam-5962	52	5	whole	whole	ADJ
bam-5962	52	6	-	-	PUNCT
bam-5962	52	7	body	body	NOUN
bam-5962	52	8	pet	pet	NOUN
bam-5962	52	9	/	/	SYM
bam-5962	52	10	ct	ct	PROPN
bam-5962	52	11	imaging	imaging	NOUN
bam-5962	52	12	,	,	PUNCT
bam-5962	52	13	and	and	CCONJ
bam-5962	52	14	screening	screen	VERB
bam-5962	52	15	for	for	ADP
bam-5962	52	16	tumor	tumor	NOUN
bam-5962	52	17	markers	marker	NOUN
bam-5962	52	18	were	be	AUX
bam-5962	52	19	negative	negative	ADJ
bam-5962	52	20	.	.	PUNCT
bam-5962	53	1	the	the	DET
bam-5962	53	2	patient	patient	NOUN
bam-5962	53	3	received	receive	VERB
bam-5962	53	4	intravenous	intravenous	ADJ
bam-5962	53	5	pyridostigmine	pyridostigmine	NOUN
bam-5962	53	6	with	with	ADP
bam-5962	53	7	initially	initially	ADV
bam-5962	53	8	little	little	ADJ
bam-5962	53	9	effect	effect	NOUN
bam-5962	53	10	,	,	PUNCT
bam-5962	53	11	intravenous	intravenous	ADJ
bam-5962	53	12	immunoglobulins	immunoglobulin	NOUN
bam-5962	53	13	(	(	PUNCT
bam-5962	53	14	35	35	NUM
bam-5962	53	15	g	g	NOUN
bam-5962	53	16	per	per	ADP
bam-5962	53	17	day	day	NOUN
bam-5962	53	18	over	over	ADP
bam-5962	53	19	5	5	NUM
bam-5962	53	20	days	day	NOUN
bam-5962	53	21	)	)	PUNCT
bam-5962	53	22	.	.	PUNCT
bam-5962	54	1	the	the	DET
bam-5962	54	2	intravenous	intravenous	ADJ
bam-5962	54	3	application	application	NOUN
bam-5962	54	4	of	of	ADP
bam-5962	54	5	immunoglobulins	immunoglobulin	NOUN
bam-5962	54	6	was	be	AUX
bam-5962	54	7	repeated	repeat	VERB
bam-5962	54	8	after	after	ADP
bam-5962	54	9	14	14	NUM
bam-5962	54	10	days	day	NOUN
bam-5962	54	11	without	without	ADP
bam-5962	54	12	significant	significant	ADJ
bam-5962	54	13	clinical	clinical	ADJ
bam-5962	54	14	improvement	improvement	NOUN
bam-5962	54	15	.	.	PUNCT
bam-5962	55	1	then	then	ADV
bam-5962	55	2	a	a	DET
bam-5962	55	3	treatment	treatment	NOUN
bam-5962	55	4	with	with	ADP
bam-5962	55	5	3,4	3,4	NUM
bam-5962	55	6	-	-	NUM
bam-5962	55	7	diaminopyridine	diaminopyridine	NOUN
bam-5962	55	8	(	(	PUNCT
bam-5962	55	9	3x15	3x15	NUM
bam-5962	55	10	mg	mg	NOUN
bam-5962	55	11	per	per	ADP
bam-5962	55	12	day	day	NOUN
bam-5962	55	13	)	)	PUNCT
bam-5962	55	14	was	be	AUX
bam-5962	55	15	started	start	VERB
bam-5962	55	16	which	which	PRON
bam-5962	55	17	resulted	result	VERB
bam-5962	55	18	in	in	ADP
bam-5962	55	19	a	a	DET
bam-5962	55	20	rapid	rapid	ADJ
bam-5962	55	21	improvement	improvement	NOUN
bam-5962	55	22	of	of	ADP
bam-5962	55	23	symptoms	symptom	NOUN
bam-5962	55	24	over	over	ADP
bam-5962	55	25	a	a	DET
bam-5962	55	26	few	few	ADJ
bam-5962	55	27	days	day	NOUN
bam-5962	55	28	.	.	PUNCT
bam-5962	56	1	while	while	SCONJ
bam-5962	56	2	severe	severe	ADJ
bam-5962	56	3	tetraparesis	tetraparesis	PROPN
bam-5962	56	4	,	,	PUNCT
bam-5962	56	5	dropped	drop	VERB
bam-5962	56	6	head	head	NOUN
bam-5962	56	7	syndrome	syndrome	NOUN
bam-5962	56	8	,	,	PUNCT
bam-5962	56	9	and	and	CCONJ
bam-5962	56	10	diarrhea	diarrhea	NOUN
bam-5962	56	11	significantly	significantly	ADV
bam-5962	56	12	improved	improve	VERB
bam-5962	56	13	,	,	PUNCT
bam-5962	56	14	dysphagia	dysphagia	PROPN
bam-5962	56	15	first	first	ADV
bam-5962	56	16	persisted	persist	VERB
bam-5962	56	17	and	and	CCONJ
bam-5962	56	18	a	a	DET
bam-5962	56	19	percutaneous	percutaneous	ADJ
bam-5962	56	20	endoscopic	endoscopic	ADJ
bam-5962	56	21	gastrostomy	gastrostomy	NOUN
bam-5962	56	22	(	(	PUNCT
bam-5962	56	23	peg	peg	NOUN
bam-5962	56	24	)	)	PUNCT
bam-5962	56	25	probe	probe	NOUN
bam-5962	56	26	was	be	AUX
bam-5962	56	27	placed	place	VERB
bam-5962	56	28	.	.	PUNCT
bam-5962	57	1	intravenous	intravenous	ADJ
bam-5962	57	2	pyridostigmine	pyridostigmine	PROPN
bam-5962	57	3	was	be	AUX
bam-5962	57	4	switched	switch	VERB
bam-5962	57	5	to	to	ADP
bam-5962	57	6	oral	oral	ADJ
bam-5962	57	7	pyridostigmine	pyridostigmine	ADJ
bam-5962	57	8	bromide	bromide	NOUN
bam-5962	57	9	(	(	PUNCT
bam-5962	57	10	mestinon	mestinon	X
bam-5962	57	11	)	)	PUNCT
bam-5962	57	12	30	30	NUM
bam-5962	57	13	mg	mg	PROPN
bam-5962	57	14	three	three	NUM
bam-5962	57	15	times	time	NOUN
bam-5962	57	16	a	a	DET
bam-5962	57	17	day	day	NOUN
bam-5962	57	18	.	.	PUNCT
bam-5962	58	1	we	we	PRON
bam-5962	58	2	started	start	VERB
bam-5962	58	3	immunosuppressive	immunosuppressive	ADJ
bam-5962	58	4	treatment	treatment	NOUN
bam-5962	58	5	with	with	ADP
bam-5962	58	6	mycophenolate	mycophenolate	NOUN
bam-5962	58	7	mofetil	mofetil	PROPN
bam-5962	58	8	(	(	PUNCT
bam-5962	58	9	1500	1500	NUM
bam-5962	58	10	mg	mg	NOUN
bam-5962	58	11	per	per	ADP
bam-5962	58	12	day	day	NOUN
bam-5962	58	13	)	)	PUNCT
bam-5962	58	14	accompanied	accompany	VERB
bam-5962	58	15	by	by	ADP
bam-5962	58	16	steroids	steroid	NOUN
bam-5962	58	17	(	(	PUNCT
bam-5962	58	18	70	70	NUM
bam-5962	58	19	mg	mg	NOUN
bam-5962	58	20	prednisone	prednisone	NOUN
bam-5962	58	21	per	per	ADP
bam-5962	58	22	day	day	NOUN
bam-5962	58	23	)	)	PUNCT
bam-5962	58	24	and	and	CCONJ
bam-5962	58	25	intensive	intensive	ADJ
bam-5962	58	26	speech	speech	NOUN
bam-5962	58	27	therapy	therapy	NOUN
bam-5962	58	28	.	.	PUNCT
bam-5962	59	1	in	in	ADP
bam-5962	59	2	the	the	DET
bam-5962	59	3	course	course	NOUN
bam-5962	59	4	of	of	ADP
bam-5962	59	5	the	the	DET
bam-5962	59	6	hospitalization	hospitalization	NOUN
bam-5962	59	7	,	,	PUNCT
bam-5962	59	8	dysphagia	dysphagia	NOUN
bam-5962	59	9	improved	improve	VERB
bam-5962	59	10	and	and	CCONJ
bam-5962	59	11	the	the	DET
bam-5962	59	12	tracheostomy	tracheostomy	NOUN
bam-5962	59	13	tube	tube	NOUN
bam-5962	59	14	could	could	AUX
bam-5962	59	15	be	be	AUX
bam-5962	59	16	removed	remove	VERB
bam-5962	59	17	.	.	PUNCT
bam-5962	60	1	at	at	ADP
bam-5962	60	2	discharge	discharge	NOUN
bam-5962	60	3	the	the	DET
bam-5962	60	4	patient	patient	NOUN
bam-5962	60	5	was	be	AUX
bam-5962	60	6	fully	fully	ADV
bam-5962	60	7	mobilized	mobilize	VERB
bam-5962	60	8	and	and	CCONJ
bam-5962	60	9	able	able	ADJ
bam-5962	60	10	to	to	PART
bam-5962	60	11	eat	eat	VERB
bam-5962	60	12	and	and	CCONJ
bam-5962	60	13	drink	drink	VERB
bam-5962	60	14	without	without	ADP
bam-5962	60	15	difficulties	difficulty	NOUN
bam-5962	60	16	,	,	PUNCT
bam-5962	60	17	anti	anti	ADJ
bam-5962	60	18	-	-	ADJ
bam-5962	60	19	vgcc	vgcc	ADJ
bam-5962	60	20	n	n	CCONJ
bam-5962	60	21	-	-	PUNCT
bam-5962	60	22	type	type	NOUN
bam-5962	60	23	antibodies	antibody	NOUN
bam-5962	60	24	were	be	AUX
bam-5962	60	25	negative	negative	ADJ
bam-5962	60	26	.	.	PUNCT
bam-5962	61	1	no	no	DET
bam-5962	61	2	diarrhea	diarrhea	NOUN
bam-5962	61	3	was	be	AUX
bam-5962	61	4	observed	observe	VERB
bam-5962	61	5	.	.	PUNCT
bam-5962	62	1	at	at	ADP
bam-5962	62	2	follow	follow	NOUN
bam-5962	62	3	-	-	PUNCT
bam-5962	62	4	up	up	NOUN
bam-5962	62	5	a	a	DET
bam-5962	62	6	few	few	ADJ
bam-5962	62	7	weeks	week	NOUN
bam-5962	62	8	later	later	ADV
bam-5962	62	9	the	the	DET
bam-5962	62	10	patient	patient	NOUN
bam-5962	62	11	was	be	AUX
bam-5962	62	12	able	able	ADJ
bam-5962	62	13	to	to	PART
bam-5962	62	14	play	play	VERB
bam-5962	62	15	golf	golf	NOUN
bam-5962	62	16	again	again	ADV
bam-5962	62	17	.	.	PUNCT
bam-5962	63	1	in	in	ADP
bam-5962	63	2	the	the	DET
bam-5962	63	3	one	one	NUM
bam-5962	63	4	and	and	CCONJ
bam-5962	63	5	two	two	NUM
bam-5962	63	6	-	-	PUNCT
bam-5962	63	7	year	year	NOUN
bam-5962	63	8	follow	follow	NOUN
bam-5962	63	9	up	up	ADP
bam-5962	63	10	,	,	PUNCT
bam-5962	63	11	the	the	DET
bam-5962	63	12	patient	patient	NOUN
bam-5962	63	13	does	do	AUX
bam-5962	63	14	not	not	PART
bam-5962	63	15	complain	complain	VERB
bam-5962	63	16	any	any	DET
bam-5962	63	17	neuromuscular	neuromuscular	ADJ
bam-5962	63	18	symptoms	symptom	NOUN
bam-5962	63	19	,	,	PUNCT
bam-5962	63	20	cancer	cancer	NOUN
bam-5962	63	21	screening	screening	NOUN
bam-5962	63	22	was	be	AUX
bam-5962	63	23	negative	negative	ADJ
bam-5962	63	24	.	.	PUNCT
bam-5962	64	1	the	the	DET
bam-5962	64	2	repetitive	repetitive	ADJ
bam-5962	64	3	nerve	nerve	NOUN
bam-5962	64	4	stimulation	stimulation	NOUN
bam-5962	64	5	tests	test	NOUN
bam-5962	64	6	were	be	AUX
bam-5962	64	7	normal	normal	ADJ
bam-5962	64	8	.	.	PUNCT
bam-5962	65	1	patient	patient	ADJ
bam-5962	65	2	#	#	SYM
bam-5962	65	3	2	2	NUM
bam-5962	65	4	an	an	DET
bam-5962	65	5	80	80	NUM
bam-5962	65	6	-	-	PUNCT
bam-5962	65	7	year	year	NOUN
bam-5962	65	8	old	old	ADJ
bam-5962	65	9	male	male	ADJ
bam-5962	65	10	caucasian	caucasian	ADJ
bam-5962	65	11	,	,	PUNCT
bam-5962	65	12	non	non	ADJ
bam-5962	65	13	-	-	ADJ
bam-5962	65	14	smoker	smoker	ADJ
bam-5962	65	15	,	,	PUNCT
bam-5962	65	16	presented	present	VERB
bam-5962	65	17	in	in	ADP
bam-5962	65	18	2013	2013	NUM
bam-5962	65	19	with	with	ADP
bam-5962	65	20	myasthenic	myasthenic	ADJ
bam-5962	65	21	syndrome	syndrome	NOUN
bam-5962	65	22	accompanied	accompany	VERB
bam-5962	65	23	by	by	ADP
bam-5962	65	24	dropped	drop	VERB
bam-5962	65	25	head	head	NOUN
bam-5962	65	26	syndrome	syndrome	NOUN
bam-5962	65	27	,	,	PUNCT
bam-5962	65	28	dysarthria	dysarthria	NOUN
bam-5962	65	29	and	and	CCONJ
bam-5962	65	30	dysphagia	dysphagia	NOUN
bam-5962	65	31	.	.	PUNCT
bam-5962	66	1	a	a	DET
bam-5962	66	2	few	few	ADJ
bam-5962	66	3	weeks	week	NOUN
bam-5962	66	4	upon	upon	SCONJ
bam-5962	66	5	arrival	arrival	NOUN
bam-5962	66	6	at	at	ADP
bam-5962	66	7	our	our	PRON
bam-5962	66	8	department	department	PROPN
bam-5962	66	9	of	of	ADP
bam-5962	66	10	neurology	neurology	NOUN
bam-5962	66	11	,	,	PUNCT
bam-5962	66	12	the	the	DET
bam-5962	66	13	patient	patient	NOUN
bam-5962	66	14	was	be	AUX
bam-5962	66	15	diagnosed	diagnose	VERB
bam-5962	66	16	with	with	ADP
bam-5962	66	17	urothelial	urothelial	ADJ
bam-5962	66	18	squamous	squamous	ADJ
bam-5962	66	19	cell	cell	NOUN
bam-5962	66	20	carcinoma	carcinoma	NOUN
bam-5962	66	21	of	of	ADP
bam-5962	66	22	the	the	DET
bam-5962	66	23	urine	urine	NOUN
bam-5962	66	24	bladder	bladder	NOUN
bam-5962	66	25	with	with	ADP
bam-5962	66	26	lymphatic	lymphatic	ADJ
bam-5962	66	27	and	and	CCONJ
bam-5962	66	28	possible	possible	ADJ
bam-5962	66	29	pulmonary	pulmonary	ADJ
bam-5962	66	30	metastasis	metastasis	NOUN
bam-5962	66	31	.	.	PUNCT
bam-5962	67	1	he	he	PRON
bam-5962	67	2	received	receive	VERB
bam-5962	67	3	radical	radical	ADJ
bam-5962	67	4	cystoprostatectomy	cystoprostatectomy	NOUN
bam-5962	67	5	,	,	PUNCT
bam-5962	67	6	pelvic	pelvic	ADJ
bam-5962	67	7	lymphadenectomy	lymphadenectomy	NOUN
bam-5962	67	8	and	and	CCONJ
bam-5962	67	9	an	an	DET
bam-5962	67	10	ileal	ileal	ADJ
bam-5962	67	11	conduit	conduit	NOUN
bam-5962	67	12	.	.	PUNCT
bam-5962	68	1	chemotherapy	chemotherapy	NOUN
bam-5962	68	2	had	have	AUX
bam-5962	68	3	not	not	PART
bam-5962	68	4	been	be	AUX
bam-5962	68	5	started	start	VERB
bam-5962	68	6	yet	yet	ADV
bam-5962	68	7	.	.	PUNCT
bam-5962	69	1	the	the	DET
bam-5962	69	2	weakness	weakness	NOUN
bam-5962	69	3	of	of	ADP
bam-5962	69	4	the	the	DET
bam-5962	69	5	neck	neck	NOUN
bam-5962	69	6	muscles	muscle	NOUN
bam-5962	69	7	had	have	AUX
bam-5962	69	8	developed	develop	VERB
bam-5962	69	9	over	over	ADP
bam-5962	69	10	several	several	ADJ
bam-5962	69	11	months	month	NOUN
bam-5962	69	12	in	in	ADP
bam-5962	69	13	advance	advance	NOUN
bam-5962	69	14	.	.	PUNCT
bam-5962	70	1	next	next	ADJ
bam-5962	70	2	to	to	ADP
bam-5962	70	3	paresis	paresis	NOUN
bam-5962	70	4	of	of	ADP
bam-5962	70	5	the	the	DET
bam-5962	70	6	neck	neck	NOUN
bam-5962	70	7	muscles	muscle	NOUN
bam-5962	70	8	resulting	result	VERB
bam-5962	70	9	into	into	ADP
bam-5962	70	10	dropped	drop	VERB
bam-5962	70	11	head	head	NOUN
bam-5962	70	12	syndrome	syndrome	NOUN
bam-5962	70	13	with	with	ADP
bam-5962	70	14	lateral	lateral	ADJ
bam-5962	70	15	shift	shift	NOUN
bam-5962	70	16	,	,	PUNCT
bam-5962	70	17	physical	physical	ADJ
bam-5962	70	18	exam	exam	NOUN
bam-5962	70	19	showed	show	VERB
bam-5962	70	20	long	long	ADV
bam-5962	70	21	known	know	VERB
bam-5962	70	22	bilateral	bilateral	ADJ
bam-5962	70	23	ptosis	ptosis	NOUN
bam-5962	70	24	,	,	PUNCT
bam-5962	70	25	moderate	moderate	ADJ
bam-5962	70	26	to	to	ADP
bam-5962	70	27	severe	severe	ADJ
bam-5962	70	28	dysarthria	dysarthria	NOUN
bam-5962	70	29	and	and	CCONJ
bam-5962	70	30	dysphagia	dysphagia	ADJ
bam-5962	70	31	and	and	CCONJ
bam-5962	70	32	mild	mild	ADJ
bam-5962	70	33	weakness	weakness	NOUN
bam-5962	70	34	of	of	ADP
bam-5962	70	35	the	the	DET
bam-5962	70	36	upper	upper	ADJ
bam-5962	70	37	proximal	proximal	ADJ
bam-5962	70	38	extremities	extremity	NOUN
bam-5962	70	39	.	.	PUNCT
bam-5962	71	1	deep	deep	ADJ
bam-5962	71	2	tendon	tendon	NOUN
bam-5962	71	3	reflexes	reflex	NOUN
bam-5962	71	4	were	be	AUX
bam-5962	71	5	normal	normal	ADJ
bam-5962	71	6	.	.	PUNCT
bam-5962	72	1	blood	blood	NOUN
bam-5962	72	2	pressure	pressure	NOUN
bam-5962	72	3	controls	control	NOUN
bam-5962	72	4	reveal	reveal	VERB
bam-5962	72	5	a	a	DET
bam-5962	72	6	severe	severe	ADJ
bam-5962	72	7	arterial	arterial	ADJ
bam-5962	72	8	hypotension	hypotension	NOUN
bam-5962	72	9	.	.	PUNCT
bam-5962	73	1	pathological	pathological	ADJ
bam-5962	73	2	decrement	decrement	NOUN
bam-5962	73	3	of	of	ADP
bam-5962	73	4	the	the	DET
bam-5962	73	5	n.	n.	PROPN
bam-5962	73	6	accessorius	accessorius	PROPN
bam-5962	73	7	was	be	AUX
bam-5962	73	8	measured	measure	VERB
bam-5962	73	9	(	(	PUNCT
bam-5962	73	10	>	>	SYM
bam-5962	73	11	20	20	NUM
bam-5962	73	12	%	%	NOUN
bam-5962	73	13	reduction	reduction	NOUN
bam-5962	73	14	of	of	ADP
bam-5962	73	15	amplitude	amplitude	NOUN
bam-5962	73	16	)	)	PUNCT
bam-5962	73	17	with	with	ADP
bam-5962	73	18	3hz	3hz	ADJ
bam-5962	73	19	-	-	PUNCT
bam-5962	73	20	stimulation	stimulation	NOUN
bam-5962	73	21	preand	preand	NOUN
bam-5962	73	22	post	post	ADJ
bam-5962	73	23	-	-	NOUN
bam-5962	73	24	exercise	exercise	NOUN
bam-5962	73	25	.	.	PUNCT
bam-5962	74	1	a	a	DET
bam-5962	74	2	lowered	lower	VERB
bam-5962	74	3	cmap	cmap	NOUN
bam-5962	74	4	of	of	ADP
bam-5962	74	5	the	the	DET
bam-5962	74	6	facial	facial	ADJ
bam-5962	74	7	nerve	nerve	NOUN
bam-5962	74	8	could	could	AUX
bam-5962	74	9	be	be	AUX
bam-5962	74	10	detected	detect	VERB
bam-5962	74	11	.	.	PUNCT
bam-5962	75	1	edrophonium	edrophonium	PROPN
bam-5962	75	2	chloride	chloride	PROPN
bam-5962	75	3	test	test	NOUN
bam-5962	75	4	was	be	AUX
bam-5962	75	5	positive	positive	ADJ
bam-5962	75	6	.	.	PUNCT
bam-5962	76	1	computer	computer	NOUN
bam-5962	76	2	tomography	tomography	NOUN
bam-5962	76	3	(	(	PUNCT
bam-5962	76	4	ct	ct	NOUN
bam-5962	76	5	)	)	PUNCT
bam-5962	76	6	of	of	ADP
bam-5962	76	7	the	the	DET
bam-5962	76	8	chest	chest	NOUN
bam-5962	76	9	found	find	VERB
bam-5962	76	10	no	no	DET
bam-5962	76	11	thymoma	thymoma	NOUN
bam-5962	76	12	.	.	PUNCT
bam-5962	77	1	the	the	DET
bam-5962	77	2	patient	patient	NOUN
bam-5962	77	3	was	be	AUX
bam-5962	77	4	started	start	VERB
bam-5962	77	5	on	on	ADP
bam-5962	77	6	oral	oral	ADJ
bam-5962	77	7	pyridostigmine	pyridostigmine	ADJ
bam-5962	77	8	bromide	bromide	NOUN
bam-5962	77	9	(	(	PUNCT
bam-5962	77	10	mestinon	mestinon	X
bam-5962	77	11	)	)	PUNCT
bam-5962	77	12	and	and	CCONJ
bam-5962	77	13	immunosuppression	immunosuppression	NOUN
bam-5962	77	14	with	with	ADP
bam-5962	77	15	steroids	steroid	NOUN
bam-5962	77	16	(	(	PUNCT
bam-5962	77	17	prednisone	prednisone	NOUN
bam-5962	77	18	20	20	NUM
bam-5962	77	19	mg	mg	NOUN
bam-5962	77	20	per	per	ADP
bam-5962	77	21	day	day	NOUN
bam-5962	77	22	starting	start	VERB
bam-5962	77	23	dosage	dosage	NOUN
bam-5962	77	24	)	)	PUNCT
bam-5962	77	25	.	.	PUNCT
bam-5962	78	1	during	during	ADP
bam-5962	78	2	the	the	DET
bam-5962	78	3	next	next	ADJ
bam-5962	78	4	few	few	ADJ
bam-5962	78	5	days	day	NOUN
bam-5962	78	6	,	,	PUNCT
bam-5962	78	7	dysarthria	dysarthria	NOUN
bam-5962	78	8	and	and	CCONJ
bam-5962	78	9	dysphagia	dysphagia	NOUN
bam-5962	78	10	had	have	AUX
bam-5962	78	11	almost	almost	ADV
bam-5962	78	12	completely	completely	ADV
bam-5962	78	13	resolved	resolve	VERB
bam-5962	78	14	,	,	PUNCT
bam-5962	78	15	dropped	drop	VERB
bam-5962	78	16	head	head	NOUN
bam-5962	78	17	syndrome	syndrome	NOUN
bam-5962	78	18	improved	improve	VERB
bam-5962	78	19	.	.	PUNCT
bam-5962	79	1	electrophysiology	electrophysiology	NOUN
bam-5962	79	2	showed	show	VERB
bam-5962	79	3	decline	decline	NOUN
bam-5962	79	4	of	of	ADP
bam-5962	79	5	the	the	DET
bam-5962	79	6	pathological	pathological	ADJ
bam-5962	79	7	decrement	decrement	NOUN
bam-5962	79	8	.	.	PUNCT
bam-5962	80	1	at	at	ADP
bam-5962	80	2	discharge	discharge	NOUN
bam-5962	80	3	the	the	DET
bam-5962	80	4	patient	patient	NOUN
bam-5962	80	5	was	be	AUX
bam-5962	80	6	on	on	ADP
bam-5962	80	7	pyridostigmine	pyridostigmine	ADJ
bam-5962	80	8	bromide	bromide	NOUN
bam-5962	80	9	with	with	ADP
bam-5962	80	10	a	a	DET
bam-5962	80	11	total	total	ADJ
bam-5962	80	12	daily	daily	ADJ
bam-5962	80	13	dosage	dosage	NOUN
bam-5962	80	14	of	of	ADP
bam-5962	80	15	345	345	NUM
bam-5962	80	16	mg	mg	NOUN
bam-5962	80	17	and	and	CCONJ
bam-5962	80	18	prednisone	prednisone	PROPN
bam-5962	80	19	40	40	NUM
bam-5962	80	20	mg	mg	NOUN
bam-5962	80	21	.	.	PUNCT
bam-5962	81	1	anti	anti	ADJ
bam-5962	81	2	-	-	ADJ
bam-5962	81	3	achr	achr	ADJ
bam-5962	81	4	antibodies	antibodie	VERB
bam-5962	81	5	,	,	PUNCT
bam-5962	81	6	anti	anti	ADJ
bam-5962	81	7	-	-	ADJ
bam-5962	81	8	titin	titin	ADJ
bam-5962	81	9	antibodies	antibodie	VERB
bam-5962	81	10	,	,	PUNCT
bam-5962	81	11	anti	anti	ADJ
bam-5962	81	12	-	-	ADJ
bam-5962	81	13	musk	musk	ADJ
bam-5962	81	14	antibodies	antibody	NOUN
bam-5962	81	15	,	,	PUNCT
bam-5962	81	16	and	and	CCONJ
bam-5962	81	17	antiactin	antiactin	NOUN
bam-5962	81	18	(	(	PUNCT
bam-5962	81	19	anti	anti	ADJ
bam-5962	81	20	-	-	ADJ
bam-5962	81	21	striated	striated	ADJ
bam-5962	81	22	muscles	muscle	NOUN
bam-5962	81	23	)	)	PUNCT
bam-5962	81	24	antibodies	antibody	NOUN
bam-5962	81	25	were	be	AUX
bam-5962	81	26	negative	negative	ADJ
bam-5962	81	27	.	.	PUNCT
bam-5962	82	1	later	late	ADJ
bam-5962	82	2	results	result	NOUN
bam-5962	82	3	were	be	AUX
bam-5962	82	4	positive	positive	ADJ
bam-5962	82	5	for	for	ADP
bam-5962	82	6	anti	anti	ADJ
bam-5962	82	7	-	-	ADJ
bam-5962	82	8	vgcc	vgcc	ADJ
bam-5962	82	9	n	n	CCONJ
bam-5962	82	10	-	-	PUNCT
bam-5962	82	11	type	type	NOUN
bam-5962	82	12	antibodies	antibody	NOUN
bam-5962	82	13	(	(	PUNCT
bam-5962	82	14	antibody	antibody	NOUN
bam-5962	82	15	ratio	ratio	NOUN
bam-5962	82	16	71.1	71.1	NUM
bam-5962	82	17	,	,	PUNCT
bam-5962	82	18	reference	reference	NOUN
bam-5962	82	19	ratio	ratio	NOUN
bam-5962	82	20	<	<	X
bam-5962	82	21	15.0	15.0	NUM
bam-5962	82	22	,	,	PUNCT
bam-5962	82	23	same	same	ADJ
bam-5962	82	24	radioreceptor	radioreceptor	NOUN
bam-5962	82	25	assay	assay	VERB
bam-5962	82	26	as	as	SCONJ
bam-5962	82	27	mentioned	mention	VERB
bam-5962	82	28	above	above	ADV
bam-5962	82	29	)	)	PUNCT
bam-5962	82	30	and	and	CCONJ
bam-5962	82	31	negative	negative	ADJ
bam-5962	82	32	for	for	ADP
bam-5962	82	33	anti	anti	ADJ
bam-5962	82	34	-	-	ADJ
bam-5962	82	35	vgcc	vgcc	ADJ
bam-5962	82	36	p	p	X
bam-5962	82	37	/	/	SYM
bam-5962	82	38	q	q	ADJ
bam-5962	82	39	-	-	PUNCT
bam-5962	82	40	type	type	NOUN
bam-5962	82	41	antibodies	antibodie	VERB
bam-5962	82	42	.	.	PUNCT
bam-5962	83	1	two	two	NUM
bam-5962	83	2	months	month	NOUN
bam-5962	83	3	later	later	ADV
bam-5962	83	4	,	,	PUNCT
bam-5962	83	5	the	the	DET
bam-5962	83	6	patient	patient	NOUN
bam-5962	83	7	presented	present	VERB
bam-5962	83	8	to	to	ADP
bam-5962	83	9	our	our	PRON
bam-5962	83	10	hospital	hospital	NOUN
bam-5962	83	11	with	with	ADP
bam-5962	83	12	dyspnea	dyspnea	PROPN
bam-5962	83	13	.	.	PROPN
bam-5962	84	1	dropped	drop	VERB
bam-5962	84	2	head	head	NOUN
bam-5962	84	3	syndrome	syndrome	NOUN
bam-5962	84	4	,	,	PUNCT
bam-5962	84	5	dysphagia	dysphagia	NOUN
bam-5962	84	6	and	and	CCONJ
bam-5962	84	7	dysarthria	dysarthria	NOUN
bam-5962	84	8	were	be	AUX
bam-5962	84	9	almost	almost	ADV
bam-5962	84	10	on	on	ADP
bam-5962	84	11	the	the	DET
bam-5962	84	12	same	same	ADJ
bam-5962	84	13	level	level	NOUN
bam-5962	84	14	as	as	ADP
bam-5962	84	15	at	at	ADP
bam-5962	84	16	discharge	discharge	NOUN
bam-5962	84	17	.	.	PUNCT
bam-5962	85	1	the	the	DET
bam-5962	85	2	chest	chest	NOUN
bam-5962	85	3	ct	ct	PROPN
bam-5962	85	4	revealed	reveal	VERB
bam-5962	85	5	a	a	DET
bam-5962	85	6	bilateral	bilateral	ADJ
bam-5962	85	7	pulmonary	pulmonary	ADJ
bam-5962	85	8	embolism	embolism	NOUN
bam-5962	85	9	and	and	CCONJ
bam-5962	85	10	heparin	heparin	ADJ
bam-5962	85	11	drip	drip	NOUN
bam-5962	85	12	was	be	AUX
bam-5962	85	13	initiated	initiate	VERB
bam-5962	85	14	.	.	PUNCT
bam-5962	86	1	due	due	ADP
bam-5962	86	2	to	to	ADP
bam-5962	86	3	pulmonary	pulmonary	ADJ
bam-5962	86	4	embolism	embolism	NOUN
bam-5962	86	5	,	,	PUNCT
bam-5962	86	6	the	the	DET
bam-5962	86	7	severe	severe	ADJ
bam-5962	86	8	conditional	conditional	ADJ
bam-5962	86	9	state	state	NOUN
bam-5962	86	10	of	of	ADP
bam-5962	86	11	the	the	DET
bam-5962	86	12	patient	patient	ADJ
bam-5962	86	13	and	and	CCONJ
bam-5962	86	14	progressive	progressive	ADJ
bam-5962	86	15	metastasis	metastasis	NOUN
bam-5962	86	16	chemotherapy	chemotherapy	NOUN
bam-5962	86	17	was	be	AUX
bam-5962	86	18	not	not	PART
bam-5962	86	19	started	start	VERB
bam-5962	86	20	.	.	PUNCT
bam-5962	87	1	consecutively	consecutively	ADV
bam-5962	87	2	,	,	PUNCT
bam-5962	87	3	the	the	DET
bam-5962	87	4	patient	patient	NOUN
bam-5962	87	5	developed	develop	VERB
bam-5962	87	6	pneumonia	pneumonia	NOUN
bam-5962	87	7	that	that	PRON
bam-5962	87	8	was	be	AUX
bam-5962	87	9	successfully	successfully	ADV
bam-5962	87	10	treated	treat	VERB
bam-5962	87	11	with	with	ADP
bam-5962	87	12	antibiotics	antibiotic	NOUN
bam-5962	87	13	.	.	PUNCT
bam-5962	88	1	dysphagia	dysphagia	ADJ
bam-5962	88	2	,	,	PUNCT
bam-5962	88	3	dysarthria	dysarthria	NOUN
bam-5962	88	4	,	,	PUNCT
bam-5962	88	5	dropped	drop	VERB
bam-5962	88	6	head	head	NOUN
bam-5962	88	7	syndrome	syndrome	NOUN
bam-5962	88	8	,	,	PUNCT
bam-5962	88	9	and	and	CCONJ
bam-5962	88	10	respiratory	respiratory	ADJ
bam-5962	88	11	muscle	muscle	NOUN
bam-5962	88	12	weakness	weakness	NOUN
bam-5962	88	13	worsened	worsen	VERB
bam-5962	88	14	,	,	PUNCT
bam-5962	88	15	although	although	SCONJ
bam-5962	88	16	pyridostigmine	pyridostigmine	NOUN
bam-5962	88	17	was	be	AUX
bam-5962	88	18	increased	increase	VERB
bam-5962	88	19	.	.	PUNCT
bam-5962	89	1	again	again	ADV
bam-5962	89	2	antivgcc	antivgcc	VERB
bam-5962	89	3	n	n	CCONJ
bam-5962	89	4	-	-	PUNCT
bam-5962	89	5	type	type	NOUN
bam-5962	89	6	antibodies	antibody	NOUN
bam-5962	89	7	were	be	AUX
bam-5962	89	8	positive	positive	ADJ
bam-5962	89	9	(	(	PUNCT
bam-5962	89	10	antibody	antibody	NOUN
bam-5962	89	11	ratio	ratio	NOUN
bam-5962	89	12	53.2	53.2	NUM
bam-5962	89	13	,	,	PUNCT
bam-5962	89	14	reference	reference	NOUN
bam-5962	89	15	ratio	ratio	NOUN
bam-5962	89	16	<	<	X
bam-5962	89	17	15.0	15.0	NUM
bam-5962	89	18	)	)	PUNCT
bam-5962	89	19	,	,	PUNCT
bam-5962	89	20	but	but	CCONJ
bam-5962	89	21	anti	anti	ADJ
bam-5962	89	22	-	-	ADJ
bam-5962	89	23	achr	achr	ADJ
bam-5962	89	24	antibodies	antibody	NOUN
bam-5962	89	25	were	be	AUX
bam-5962	89	26	slightly	slightly	ADV
bam-5962	89	27	elevated	elevate	VERB
bam-5962	89	28	as	as	ADV
bam-5962	89	29	well	well	ADV
bam-5962	89	30	(	(	PUNCT
bam-5962	89	31	0.74nmol	0.74nmol	PROPN
bam-5962	89	32	/	/	SYM
bam-5962	89	33	l	l	NOUN
bam-5962	89	34	,	,	PUNCT
bam-5962	89	35	reference	reference	NOUN
bam-5962	89	36	value	value	NOUN
bam-5962	89	37	<	<	X
bam-5962	89	38	0.40nmol	0.40nmol	PROPN
bam-5962	89	39	/	/	SYM
bam-5962	89	40	l	l	NOUN
bam-5962	89	41	)	)	PUNCT
bam-5962	89	42	.	.	PUNCT
bam-5962	90	1	treatment	treatment	NOUN
bam-5962	90	2	with	with	ADP
bam-5962	90	3	immunoglobulins	immunoglobulin	NOUN
bam-5962	90	4	and	and	CCONJ
bam-5962	90	5	3,4	3,4	NUM
bam-5962	90	6	-	-	NOUN
bam-5962	90	7	diaminopyridine	diaminopyridine	NOUN
bam-5962	90	8	as	as	ADV
bam-5962	90	9	well	well	ADV
bam-5962	90	10	as	as	ADP
bam-5962	90	11	mechanical	mechanical	ADJ
bam-5962	90	12	ventilation	ventilation	NOUN
bam-5962	90	13	were	be	AUX
bam-5962	90	14	discussed	discuss	VERB
bam-5962	90	15	with	with	ADP
bam-5962	90	16	the	the	DET
bam-5962	90	17	patient	patient	NOUN
bam-5962	90	18	and	and	CCONJ
bam-5962	90	19	his	his	PRON
bam-5962	90	20	family	family	NOUN
bam-5962	90	21	,	,	PUNCT
bam-5962	90	22	but	but	CCONJ
bam-5962	90	23	were	be	AUX
bam-5962	90	24	not	not	PART
bam-5962	90	25	started	start	VERB
bam-5962	90	26	due	due	ADP
bam-5962	90	27	to	to	ADP
bam-5962	90	28	the	the	DET
bam-5962	90	29	unfavorable	unfavorable	ADJ
bam-5962	90	30	prognosis	prognosis	NOUN
bam-5962	90	31	of	of	ADP
bam-5962	90	32	the	the	DET
bam-5962	90	33	cancer	cancer	NOUN
bam-5962	90	34	diagnosis	diagnosis	NOUN
bam-5962	90	35	.	.	PUNCT
bam-5962	91	1	a	a	DET
bam-5962	91	2	few	few	ADJ
bam-5962	91	3	days	day	NOUN
bam-5962	91	4	later	later	ADV
bam-5962	91	5	,	,	PUNCT
bam-5962	91	6	the	the	DET
bam-5962	91	7	patient	patient	NOUN
bam-5962	91	8	died	die	VERB
bam-5962	91	9	due	due	ADJ
bam-5962	91	10	to	to	ADP
bam-5962	91	11	a	a	DET
bam-5962	91	12	respiratory	respiratory	ADJ
bam-5962	91	13	failure	failure	NOUN
bam-5962	91	14	.	.	PUNCT
bam-5962	92	1	patient	patient	ADJ
bam-5962	92	2	#	#	SYM
bam-5962	92	3	3	3	NUM
bam-5962	92	4	a	a	DET
bam-5962	92	5	71	71	NUM
bam-5962	92	6	-	-	PUNCT
bam-5962	92	7	year	year	NOUN
bam-5962	92	8	old	old	ADJ
bam-5962	92	9	female	female	NOUN
bam-5962	92	10	presented	present	VERB
bam-5962	92	11	with	with	ADP
bam-5962	92	12	myasthenic	myasthenic	ADJ
bam-5962	92	13	symptoms	symptom	NOUN
bam-5962	92	14	since	since	SCONJ
bam-5962	92	15	1970	1970	NUM
bam-5962	92	16	.	.	PUNCT
bam-5962	93	1	the	the	DET
bam-5962	93	2	patient	patient	NOUN
bam-5962	93	3	reported	report	VERB
bam-5962	93	4	of	of	ADP
bam-5962	93	5	neuromuscular	neuromuscular	ADJ
bam-5962	93	6	symptoms	symptom	NOUN
bam-5962	93	7	including	include	VERB
bam-5962	93	8	diplopia	diplopia	PROPN
bam-5962	93	9	,	,	PUNCT
bam-5962	93	10	bulbar	bulbar	ADJ
bam-5962	93	11	symptoms	symptom	NOUN
bam-5962	93	12	,	,	PUNCT
bam-5962	93	13	a	a	DET
bam-5962	93	14	proximal	proximal	ADJ
bam-5962	93	15	muscle	muscle	NOUN
bam-5962	93	16	weakness	weakness	NOUN
bam-5962	93	17	,	,	PUNCT
bam-5962	93	18	dropped	drop	VERB
bam-5962	93	19	-	-	PUNCT
bam-5962	93	20	head	head	NOUN
bam-5962	93	21	syndrome	syndrome	NOUN
bam-5962	93	22	and	and	CCONJ
bam-5962	93	23	dyspnea	dyspnea	VERB
bam-5962	93	24	with	with	ADP
bam-5962	93	25	no	no	DET
bam-5962	93	26	diurnal	diurnal	ADJ
bam-5962	93	27	or	or	CCONJ
bam-5962	93	28	exercise	exercise	NOUN
bam-5962	93	29	dependency	dependency	NOUN
bam-5962	93	30	and	and	CCONJ
bam-5962	93	31	an	an	DET
bam-5962	93	32	improvement	improvement	NOUN
bam-5962	93	33	under	under	ADP
bam-5962	93	34	pyridostigmin	pyridostigmin	NOUN
bam-5962	93	35	only	only	ADV
bam-5962	93	36	in	in	ADP
bam-5962	93	37	the	the	DET
bam-5962	93	38	initial	initial	ADJ
bam-5962	93	39	phase	phase	NOUN
bam-5962	93	40	of	of	ADP
bam-5962	93	41	the	the	DET
bam-5962	93	42	disease	disease	NOUN
bam-5962	93	43	.	.	PUNCT
bam-5962	94	1	deep	deep	ADJ
bam-5962	94	2	tendon	tendon	NOUN
bam-5962	94	3	reflexes	reflex	NOUN
bam-5962	94	4	were	be	AUX
bam-5962	94	5	diminished	diminish	VERB
bam-5962	94	6	.	.	PUNCT
bam-5962	95	1	a	a	DET
bam-5962	95	2	refractory	refractory	NOUN
bam-5962	95	3	diarrhea	diarrhea	NOUN
bam-5962	95	4	was	be	AUX
bam-5962	95	5	non	non	PROPN
bam-5962	95	6	co	co	X
bam-5962	95	7	mmerc	mmerc	PROPN
bam-5962	95	8	ial	ial	PROPN
bam-5962	95	9	us	us	PROPN
bam-5962	95	10	e	e	NOUN
bam-5962	95	11	o	o	NOUN
bam-5962	95	12	nly	nly	ADV
bam-5962	95	13	clinical	clinical	ADJ
bam-5962	95	14	features	feature	NOUN
bam-5962	95	15	of	of	ADP
bam-5962	95	16	n	n	CCONJ
bam-5962	95	17	-	-	PUNCT
bam-5962	95	18	type	type	NOUN
bam-5962	95	19	vgcc	vgcc	NOUN
bam-5962	95	20	neuromuscular	neuromuscular	ADJ
bam-5962	95	21	syndromes	syndrome	NOUN
bam-5962	95	22	eur	eur	PROPN
bam-5962	95	23	j	j	PROPN
bam-5962	95	24	transl	transl	PROPN
bam-5962	95	25	myol	myol	NOUN
bam-5962	95	26	26	26	NUM
bam-5962	95	27	(	(	PUNCT
bam-5962	95	28	4	4	NUM
bam-5962	95	29	):	):	PUNCT
bam-5962	95	30	301	301	NUM
bam-5962	95	31	-	-	SYM
bam-5962	95	32	306	306	NUM
bam-5962	95	33	304	304	NUM
bam-5962	95	34	reported	report	VERB
bam-5962	95	35	for	for	ADP
bam-5962	95	36	several	several	ADJ
bam-5962	95	37	years	year	NOUN
bam-5962	95	38	.	.	PUNCT
bam-5962	96	1	a	a	DET
bam-5962	96	2	few	few	ADJ
bam-5962	96	3	years	year	NOUN
bam-5962	96	4	before	before	SCONJ
bam-5962	96	5	the	the	DET
bam-5962	96	6	patient	patient	NOUN
bam-5962	96	7	was	be	AUX
bam-5962	96	8	diagnosed	diagnose	VERB
bam-5962	96	9	with	with	ADP
bam-5962	96	10	a	a	DET
bam-5962	96	11	mixed	mixed	ADJ
bam-5962	96	12	connective	connective	ADJ
bam-5962	96	13	tissue	tissue	NOUN
bam-5962	96	14	disease	disease	NOUN
bam-5962	96	15	treated	treat	VERB
bam-5962	96	16	with	with	ADP
bam-5962	96	17	azathioprine	azathioprine	NOUN
bam-5962	96	18	,	,	PUNCT
bam-5962	96	19	methotrexate	methotrexate	NOUN
bam-5962	96	20	and	and	CCONJ
bam-5962	97	1	prednisolone	prednisolone	PROPN
bam-5962	97	2	.	.	PROPN
bam-5962	97	3	ncs	ncs	PROPN
bam-5962	97	4	revealed	reveal	VERB
bam-5962	97	5	sings	sing	NOUN
bam-5962	97	6	of	of	ADP
bam-5962	97	7	an	an	DET
bam-5962	97	8	axonal	axonal	ADJ
bam-5962	97	9	sensory	sensory	ADJ
bam-5962	97	10	polyneuropathy	polyneuropathy	NOUN
bam-5962	97	11	.	.	PUNCT
bam-5962	98	1	recent	recent	ADJ
bam-5962	98	2	3hz	3hz	ADJ
bam-5962	98	3	-	-	PUNCT
bam-5962	98	4	stimulation	stimulation	NOUN
bam-5962	98	5	revealed	reveal	VERB
bam-5962	98	6	no	no	DET
bam-5962	98	7	pathological	pathological	ADJ
bam-5962	98	8	decrement	decrement	NOUN
bam-5962	98	9	,	,	PUNCT
bam-5962	98	10	although	although	SCONJ
bam-5962	98	11	former	former	ADJ
bam-5962	98	12	testings	testing	NOUN
bam-5962	98	13	describe	describe	VERB
bam-5962	98	14	a	a	DET
bam-5962	98	15	decrement	decrement	NOUN
bam-5962	98	16	of	of	ADP
bam-5962	98	17	the	the	DET
bam-5962	98	18	m.	m.	NOUN
bam-5962	98	19	trapezius	trapezius	NOUN
bam-5962	98	20	.	.	PUNCT
bam-5962	99	1	anti	anti	ADJ
bam-5962	99	2	-	-	ADJ
bam-5962	99	3	achr	achr	ADJ
bam-5962	99	4	antibodies	antibody	NOUN
bam-5962	99	5	(	(	PUNCT
bam-5962	99	6	140.0nmol	140.0nmol	NUM
bam-5962	99	7	/	/	SYM
bam-5962	99	8	l	l	NOUN
bam-5962	99	9	,	,	PUNCT
bam-5962	99	10	reference	reference	NOUN
bam-5962	99	11	value	value	NOUN
bam-5962	99	12	<	<	X
bam-5962	99	13	0.40nmol	0.40nmol	PROPN
bam-5962	99	14	/	/	SYM
bam-5962	99	15	l	l	NOUN
bam-5962	99	16	)	)	PUNCT
bam-5962	99	17	and	and	CCONJ
bam-5962	99	18	anti	anti	ADJ
bam-5962	99	19	-	-	ADJ
bam-5962	99	20	vgcc	vgcc	ADJ
bam-5962	99	21	n	n	CCONJ
bam-5962	99	22	-	-	PUNCT
bam-5962	99	23	type	type	NOUN
bam-5962	99	24	antibodies	antibody	NOUN
bam-5962	99	25	were	be	AUX
bam-5962	99	26	positive	positive	ADJ
bam-5962	99	27	(	(	PUNCT
bam-5962	99	28	antibody	antibody	NOUN
bam-5962	99	29	ratio	ratio	NOUN
bam-5962	99	30	17.3	17.3	NUM
bam-5962	99	31	,	,	PUNCT
bam-5962	99	32	reference	reference	NOUN
bam-5962	99	33	ratio	ratio	NOUN
bam-5962	99	34	<	<	X
bam-5962	99	35	15.0	15.0	NUM
bam-5962	99	36	)	)	PUNCT
bam-5962	99	37	.	.	PUNCT
bam-5962	100	1	the	the	DET
bam-5962	100	2	patient	patient	NOUN
bam-5962	100	3	reported	report	VERB
bam-5962	100	4	worsening	worsen	VERB
bam-5962	100	5	of	of	ADP
bam-5962	100	6	bulbar	bulbar	NOUN
bam-5962	100	7	and	and	CCONJ
bam-5962	100	8	ocular	ocular	ADJ
bam-5962	100	9	symptoms	symptom	NOUN
bam-5962	100	10	a	a	DET
bam-5962	100	11	few	few	ADJ
bam-5962	100	12	weeks	week	NOUN
bam-5962	100	13	before	before	ADP
bam-5962	100	14	admission	admission	NOUN
bam-5962	100	15	to	to	ADP
bam-5962	100	16	hospital	hospital	NOUN
bam-5962	100	17	but	but	CCONJ
bam-5962	100	18	declined	decline	VERB
bam-5962	100	19	a	a	DET
bam-5962	100	20	treatment	treatment	NOUN
bam-5962	100	21	trial	trial	NOUN
bam-5962	100	22	with	with	ADP
bam-5962	100	23	3,4	3,4	NUM
bam-5962	100	24	-	-	PUNCT
bam-5962	100	25	diaminopyridine	diaminopyridine	NOUN
bam-5962	100	26	or	or	CCONJ
bam-5962	100	27	a	a	DET
bam-5962	100	28	further	further	ADJ
bam-5962	100	29	medication	medication	NOUN
bam-5962	100	30	with	with	ADP
bam-5962	100	31	immunosuppressive	immunosuppressive	ADJ
bam-5962	100	32	drugs	drug	NOUN
bam-5962	100	33	and	and	CCONJ
bam-5962	100	34	was	be	AUX
bam-5962	100	35	lost	lose	VERB
bam-5962	100	36	for	for	ADP
bam-5962	100	37	follow	follow	NOUN
bam-5962	100	38	-	-	PUNCT
bam-5962	100	39	up	up	NOUN
bam-5962	100	40	.	.	PUNCT
bam-5962	101	1	discussion	discussion	NOUN
bam-5962	101	2	we	we	PRON
bam-5962	101	3	presented	present	VERB
bam-5962	101	4	three	three	NUM
bam-5962	101	5	cases	case	NOUN
bam-5962	101	6	of	of	ADP
bam-5962	101	7	a	a	DET
bam-5962	101	8	progressive	progressive	ADJ
bam-5962	101	9	myasthenic	myasthenic	ADJ
bam-5962	101	10	syndrome	syndrome	NOUN
bam-5962	101	11	and	and	CCONJ
bam-5962	101	12	highly	highly	ADV
bam-5962	101	13	positive	positive	ADJ
bam-5962	101	14	anti	anti	ADJ
bam-5962	101	15	-	-	ADJ
bam-5962	101	16	vgcc	vgcc	ADJ
bam-5962	101	17	n	n	CCONJ
bam-5962	101	18	-	-	PUNCT
bam-5962	101	19	type	type	NOUN
bam-5962	101	20	antibodies	antibody	NOUN
bam-5962	101	21	(	(	PUNCT
bam-5962	101	22	table	table	NOUN
bam-5962	101	23	1	1	NUM
bam-5962	101	24	)	)	PUNCT
bam-5962	101	25	.	.	PUNCT
bam-5962	102	1	lems	lem	VERB
bam-5962	102	2	patients	patient	NOUN
bam-5962	102	3	usually	usually	ADV
bam-5962	102	4	present	present	ADJ
bam-5962	102	5	with	with	ADP
bam-5962	102	6	proximal	proximal	ADJ
bam-5962	102	7	muscles	muscle	NOUN
bam-5962	102	8	weakness	weakness	NOUN
bam-5962	102	9	of	of	ADP
bam-5962	102	10	lower	low	ADJ
bam-5962	102	11	limb	limb	NOUN
bam-5962	102	12	,	,	PUNCT
bam-5962	102	13	autonomic	autonomic	ADJ
bam-5962	102	14	dysregulation	dysregulation	NOUN
bam-5962	102	15	and	and	CCONJ
bam-5962	102	16	hypo-/areflexia	hypo-/areflexia	NOUN
bam-5962	102	17	.	.	PUNCT
bam-5962	103	1	bulbar	bulbar	NOUN
bam-5962	103	2	and	and	CCONJ
bam-5962	103	3	respiratory	respiratory	ADJ
bam-5962	103	4	muscles	muscle	NOUN
bam-5962	103	5	are	be	AUX
bam-5962	103	6	typically	typically	ADV
bam-5962	103	7	not	not	PART
bam-5962	103	8	affected	affect	VERB
bam-5962	103	9	.	.	PUNCT
bam-5962	104	1	in	in	ADP
bam-5962	104	2	our	our	PRON
bam-5962	104	3	cases	case	NOUN
bam-5962	104	4	,	,	PUNCT
bam-5962	104	5	the	the	DET
bam-5962	104	6	patients	patient	NOUN
bam-5962	104	7	had	have	AUX
bam-5962	104	8	initially	initially	ADV
bam-5962	104	9	and	and	CCONJ
bam-5962	104	10	predominantly	predominantly	ADV
bam-5962	104	11	dysarthria	dysarthria	NOUN
bam-5962	104	12	,	,	PUNCT
bam-5962	104	13	dysphagia	dysphagia	NOUN
bam-5962	104	14	,	,	PUNCT
bam-5962	104	15	proximal	proximal	ADJ
bam-5962	104	16	muscle	muscle	NOUN
bam-5962	104	17	weakness	weakness	NOUN
bam-5962	104	18	of	of	ADP
bam-5962	104	19	the	the	DET
bam-5962	104	20	upper	upper	ADJ
bam-5962	104	21	more	more	ADJ
bam-5962	104	22	than	than	ADP
bam-5962	104	23	lower	low	ADJ
bam-5962	104	24	limbs	limb	NOUN
bam-5962	104	25	and	and	CCONJ
bam-5962	104	26	most	most	ADV
bam-5962	104	27	impressive	impressive	ADJ
bam-5962	104	28	dropped	drop	VERB
bam-5962	104	29	head	head	NOUN
bam-5962	104	30	syndrome	syndrome	NOUN
bam-5962	104	31	.	.	PUNCT
bam-5962	105	1	deep	deep	ADJ
bam-5962	105	2	tendon	tendon	NOUN
bam-5962	105	3	reflexes	reflex	NOUN
bam-5962	105	4	were	be	AUX
bam-5962	105	5	slightly	slightly	ADV
bam-5962	105	6	reduced	reduce	VERB
bam-5962	105	7	,	,	PUNCT
bam-5962	105	8	which	which	PRON
bam-5962	105	9	is	be	AUX
bam-5962	105	10	usually	usually	ADV
bam-5962	105	11	more	more	ADV
bam-5962	105	12	impressive	impressive	ADJ
bam-5962	105	13	in	in	ADP
bam-5962	105	14	lems	lem	NOUN
bam-5962	105	15	.	.	PUNCT
bam-5962	106	1	therefore	therefore	ADV
bam-5962	106	2	,	,	PUNCT
bam-5962	106	3	the	the	DET
bam-5962	106	4	diagnosis	diagnosis	NOUN
bam-5962	106	5	of	of	ADP
bam-5962	106	6	a	a	DET
bam-5962	106	7	lems	lem	NOUN
bam-5962	106	8	is	be	AUX
bam-5962	106	9	likely	likely	ADJ
bam-5962	106	10	due	due	ADJ
bam-5962	106	11	to	to	ADP
bam-5962	106	12	clinical	clinical	ADJ
bam-5962	106	13	signs	sign	NOUN
bam-5962	106	14	that	that	PRON
bam-5962	106	15	are	be	AUX
bam-5962	106	16	consistent	consistent	ADJ
bam-5962	106	17	with	with	ADP
bam-5962	106	18	a	a	DET
bam-5962	106	19	presynaptic	presynaptic	ADJ
bam-5962	106	20	involvement	involvement	NOUN
bam-5962	106	21	and	and	CCONJ
bam-5962	106	22	signs	sign	NOUN
bam-5962	106	23	of	of	ADP
bam-5962	106	24	an	an	DET
bam-5962	106	25	autonomic	autonomic	ADJ
bam-5962	106	26	dysfunction	dysfunction	NOUN
bam-5962	106	27	.	.	PUNCT
bam-5962	107	1	the	the	DET
bam-5962	107	2	first	first	ADJ
bam-5962	107	3	and	and	CCONJ
bam-5962	107	4	third	third	ADJ
bam-5962	107	5	patient	patient	NOUN
bam-5962	107	6	presented	present	VERB
bam-5962	107	7	with	with	ADP
bam-5962	107	8	diarrhea	diarrhea	NOUN
bam-5962	107	9	,	,	PUNCT
bam-5962	107	10	the	the	DET
bam-5962	107	11	second	second	ADJ
bam-5962	107	12	patient	patient	NOUN
bam-5962	107	13	an	an	DET
bam-5962	107	14	arterial	arterial	ADJ
bam-5962	107	15	hypotension	hypotension	NOUN
bam-5962	107	16	as	as	ADP
bam-5962	107	17	a	a	DET
bam-5962	107	18	sign	sign	NOUN
bam-5962	107	19	of	of	ADP
bam-5962	107	20	autonomic	autonomic	ADJ
bam-5962	107	21	dysregulation	dysregulation	NOUN
bam-5962	107	22	,	,	PUNCT
bam-5962	107	23	especially	especially	ADV
bam-5962	107	24	while	while	SCONJ
bam-5962	107	25	improving	improve	VERB
bam-5962	107	26	with	with	ADP
bam-5962	107	27	decline	decline	NOUN
bam-5962	107	28	of	of	ADP
bam-5962	107	29	vgcc	vgcc	NOUN
bam-5962	107	30	n	n	CCONJ
bam-5962	107	31	-	-	PUNCT
bam-5962	107	32	type	type	NOUN
bam-5962	107	33	antibodies	antibody	NOUN
bam-5962	107	34	in	in	ADP
bam-5962	107	35	the	the	DET
bam-5962	107	36	first	first	ADJ
bam-5962	107	37	case	case	NOUN
bam-5962	107	38	.	.	PUNCT
bam-5962	108	1	respiratory	respiratory	ADJ
bam-5962	108	2	muscles	muscle	NOUN
bam-5962	108	3	were	be	AUX
bam-5962	108	4	not	not	PART
bam-5962	108	5	spared	spare	VERB
bam-5962	108	6	,	,	PUNCT
bam-5962	108	7	which	which	PRON
bam-5962	108	8	led	lead	VERB
bam-5962	108	9	to	to	ADP
bam-5962	108	10	respiratory	respiratory	ADJ
bam-5962	108	11	insufficiency	insufficiency	NOUN
bam-5962	108	12	.	.	PUNCT
bam-5962	109	1	all	all	DET
bam-5962	109	2	patients	patient	NOUN
bam-5962	109	3	showed	show	VERB
bam-5962	109	4	at	at	ADP
bam-5962	109	5	least	least	ADJ
bam-5962	109	6	initially	initially	ADV
bam-5962	109	7	good	good	ADJ
bam-5962	109	8	response	response	NOUN
bam-5962	109	9	to	to	ADP
bam-5962	109	10	pyridostigmine	pyridostigmine	NOUN
bam-5962	109	11	(	(	PUNCT
bam-5962	109	12	mestinon	mestinon	PROPN
bam-5962	109	13	)	)	PUNCT
bam-5962	109	14	.	.	PUNCT
bam-5962	110	1	while	while	SCONJ
bam-5962	110	2	myasthenic	myasthenic	ADJ
bam-5962	110	3	symptoms	symptom	NOUN
bam-5962	110	4	and	and	CCONJ
bam-5962	110	5	the	the	DET
bam-5962	110	6	pathological	pathological	ADJ
bam-5962	110	7	decrement	decrement	NOUN
bam-5962	110	8	were	be	AUX
bam-5962	110	9	suitable	suitable	ADJ
bam-5962	110	10	for	for	ADP
bam-5962	110	11	mg	mg	PROPN
bam-5962	110	12	,	,	PUNCT
bam-5962	110	13	elevated	elevated	ADJ
bam-5962	110	14	titers	titer	NOUN
bam-5962	110	15	of	of	ADP
bam-5962	110	16	anti	anti	ADJ
bam-5962	110	17	-	-	ADJ
bam-5962	110	18	achr	achr	ADJ
bam-5962	110	19	antibodies	antibody	NOUN
bam-5962	110	20	were	be	AUX
bam-5962	110	21	measured	measure	VERB
bam-5962	110	22	,	,	PUNCT
bam-5962	110	23	but	but	CCONJ
bam-5962	110	24	no	no	DET
bam-5962	110	25	diurnal	diurnal	ADJ
bam-5962	110	26	or	or	CCONJ
bam-5962	110	27	exercise	exercise	VERB
bam-5962	110	28	dependent	dependent	ADJ
bam-5962	110	29	weakness	weakness	NOUN
bam-5962	110	30	was	be	AUX
bam-5962	110	31	found	find	VERB
bam-5962	110	32	,	,	PUNCT
bam-5962	110	33	and	and	CCONJ
bam-5962	110	34	effect	effect	NOUN
bam-5962	110	35	of	of	ADP
bam-5962	110	36	pyridostigmine	pyridostigmine	NOUN
bam-5962	110	37	therapy	therapy	NOUN
bam-5962	110	38	was	be	AUX
bam-5962	110	39	decreasing	decrease	VERB
bam-5962	110	40	.	.	PUNCT
bam-5962	111	1	possibly	possibly	ADV
bam-5962	111	2	,	,	PUNCT
bam-5962	111	3	anti	anti	ADJ
bam-5962	111	4	-	-	ADJ
bam-5962	111	5	vgcc	vgcc	ADJ
bam-5962	111	6	n	n	CCONJ
bam-5962	111	7	-	-	PUNCT
bam-5962	111	8	type	type	NOUN
bam-5962	111	9	antibodies	antibody	NOUN
bam-5962	111	10	might	might	AUX
bam-5962	111	11	be	be	AUX
bam-5962	111	12	an	an	DET
bam-5962	111	13	epiphenomenon	epiphenomenon	NOUN
bam-5962	111	14	of	of	ADP
bam-5962	111	15	another	another	DET
bam-5962	111	16	disease	disease	NOUN
bam-5962	111	17	.	.	PUNCT
bam-5962	112	1	however	however	ADV
bam-5962	112	2	,	,	PUNCT
bam-5962	112	3	using	use	VERB
bam-5962	112	4	radio	radio	NOUN
bam-5962	112	5	receptor	receptor	NOUN
bam-5962	112	6	assay	assay	VERB
bam-5962	112	7	for	for	ADP
bam-5962	112	8	detection	detection	NOUN
bam-5962	112	9	,	,	PUNCT
bam-5962	112	10	in	in	ADP
bam-5962	112	11	our	our	PRON
bam-5962	112	12	opinion	opinion	NOUN
bam-5962	112	13	antibody	antibody	NOUN
bam-5962	112	14	levels	level	NOUN
bam-5962	112	15	were	be	AUX
bam-5962	112	16	too	too	ADV
bam-5962	112	17	high	high	ADJ
bam-5962	112	18	to	to	PART
bam-5962	112	19	be	be	AUX
bam-5962	112	20	a	a	DET
bam-5962	112	21	considerable	considerable	ADJ
bam-5962	112	22	epiphenomenon	epiphenomenon	NOUN
bam-5962	112	23	or	or	CCONJ
bam-5962	112	24	laboratory	laboratory	NOUN
bam-5962	112	25	failure	failure	NOUN
bam-5962	112	26	and	and	CCONJ
bam-5962	112	27	the	the	DET
bam-5962	112	28	clinical	clinical	ADJ
bam-5962	112	29	improvement	improvement	NOUN
bam-5962	112	30	of	of	ADP
bam-5962	112	31	case	case	NOUN
bam-5962	112	32	one	one	NUM
bam-5962	112	33	under	under	ADP
bam-5962	112	34	3,4	3,4	NUM
bam-5962	112	35	-	-	PUNCT
bam-5962	112	36	diaminopyridine	diaminopyridine	NOUN
bam-5962	112	37	with	with	ADP
bam-5962	112	38	decreasing	decrease	VERB
bam-5962	112	39	anti	anti	ADJ
bam-5962	112	40	-	-	ADJ
bam-5962	112	41	vgcc	vgcc	ADJ
bam-5962	112	42	n	n	CCONJ
bam-5962	112	43	-	-	PUNCT
bam-5962	112	44	type	type	NOUN
bam-5962	112	45	antibodies	antibody	NOUN
bam-5962	112	46	level	level	NOUN
bam-5962	112	47	was	be	AUX
bam-5962	112	48	too	too	ADV
bam-5962	112	49	impressive	impressive	ADJ
bam-5962	112	50	.	.	PUNCT
bam-5962	113	1	we	we	PRON
bam-5962	113	2	therefore	therefore	ADV
bam-5962	113	3	considered	consider	VERB
bam-5962	113	4	a	a	DET
bam-5962	113	5	mlos	mlo	NOUN
bam-5962	113	6	with	with	ADP
bam-5962	113	7	postand	postand	NOUN
bam-5962	113	8	presynaptic	presynaptic	ADJ
bam-5962	113	9	features	feature	NOUN
bam-5962	113	10	.	.	PUNCT
bam-5962	114	1	the	the	DET
bam-5962	114	2	rapid	rapid	ADJ
bam-5962	114	3	clinical	clinical	ADJ
bam-5962	114	4	improvement	improvement	NOUN
bam-5962	114	5	after	after	ADP
bam-5962	114	6	beginning	begin	VERB
bam-5962	114	7	with	with	ADP
bam-5962	114	8	the	the	DET
bam-5962	114	9	3,4	3,4	NUM
bam-5962	114	10	-	-	PUNCT
bam-5962	114	11	diaminopyridin	diaminopyridin	NOUN
bam-5962	114	12	treatment	treatment	NOUN
bam-5962	114	13	strongly	strongly	ADV
bam-5962	114	14	suggests	suggest	VERB
bam-5962	114	15	a	a	DET
bam-5962	114	16	presynaptic	presynaptic	ADJ
bam-5962	114	17	involvement	involvement	NOUN
bam-5962	114	18	,	,	PUNCT
bam-5962	114	19	nevertheless	nevertheless	ADV
bam-5962	114	20	additional	additional	ADJ
bam-5962	114	21	effects	effect	NOUN
bam-5962	114	22	of	of	ADP
bam-5962	114	23	the	the	DET
bam-5962	114	24	immunosuppressive	immunosuppressive	ADJ
bam-5962	114	25	treatment	treatment	NOUN
bam-5962	114	26	could	could	AUX
bam-5962	114	27	not	not	PART
bam-5962	114	28	be	be	AUX
bam-5962	114	29	excluded	exclude	VERB
bam-5962	114	30	.	.	PUNCT
bam-5962	115	1	underlying	underlie	VERB
bam-5962	115	2	cause	cause	NOUN
bam-5962	115	3	of	of	ADP
bam-5962	115	4	anti	anti	ADJ
bam-5962	115	5	-	-	ADJ
bam-5962	115	6	vgcc	vgcc	ADJ
bam-5962	115	7	n	n	CCONJ
bam-5962	115	8	-	-	PUNCT
bam-5962	115	9	type	type	NOUN
bam-5962	115	10	antibodies	antibody	NOUN
bam-5962	115	11	production	production	NOUN
bam-5962	115	12	in	in	ADP
bam-5962	115	13	both	both	DET
bam-5962	115	14	cases	case	NOUN
bam-5962	115	15	remains	remain	VERB
bam-5962	115	16	unknown	unknown	ADJ
bam-5962	115	17	.	.	PUNCT
bam-5962	116	1	in	in	ADP
bam-5962	116	2	case	case	NOUN
bam-5962	116	3	one	one	NUM
bam-5962	116	4	,	,	PUNCT
bam-5962	116	5	the	the	DET
bam-5962	116	6	antibody	antibody	NOUN
bam-5962	116	7	work	work	NOUN
bam-5962	116	8	-	-	PUNCT
bam-5962	116	9	up	up	NOUN
bam-5962	116	10	implied	imply	VERB
bam-5962	116	11	an	an	DET
bam-5962	116	12	autoimmune	autoimmune	ADJ
bam-5962	116	13	vasculitis	vasculitis	NOUN
bam-5962	116	14	.	.	PUNCT
bam-5962	117	1	positive	positive	ADJ
bam-5962	117	2	history	history	NOUN
bam-5962	117	3	of	of	ADP
bam-5962	117	4	sarcoidosis	sarcoidosis	NOUN
bam-5962	117	5	may	may	AUX
bam-5962	117	6	support	support	VERB
bam-5962	117	7	this	this	DET
bam-5962	117	8	theory	theory	NOUN
bam-5962	117	9	.	.	PUNCT
bam-5962	118	1	17	17	NUM
bam-5962	118	2	however	however	ADV
bam-5962	118	3	,	,	PUNCT
bam-5962	118	4	although	although	SCONJ
bam-5962	118	5	extensive	extensive	ADJ
bam-5962	118	6	tumor	tumor	NOUN
bam-5962	118	7	screening	screening	NOUN
bam-5962	118	8	was	be	AUX
bam-5962	118	9	negative	negative	ADJ
bam-5962	118	10	,	,	PUNCT
bam-5962	118	11	an	an	DET
bam-5962	118	12	occult	occult	NOUN
bam-5962	118	13	carcinoma	carcinoma	NOUN
bam-5962	118	14	can	can	AUX
bam-5962	118	15	not	not	PART
bam-5962	118	16	be	be	AUX
bam-5962	118	17	ruled	rule	VERB
bam-5962	118	18	out	out	ADP
bam-5962	118	19	.	.	PUNCT
bam-5962	119	1	the	the	DET
bam-5962	119	2	urothelial	urothelial	ADJ
bam-5962	119	3	cancer	cancer	NOUN
bam-5962	119	4	found	find	VERB
bam-5962	119	5	in	in	ADP
bam-5962	119	6	the	the	DET
bam-5962	119	7	second	second	ADJ
bam-5962	119	8	patient	patient	NOUN
bam-5962	119	9	is	be	AUX
bam-5962	119	10	not	not	PART
bam-5962	119	11	a	a	DET
bam-5962	119	12	typical	typical	ADJ
bam-5962	119	13	cause	cause	NOUN
bam-5962	119	14	of	of	ADP
bam-5962	119	15	paraneoplastic	paraneoplastic	ADJ
bam-5962	119	16	syndrome	syndrome	NOUN
bam-5962	119	17	.	.	PUNCT
bam-5962	120	1	on	on	ADP
bam-5962	120	2	the	the	DET
bam-5962	120	3	other	other	ADJ
bam-5962	120	4	hand	hand	NOUN
bam-5962	120	5	,	,	PUNCT
bam-5962	120	6	pulmonary	pulmonary	ADJ
bam-5962	120	7	metastasis	metastasis	NOUN
bam-5962	120	8	might	might	AUX
bam-5962	120	9	have	have	AUX
bam-5962	120	10	masked	mask	VERB
bam-5962	120	11	an	an	DET
bam-5962	120	12	underlying	underlying	ADJ
bam-5962	120	13	bronchial	bronchial	ADJ
bam-5962	120	14	carcinoma	carcinoma	NOUN
bam-5962	120	15	.	.	PUNCT
bam-5962	121	1	the	the	DET
bam-5962	121	2	systematic	systematic	PROPN
bam-5962	121	3	literature	literature	NOUN
bam-5962	121	4	search	search	NOUN
bam-5962	121	5	identified	identify	VERB
bam-5962	121	6	only	only	ADV
bam-5962	121	7	few	few	ADJ
bam-5962	121	8	cases	case	NOUN
bam-5962	121	9	of	of	ADP
bam-5962	121	10	mg	mg	NUM
bam-5962	121	11	and	and	CCONJ
bam-5962	121	12	presynaptic	presynaptic	ADJ
bam-5962	121	13	overlap	overlap	NOUN
bam-5962	121	14	syndrome	syndrome	NOUN
bam-5962	121	15	.	.	PUNCT
bam-5962	122	1	15,18	15,18	NUM
bam-5962	122	2	-	-	SYM
bam-5962	122	3	21	21	NUM
bam-5962	122	4	these	these	DET
bam-5962	122	5	cases	case	NOUN
bam-5962	122	6	were	be	AUX
bam-5962	122	7	characterized	characterize	VERB
bam-5962	122	8	by	by	ADP
bam-5962	122	9	ocula	ocula	ADJ
bam-5962	122	10	-	-	PUNCT
bam-5962	122	11	bulbar	bulbar	NOUN
bam-5962	122	12	symptoms	symptom	NOUN
bam-5962	122	13	,	,	PUNCT
bam-5962	122	14	a	a	DET
bam-5962	122	15	response	response	NOUN
bam-5962	122	16	to	to	AUX
bam-5962	122	17	edrophonium	edrophonium	VERB
bam-5962	122	18	,	,	PUNCT
bam-5962	122	19	hyporeflexia	hyporeflexia	NOUN
bam-5962	122	20	and	and	CCONJ
bam-5962	122	21	an	an	DET
bam-5962	122	22	increment	increment	NOUN
bam-5962	122	23	of	of	ADP
bam-5962	122	24	reduced	reduce	VERB
bam-5962	122	25	cmap	cmap	NOUN
bam-5962	122	26	in	in	ADP
bam-5962	122	27	ncs	ncs	NOUN
bam-5962	122	28	.	.	PUNCT
bam-5962	123	1	oh	oh	INTJ
bam-5962	123	2	and	and	CCONJ
bam-5962	123	3	colleagues	colleague	NOUN
bam-5962	123	4	presented	present	VERB
bam-5962	123	5	a	a	DET
bam-5962	123	6	case	case	NOUN
bam-5962	123	7	of	of	ADP
bam-5962	123	8	a	a	DET
bam-5962	123	9	young	young	ADJ
bam-5962	123	10	women	woman	NOUN
bam-5962	123	11	with	with	ADP
bam-5962	123	12	myasthenic	myasthenic	ADJ
bam-5962	123	13	symptoms	symptom	NOUN
bam-5962	123	14	as	as	ADV
bam-5962	123	15	well	well	ADV
bam-5962	123	16	as	as	ADP
bam-5962	123	17	proximal	proximal	ADJ
bam-5962	123	18	muscle	muscle	NOUN
bam-5962	123	19	weakness	weakness	NOUN
bam-5962	123	20	,	,	PUNCT
bam-5962	123	21	elevated	elevated	ADJ
bam-5962	123	22	anti	anti	ADJ
bam-5962	123	23	-	-	ADJ
bam-5962	123	24	vgcc	vgcc	ADJ
bam-5962	123	25	n	n	CCONJ
bam-5962	123	26	-	-	PUNCT
bam-5962	123	27	type	type	NOUN
bam-5962	123	28	antibodies	antibody	NOUN
bam-5962	123	29	and	and	CCONJ
bam-5962	123	30	response	response	NOUN
bam-5962	123	31	to	to	ADP
bam-5962	123	32	intravenous	intravenous	ADJ
bam-5962	123	33	immunoglobulins	immunoglobulin	NOUN
bam-5962	123	34	.	.	PUNCT
bam-5962	124	1	19	19	NUM
bam-5962	124	2	ueda	ueda	PROPN
bam-5962	124	3	et	et	PROPN
bam-5962	124	4	al	al	PROPN
bam-5962	124	5	.	.	PROPN
bam-5962	124	6	described	describe	VERB
bam-5962	124	7	a	a	DET
bam-5962	124	8	case	case	NOUN
bam-5962	124	9	of	of	ADP
bam-5962	124	10	anti	anti	ADJ
bam-5962	124	11	-	-	ADJ
bam-5962	124	12	vgcc	vgcc	ADJ
bam-5962	124	13	p	p	X
bam-5962	124	14	/	/	SYM
bam-5962	124	15	q	q	ADJ
bam-5962	124	16	-	-	PUNCT
bam-5962	124	17	type	type	NOUN
bam-5962	124	18	antibodies	antibody	NOUN
bam-5962	124	19	with	with	ADP
bam-5962	124	20	dropped	drop	VERB
bam-5962	124	21	head	head	NOUN
bam-5962	124	22	syndrome	syndrome	NOUN
bam-5962	124	23	as	as	SCONJ
bam-5962	124	24	found	find	VERB
bam-5962	124	25	in	in	ADP
bam-5962	124	26	our	our	PRON
bam-5962	124	27	patients.21	patients.21	NOUN
bam-5962	124	28	a	a	DET
bam-5962	124	29	recent	recent	ADJ
bam-5962	124	30	overview	overview	NOUN
bam-5962	124	31	of	of	ADP
bam-5962	124	32	oh	oh	INTJ
bam-5962	124	33	compared	compare	VERB
bam-5962	124	34	39	39	NUM
bam-5962	124	35	as	as	SCONJ
bam-5962	124	36	mlos	mlo	NOUN
bam-5962	124	37	classified	classify	VERB
bam-5962	124	38	cases	case	NOUN
bam-5962	124	39	with	with	ADP
bam-5962	124	40	typical	typical	ADJ
bam-5962	124	41	signs	sign	NOUN
bam-5962	124	42	of	of	ADP
bam-5962	124	43	mg	mg	PROPN
bam-5962	124	44	and	and	CCONJ
bam-5962	124	45	lems	lem	NOUN
bam-5962	124	46	.	.	PUNCT
bam-5962	125	1	while	while	SCONJ
bam-5962	125	2	in	in	ADP
bam-5962	125	3	lems	lem	NOUN
bam-5962	125	4	98	98	NUM
bam-5962	125	5	%	%	NOUN
bam-5962	125	6	of	of	ADP
bam-5962	125	7	the	the	DET
bam-5962	125	8	patient	patient	NOUN
bam-5962	125	9	has	have	AUX
bam-5962	125	10	decreased	decrease	VERB
bam-5962	125	11	or	or	CCONJ
bam-5962	125	12	absent	absent	ADJ
bam-5962	125	13	reflexes	reflex	NOUN
bam-5962	125	14	,	,	PUNCT
bam-5962	125	15	in	in	ADP
bam-5962	125	16	overlap	overlap	NOUN
bam-5962	125	17	syndromes	syndrome	NOUN
bam-5962	125	18	this	this	PRON
bam-5962	125	19	was	be	AUX
bam-5962	125	20	only	only	ADV
bam-5962	125	21	documented	document	VERB
bam-5962	125	22	in	in	ADP
bam-5962	125	23	74	74	NUM
bam-5962	125	24	%	%	NOUN
bam-5962	125	25	of	of	ADP
bam-5962	125	26	the	the	DET
bam-5962	125	27	patients	patient	NOUN
bam-5962	125	28	.	.	PUNCT
bam-5962	126	1	15	15	NUM
bam-5962	126	2	therefore	therefore	ADV
bam-5962	126	3	,	,	PUNCT
bam-5962	126	4	normal	normal	ADJ
bam-5962	126	5	reflexes	reflex	NOUN
bam-5962	126	6	do	do	AUX
bam-5962	126	7	not	not	PART
bam-5962	126	8	exclude	exclude	VERB
bam-5962	126	9	the	the	DET
bam-5962	126	10	diagnosis	diagnosis	NOUN
bam-5962	126	11	of	of	ADP
bam-5962	126	12	a	a	DET
bam-5962	126	13	potential	potential	ADJ
bam-5962	126	14	mlos	mlo	NOUN
bam-5962	126	15	.	.	PUNCT
bam-5962	127	1	the	the	DET
bam-5962	127	2	detection	detection	NOUN
bam-5962	127	3	of	of	ADP
bam-5962	127	4	anti	anti	ADJ
bam-5962	127	5	-	-	ADJ
bam-5962	127	6	vgcc	vgcc	ADJ
bam-5962	127	7	n	n	CCONJ
bam-5962	127	8	-	-	PUNCT
bam-5962	127	9	type	type	NOUN
bam-5962	127	10	antibodies	antibody	NOUN
bam-5962	127	11	is	be	AUX
bam-5962	127	12	often	often	ADV
bam-5962	127	13	accompanied	accompany	VERB
bam-5962	127	14	by	by	ADP
bam-5962	127	15	a	a	DET
bam-5962	127	16	cancer	cancer	NOUN
bam-5962	127	17	disease	disease	NOUN
bam-5962	127	18	,	,	PUNCT
bam-5962	127	19	typically	typically	ADV
bam-5962	127	20	a	a	DET
bam-5962	127	21	small	small	ADJ
bam-5962	127	22	cell	cell	NOUN
bam-5962	127	23	lung	lung	NOUN
bam-5962	127	24	cancer	cancer	NOUN
bam-5962	127	25	(	(	PUNCT
bam-5962	127	26	sclc	sclc	PROPN
bam-5962	127	27	)	)	PUNCT
bam-5962	127	28	.	.	PUNCT
bam-5962	128	1	while	while	SCONJ
bam-5962	128	2	scls	scls	PROPN
bam-5962	128	3	can	can	AUX
bam-5962	128	4	be	be	AUX
bam-5962	128	5	detected	detect	VERB
bam-5962	128	6	in	in	ADP
bam-5962	128	7	~50	~50	ADP
bam-5962	128	8	%	%	NOUN
bam-5962	128	9	of	of	ADP
bam-5962	128	10	the	the	DET
bam-5962	128	11	patients	patient	NOUN
bam-5962	128	12	with	with	ADP
bam-5962	128	13	lems	lem	NOUN
bam-5962	128	14	,	,	PUNCT
bam-5962	128	15	in	in	ADP
bam-5962	128	16	overlap	overlap	NOUN
bam-5962	128	17	syndromes	syndrome	NOUN
bam-5962	128	18	sclc	sclc	PROPN
bam-5962	128	19	was	be	AUX
bam-5962	128	20	found	find	VERB
bam-5962	128	21	in	in	ADP
bam-5962	128	22	18%.15	18%.15	NUM
bam-5962	128	23	in	in	ADP
bam-5962	128	24	the	the	DET
bam-5962	128	25	case	case	NOUN
bam-5962	128	26	series	series	NOUN
bam-5962	128	27	of	of	ADP
bam-5962	128	28	oh	oh	INTJ
bam-5962	128	29	et	et	PROPN
bam-5962	128	30	al	al	PROPN
bam-5962	128	31	.	.	PROPN
bam-5962	128	32	,	,	PUNCT
bam-5962	128	33	patients	patient	NOUN
bam-5962	128	34	were	be	AUX
bam-5962	128	35	positive	positive	ADJ
bam-5962	128	36	for	for	ADP
bam-5962	128	37	anti	anti	ADJ
bam-5962	128	38	-	-	ADJ
bam-5962	128	39	vgcc	vgcc	ADJ
bam-5962	128	40	n	n	CCONJ
bam-5962	128	41	-	-	PUNCT
bam-5962	128	42	type	type	NOUN
bam-5962	128	43	and	and	CCONJ
bam-5962	128	44	anti	anti	ADJ
bam-5962	128	45	-	-	ADJ
bam-5962	128	46	vgcc	vgcc	ADJ
bam-5962	128	47	p	p	X
bam-5962	128	48	/	/	SYM
bam-5962	128	49	q	q	ADJ
bam-5962	128	50	-	-	PUNCT
bam-5962	128	51	type	type	NOUN
bam-5962	128	52	antibodies	antibodie	VERB
bam-5962	128	53	.	.	PUNCT
bam-5962	129	1	however	however	ADV
bam-5962	129	2	,	,	PUNCT
bam-5962	129	3	lems	lem	VERB
bam-5962	129	4	cases	case	NOUN
bam-5962	129	5	with	with	ADP
bam-5962	129	6	isolated	isolated	ADJ
bam-5962	129	7	anti	anti	ADJ
bam-5962	129	8	-	-	ADJ
bam-5962	129	9	vgcc	vgcc	ADJ
bam-5962	129	10	n	n	CCONJ
bam-5962	129	11	-	-	PUNCT
bam-5962	129	12	type	type	NOUN
bam-5962	129	13	antibodies	antibody	NOUN
bam-5962	129	14	are	be	AUX
bam-5962	129	15	rare	rare	ADJ
bam-5962	129	16	.	.	PUNCT
bam-5962	130	1	15	15	NUM
bam-5962	130	2	recently	recently	ADV
bam-5962	130	3	a	a	DET
bam-5962	130	4	similar	similar	ADJ
bam-5962	130	5	case	case	NOUN
bam-5962	130	6	of	of	ADP
bam-5962	130	7	dropped	drop	VERB
bam-5962	130	8	head	head	NOUN
bam-5962	130	9	syndrome	syndrome	NOUN
bam-5962	130	10	with	with	ADP
bam-5962	130	11	positive	positive	ADJ
bam-5962	130	12	anti	anti	ADJ
bam-5962	130	13	-	-	ADJ
bam-5962	130	14	vgcc	vgcc	ADJ
bam-5962	130	15	n	n	CCONJ
bam-5962	130	16	-	-	PUNCT
bam-5962	130	17	type	type	NOUN
bam-5962	130	18	antibodies	antibody	NOUN
bam-5962	130	19	was	be	AUX
bam-5962	130	20	published	publish	VERB
bam-5962	130	21	,	,	PUNCT
bam-5962	130	22	suggesting	suggest	VERB
bam-5962	130	23	an	an	DET
bam-5962	130	24	anti	anti	ADJ
bam-5962	130	25	-	-	ADJ
bam-5962	130	26	vgcc	vgcc	ADJ
bam-5962	130	27	n	n	CCONJ
bam-5962	130	28	-	-	PUNCT
bam-5962	130	29	type	type	NOUN
bam-5962	130	30	mediated	mediate	VERB
bam-5962	130	31	,	,	PUNCT
bam-5962	130	32	non	non	ADJ
bam-5962	130	33	-	-	ADJ
bam-5962	130	34	paraneoplastic	paraneoplastic	ADJ
bam-5962	130	35	lems	lem	NOUN
bam-5962	130	36	.	.	PUNCT
bam-5962	131	1	20	20	NUM
bam-5962	131	2	in	in	ADP
bam-5962	131	3	this	this	DET
bam-5962	131	4	patient	patient	NOUN
bam-5962	131	5	neither	neither	CCONJ
bam-5962	131	6	sclc	sclc	PROPN
bam-5962	131	7	nor	nor	CCONJ
bam-5962	131	8	anti	anti	ADJ
bam-5962	131	9	-	-	ADJ
bam-5962	131	10	vgcc	vgcc	ADJ
bam-5962	131	11	p	p	X
bam-5962	131	12	/	/	SYM
bam-5962	131	13	q	q	ADJ
bam-5962	131	14	-	-	PUNCT
bam-5962	131	15	type	type	NOUN
bam-5962	131	16	antibodies	antibody	NOUN
bam-5962	131	17	could	could	AUX
bam-5962	131	18	be	be	AUX
bam-5962	131	19	detected	detect	VERB
bam-5962	131	20	and	and	CCONJ
bam-5962	131	21	the	the	DET
bam-5962	131	22	patient	patient	NOUN
bam-5962	131	23	improved	improve	VERB
bam-5962	131	24	under	under	ADP
bam-5962	131	25	table	table	NOUN
bam-5962	131	26	1	1	NUM
bam-5962	131	27	.	.	PUNCT
bam-5962	132	1	demographics	demographic	NOUN
bam-5962	132	2	and	and	CCONJ
bam-5962	132	3	symptoms	symptom	NOUN
bam-5962	132	4	of	of	ADP
bam-5962	132	5	the	the	DET
bam-5962	132	6	reported	report	VERB
bam-5962	132	7	patients	patient	NOUN
bam-5962	132	8	.	.	PUNCT
bam-5962	133	1	no	no	INTJ
bam-5962	133	2	.	.	PUNCT
bam-5962	134	1	age	age	NOUN
bam-5962	134	2	gender	gender	NOUN
bam-5962	134	3	vgcc	vgcc	PROPN
bam-5962	134	4	n	n	CCONJ
bam-5962	134	5	-	-	PUNCT
bam-5962	134	6	type	type	NOUN
bam-5962	134	7	ach	ach	NOUN
bam-5962	134	8	-	-	PUNCT
bam-5962	134	9	r	r	NOUN
bam-5962	134	10	-	-	PUNCT
bam-5962	134	11	ab	ab	NOUN
bam-5962	134	12	decrement	decrement	ADJ
bam-5962	134	13	increment	increment	VERB
bam-5962	134	14	autonomic	autonomic	ADJ
bam-5962	134	15	symptons	sympton	NOUN
bam-5962	134	16	response	response	NOUN
bam-5962	134	17	to	to	PART
bam-5962	134	18	pyridostigmin	pyridostigmin	VERB
bam-5962	134	19	#	#	NOUN
bam-5962	134	20	1	1	NUM
bam-5962	134	21	71	71	NUM
bam-5962	134	22	m	m	NOUN
bam-5962	134	23	y	y	NOUN
bam-5962	134	24	y	y	PROPN
bam-5962	134	25	y	y	PROPN
bam-5962	134	26	y	y	PROPN
bam-5962	134	27	y	y	PROPN
bam-5962	134	28	initially	initially	ADV
bam-5962	134	29	#	#	NOUN
bam-5962	134	30	2	2	NUM
bam-5962	134	31	80	80	NUM
bam-5962	134	32	m	m	NOUN
bam-5962	134	33	y	y	PROPN
bam-5962	134	34	n	n	CCONJ
bam-5962	134	35	y	y	PROPN
bam-5962	134	36	n	n	CCONJ
bam-5962	134	37	y	y	PROPN
bam-5962	134	38	initially	initially	ADV
bam-5962	134	39	#	#	NOUN
bam-5962	134	40	3	3	NUM
bam-5962	134	41	71	71	NUM
bam-5962	134	42	f	f	NOUN
bam-5962	134	43	y	y	PROPN
bam-5962	134	44	y	y	PROPN
bam-5962	134	45	y	y	PROPN
bam-5962	135	1	n	n	CCONJ
bam-5962	135	2	y	y	PROPN
bam-5962	135	3	initially	initially	ADV
bam-5962	135	4	non	non	ADJ
bam-5962	135	5	co	co	PROPN
bam-5962	135	6	mmerc	mmerc	PROPN
bam-5962	135	7	ial	ial	PROPN
bam-5962	135	8	us	us	PROPN
bam-5962	135	9	e	e	NOUN
bam-5962	135	10	o	o	NOUN
bam-5962	135	11	nly	nly	ADV
bam-5962	135	12	clinical	clinical	ADJ
bam-5962	135	13	features	feature	NOUN
bam-5962	135	14	of	of	ADP
bam-5962	135	15	n	n	CCONJ
bam-5962	135	16	-	-	PUNCT
bam-5962	135	17	type	type	NOUN
bam-5962	135	18	vgcc	vgcc	NOUN
bam-5962	135	19	neuromuscular	neuromuscular	ADJ
bam-5962	135	20	syndromes	syndrome	NOUN
bam-5962	135	21	eur	eur	PROPN
bam-5962	135	22	j	j	PROPN
bam-5962	135	23	transl	transl	PROPN
bam-5962	135	24	myol	myol	NOUN
bam-5962	135	25	26	26	NUM
bam-5962	135	26	(	(	PUNCT
bam-5962	135	27	4	4	NUM
bam-5962	135	28	):	):	PUNCT
bam-5962	135	29	301	301	NUM
bam-5962	135	30	-	-	SYM
bam-5962	135	31	306	306	NUM
bam-5962	135	32	305	305	NUM
bam-5962	135	33	immunosuppressive	immunosuppressive	ADJ
bam-5962	135	34	and	and	CCONJ
bam-5962	135	35	symptomatic	symptomatic	ADJ
bam-5962	135	36	treatment	treatment	NOUN
bam-5962	135	37	.	.	PUNCT
bam-5962	136	1	as	as	ADV
bam-5962	136	2	far	far	ADV
bam-5962	136	3	as	as	SCONJ
bam-5962	136	4	we	we	PRON
bam-5962	136	5	know	know	VERB
bam-5962	136	6	,	,	PUNCT
bam-5962	136	7	we	we	PRON
bam-5962	136	8	present	present	VERB
bam-5962	136	9	the	the	DET
bam-5962	136	10	first	first	ADJ
bam-5962	136	11	series	series	NOUN
bam-5962	136	12	with	with	ADP
bam-5962	136	13	mlos	mlo	NOUN
bam-5962	136	14	characterized	characterize	VERB
bam-5962	136	15	by	by	ADP
bam-5962	136	16	remarkable	remarkable	ADJ
bam-5962	136	17	dropped	drop	VERB
bam-5962	136	18	head	head	NOUN
bam-5962	136	19	syndrome	syndrome	NOUN
bam-5962	136	20	,	,	PUNCT
bam-5962	136	21	bulbar	bulbar	NOUN
bam-5962	136	22	symptoms	symptom	NOUN
bam-5962	136	23	and	and	CCONJ
bam-5962	136	24	respiratory	respiratory	ADJ
bam-5962	136	25	muscles	muscle	NOUN
bam-5962	136	26	weakness	weakness	NOUN
bam-5962	136	27	,	,	PUNCT
bam-5962	136	28	and	and	CCONJ
bam-5962	136	29	positive	positive	ADJ
bam-5962	136	30	anti	anti	ADJ
bam-5962	136	31	-	-	ADJ
bam-5962	136	32	vgcc	vgcc	ADJ
bam-5962	136	33	n	n	NOUN
bam-5962	136	34	-	-	PUNCT
bam-5962	136	35	type	type	NOUN
bam-5962	136	36	but	but	CCONJ
bam-5962	136	37	not	not	PART
bam-5962	136	38	p	p	X
bam-5962	136	39	/	/	SYM
bam-5962	136	40	q	q	ADJ
bam-5962	136	41	-	-	PUNCT
bam-5962	136	42	type	type	NOUN
bam-5962	136	43	antibodies	antibodie	VERB
bam-5962	136	44	.	.	PUNCT
bam-5962	137	1	although	although	SCONJ
bam-5962	137	2	the	the	DET
bam-5962	137	3	role	role	NOUN
bam-5962	137	4	of	of	ADP
bam-5962	137	5	n	n	CCONJ
bam-5962	137	6	-	-	PUNCT
bam-5962	137	7	type	type	NOUN
bam-5962	137	8	vgcc	vgcc	NOUN
bam-5962	137	9	in	in	ADP
bam-5962	137	10	neuromuscular	neuromuscular	ADJ
bam-5962	137	11	junction	junction	NOUN
bam-5962	137	12	disorders	disorder	NOUN
bam-5962	137	13	remains	remain	VERB
bam-5962	137	14	unclear	unclear	ADJ
bam-5962	137	15	,	,	PUNCT
bam-5962	137	16	detectable	detectable	ADJ
bam-5962	137	17	antibodies	antibody	NOUN
bam-5962	137	18	has	have	VERB
bam-5962	137	19	to	to	PART
bam-5962	137	20	be	be	AUX
bam-5962	137	21	taken	take	VERB
bam-5962	137	22	in	in	ADP
bam-5962	137	23	account	account	NOUN
bam-5962	137	24	for	for	ADP
bam-5962	137	25	the	the	DET
bam-5962	137	26	planning	planning	NOUN
bam-5962	137	27	of	of	ADP
bam-5962	137	28	symptomatic	symptomatic	ADJ
bam-5962	137	29	treatment	treatment	NOUN
bam-5962	137	30	with	with	ADP
bam-5962	137	31	pyridostigmin	pyridostigmin	NOUN
bam-5962	137	32	or	or	CCONJ
bam-5962	137	33	3,4	3,4	NUM
bam-5962	137	34	-	-	PUNCT
bam-5962	137	35	diaminopyridin	diaminopyridin	NOUN
bam-5962	137	36	.	.	PUNCT
bam-5962	138	1	however	however	ADV
bam-5962	138	2	,	,	PUNCT
bam-5962	138	3	the	the	DET
bam-5962	138	4	rarity	rarity	NOUN
bam-5962	138	5	of	of	ADP
bam-5962	138	6	this	this	DET
bam-5962	138	7	disease	disease	NOUN
bam-5962	138	8	will	will	AUX
bam-5962	138	9	limit	limit	VERB
bam-5962	138	10	exact	exact	ADJ
bam-5962	138	11	characterization	characterization	NOUN
bam-5962	138	12	.	.	PUNCT
bam-5962	139	1	this	this	DET
bam-5962	139	2	phenotype	phenotype	NOUN
bam-5962	139	3	and	and	CCONJ
bam-5962	139	4	serological	serological	ADJ
bam-5962	139	5	findings	finding	NOUN
bam-5962	139	6	should	should	AUX
bam-5962	139	7	prompt	prompt	VERB
bam-5962	139	8	a	a	DET
bam-5962	139	9	search	search	NOUN
bam-5962	139	10	for	for	ADP
bam-5962	139	11	neoplasms	neoplasm	NOUN
bam-5962	139	12	beyond	beyond	ADP
bam-5962	139	13	thymoma	thymoma	NOUN
bam-5962	139	14	,	,	PUNCT
bam-5962	139	15	especially	especially	ADV
bam-5962	139	16	carcinoma	carcinoma	NOUN
bam-5962	139	17	like	like	ADP
bam-5962	139	18	sclc.22	sclc.22	NOUN
bam-5962	139	19	in	in	ADP
bam-5962	139	20	conclusion	conclusion	NOUN
bam-5962	139	21	,	,	PUNCT
bam-5962	139	22	myasthenic	myasthenic	ADJ
bam-5962	139	23	patients	patient	NOUN
bam-5962	139	24	with	with	ADP
bam-5962	139	25	dropped	drop	VERB
bam-5962	139	26	head	head	NOUN
bam-5962	139	27	syndrome	syndrome	NOUN
bam-5962	139	28	,	,	PUNCT
bam-5962	139	29	bulbar	bulbar	NOUN
bam-5962	139	30	symptoms	symptom	NOUN
bam-5962	139	31	,	,	PUNCT
bam-5962	139	32	and	and	CCONJ
bam-5962	139	33	axial	axial	ADJ
bam-5962	139	34	and	and	CCONJ
bam-5962	139	35	possible	possible	ADJ
bam-5962	139	36	respiratory	respiratory	ADJ
bam-5962	139	37	muscle	muscle	NOUN
bam-5962	139	38	weakness	weakness	NOUN
bam-5962	139	39	should	should	AUX
bam-5962	139	40	carefully	carefully	ADV
bam-5962	139	41	be	be	AUX
bam-5962	139	42	searched	search	VERB
bam-5962	139	43	for	for	ADP
bam-5962	139	44	the	the	DET
bam-5962	139	45	detection	detection	NOUN
bam-5962	139	46	of	of	ADP
bam-5962	139	47	anti	anti	ADJ
bam-5962	139	48	-	-	ADJ
bam-5962	139	49	vgcc	vgcc	ADJ
bam-5962	139	50	n	n	CCONJ
bam-5962	139	51	-	-	PUNCT
bam-5962	139	52	type	type	NOUN
bam-5962	139	53	antibodies	antibody	NOUN
bam-5962	139	54	,	,	PUNCT
bam-5962	139	55	especially	especially	ADV
bam-5962	139	56	when	when	SCONJ
bam-5962	139	57	treated	treat	VERB
bam-5962	139	58	unsatisfactorily	unsatisfactorily	ADV
bam-5962	139	59	with	with	ADP
bam-5962	139	60	pyridostigmine	pyridostigmine	PROPN
bam-5962	139	61	.	.	PUNCT
bam-5962	140	1	if	if	SCONJ
bam-5962	140	2	anti	anti	ADJ
bam-5962	140	3	-	-	ADJ
bam-5962	140	4	vgcc	vgcc	ADJ
bam-5962	140	5	n	n	CCONJ
bam-5962	140	6	-	-	PUNCT
bam-5962	140	7	type	type	NOUN
bam-5962	140	8	antibodies	antibody	NOUN
bam-5962	140	9	are	be	AUX
bam-5962	140	10	positive	positive	ADJ
bam-5962	140	11	,	,	PUNCT
bam-5962	140	12	3,4	3,4	NUM
bam-5962	140	13	-	-	NUM
bam-5962	140	14	diaminopyridine	diaminopyridine	NOUN
bam-5962	140	15	might	might	AUX
bam-5962	140	16	be	be	AUX
bam-5962	140	17	a	a	DET
bam-5962	140	18	considerable	considerable	ADJ
bam-5962	140	19	addition	addition	NOUN
bam-5962	140	20	to	to	ADP
bam-5962	140	21	therapy	therapy	NOUN
bam-5962	140	22	without	without	ADP
bam-5962	140	23	severe	severe	ADJ
bam-5962	140	24	side	side	NOUN
bam-5962	140	25	-	-	PUNCT
bam-5962	140	26	effects	effect	NOUN
bam-5962	140	27	.	.	PUNCT
bam-5962	141	1	author	author	NOUN
bam-5962	141	2	’s	’s	PART
bam-5962	141	3	contributions	contribution	NOUN
bam-5962	141	4	at	at	ADP
bam-5962	141	5	wrote	write	VERB
bam-5962	141	6	the	the	DET
bam-5962	141	7	manuscript	manuscript	NOUN
bam-5962	141	8	and	and	CCONJ
bam-5962	141	9	analysed	analyse	VERB
bam-5962	141	10	the	the	DET
bam-5962	141	11	patient´s	patient´s	NOUN
bam-5962	141	12	history	history	NOUN
bam-5962	141	13	,	,	PUNCT
bam-5962	141	14	pm	pm	NOUN
bam-5962	141	15	and	and	CCONJ
bam-5962	141	16	ok	ok	INTJ
bam-5962	141	17	were	be	AUX
bam-5962	141	18	involved	involve	VERB
bam-5962	141	19	in	in	ADP
bam-5962	141	20	the	the	DET
bam-5962	141	21	patient´s	patient´s	NOUN
bam-5962	141	22	treatment	treatment	NOUN
bam-5962	141	23	and	and	CCONJ
bam-5962	141	24	have	have	AUX
bam-5962	141	25	corrected	correct	VERB
bam-5962	141	26	manuscript	manuscript	NOUN
bam-5962	141	27	,	,	PUNCT
bam-5962	141	28	th	th	X
bam-5962	141	29	was	be	AUX
bam-5962	141	30	involved	involve	VERB
bam-5962	141	31	in	in	ADP
bam-5962	141	32	the	the	DET
bam-5962	141	33	patients	patient	NOUN
bam-5962	141	34	treatment	treatment	NOUN
bam-5962	141	35	,	,	PUNCT
bam-5962	141	36	analysed	analyse	VERB
bam-5962	141	37	the	the	DET
bam-5962	141	38	patients	patient	NOUN
bam-5962	141	39	’	’	PART
bam-5962	141	40	history	history	NOUN
bam-5962	141	41	and	and	CCONJ
bam-5962	141	42	supervised	supervise	VERB
bam-5962	141	43	the	the	DET
bam-5962	141	44	manuscript	manuscript	NOUN
bam-5962	141	45	.	.	PUNCT
bam-5962	142	1	acknowledgments	acknowledgment	NOUN
bam-5962	142	2	the	the	DET
bam-5962	142	3	authors	author	NOUN
bam-5962	142	4	thank	thank	VERB
bam-5962	142	5	kathy	kathy	PROPN
bam-5962	142	6	keyvani	keyvani	PROPN
bam-5962	142	7	for	for	ADP
bam-5962	142	8	providing	provide	VERB
bam-5962	142	9	the	the	DET
bam-5962	142	10	image	image	NOUN
bam-5962	142	11	of	of	ADP
bam-5962	142	12	the	the	DET
bam-5962	142	13	muscle	muscle	NOUN
bam-5962	142	14	biopsy	biopsy	NOUN
bam-5962	142	15	.	.	PUNCT
bam-5962	143	1	conflict	conflict	NOUN
bam-5962	143	2	of	of	ADP
bam-5962	143	3	interest	interest	NOUN
bam-5962	143	4	the	the	DET
bam-5962	143	5	authors	author	NOUN
bam-5962	143	6	report	report	VERB
bam-5962	143	7	no	no	DET
bam-5962	143	8	conflicts	conflict	NOUN
bam-5962	143	9	of	of	ADP
bam-5962	143	10	interest	interest	NOUN
bam-5962	143	11	.	.	PUNCT
bam-5962	144	1	corresponding	correspond	VERB
bam-5962	144	2	author	author	NOUN
bam-5962	144	3	tim	tim	PROPN
bam-5962	144	4	hagenacker	hagenacker	PROPN
bam-5962	144	5	,	,	PUNCT
bam-5962	144	6	md	md	PROPN
bam-5962	144	7	,	,	PUNCT
bam-5962	144	8	department	department	PROPN
bam-5962	144	9	of	of	ADP
bam-5962	144	10	neurology	neurology	NOUN
bam-5962	144	11	,	,	PUNCT
bam-5962	144	12	university	university	NOUN
bam-5962	144	13	of	of	ADP
bam-5962	144	14	duisburg	duisburg	PROPN
bam-5962	144	15	-	-	PUNCT
bam-5962	144	16	essen	essen	NOUN
bam-5962	144	17	,	,	PUNCT
bam-5962	144	18	hufelandstrasse	hufelandstrasse	VERB
bam-5962	144	19	5,5	5,5	NUM
bam-5962	144	20	d45122	d45122	PROPN
bam-5962	144	21	essen	essen	PROPN
bam-5962	144	22	,	,	PUNCT
bam-5962	144	23	germany	germany	PROPN
bam-5962	144	24	email	email	NOUN
bam-5962	144	25	:	:	PUNCT
bam-5962	144	26	tim.hagenacker@uk-essen.de	tim.hagenacker@uk-essen.de	PROPN
bam-5962	144	27	e	e	X
bam-5962	144	28	-	-	NOUN
bam-5962	144	29	mails	mail	NOUN
bam-5962	144	30	of	of	ADP
bam-5962	144	31	coauthors	coauthor	NOUN
bam-5962	144	32	:	:	PUNCT
bam-5962	144	33	andreas	andreas	PROPN
bam-5962	144	34	totzeck	totzeck	PROPN
bam-5962	144	35	:	:	PUNCT
bam-5962	144	36	andreas.totzeck@uk-essen.de	andreas.totzeck@uk-essen.de	PUNCT
bam-5962	144	37	petra	petra	ADJ
bam-5962	144	38	mummel	mummel	NOUN
bam-5962	144	39	:	:	PUNCT
bam-5962	144	40	petra.mummel@uk-essen.de	petra.mummel@uk-essen.de	PROPN
bam-5962	144	41	oliver	oliver	PROPN
bam-5962	144	42	kastrup	kastrup	PROPN
bam-5962	144	43	:	:	PUNCT
bam-5962	144	44	o.kastrup@kk-essen.de	o.kastrup@kk-essen.de	NUM
bam-5962	144	45	references	reference	NOUN
bam-5962	144	46	1	1	NUM
bam-5962	144	47	.	.	PUNCT
bam-5962	144	48	carr	carr	PROPN
bam-5962	144	49	as	as	ADP
bam-5962	144	50	,	,	PUNCT
bam-5962	144	51	cardwell	cardwell	PROPN
bam-5962	144	52	cr	cr	PROPN
bam-5962	144	53	,	,	PUNCT
bam-5962	144	54	mccarron	mccarron	PROPN
bam-5962	144	55	po	po	PROPN
bam-5962	144	56	,	,	PUNCT
bam-5962	144	57	mcconville	mcconville	PROPN
bam-5962	144	58	j.	j.	PROPN
bam-5962	144	59	a	a	DET
bam-5962	144	60	systematic	systematic	ADJ
bam-5962	144	61	review	review	NOUN
bam-5962	144	62	of	of	ADP
bam-5962	144	63	population	population	NOUN
bam-5962	144	64	based	base	VERB
bam-5962	144	65	epidemiological	epidemiological	ADJ
bam-5962	144	66	studies	study	NOUN
bam-5962	144	67	in	in	ADP
bam-5962	144	68	myasthenia	myasthenia	PROPN
bam-5962	144	69	gravis	gravis	PROPN
bam-5962	144	70	.	.	PUNCT
bam-5962	145	1	bmc	bmc	PROPN
bam-5962	145	2	neurol	neurol	PROPN
bam-5962	145	3	2010;10:46	2010;10:46	NUM
bam-5962	145	4	.	.	PUNCT
bam-5962	146	1	2	2	X
bam-5962	146	2	.	.	X
bam-5962	146	3	heldal	heldal	NOUN
bam-5962	146	4	at	at	ADP
bam-5962	146	5	,	,	PUNCT
bam-5962	146	6	owe	owe	PROPN
bam-5962	146	7	jf	jf	PROPN
bam-5962	146	8	,	,	PUNCT
bam-5962	146	9	gilhus	gilhus	PROPN
bam-5962	146	10	ne	ne	PROPN
bam-5962	146	11	,	,	PUNCT
bam-5962	146	12	romi	romi	PROPN
bam-5962	146	13	f.	f.	PROPN
bam-5962	146	14	seropositive	seropositive	ADJ
bam-5962	146	15	myasthenia	myasthenia	PROPN
bam-5962	146	16	gravis	gravis	NOUN
bam-5962	146	17	:	:	PUNCT
bam-5962	146	18	a	a	DET
bam-5962	146	19	nationwide	nationwide	ADJ
bam-5962	146	20	epidemiologic	epidemiologic	ADJ
bam-5962	146	21	study	study	NOUN
bam-5962	146	22	.	.	PUNCT
bam-5962	147	1	neurology	neurology	NOUN
bam-5962	147	2	2009;73:150	2009;73:150	PROPN
bam-5962	147	3	-	-	PUNCT
bam-5962	147	4	1	1	NUM
bam-5962	147	5	.	.	NOUN
bam-5962	147	6	3	3	NUM
bam-5962	147	7	.	.	X
bam-5962	147	8	gilhus	gilhus	PROPN
bam-5962	147	9	ne	ne	PROPN
bam-5962	147	10	.	.	PUNCT
bam-5962	147	11	myasthenia	myasthenia	PROPN
bam-5962	147	12	and	and	CCONJ
bam-5962	147	13	the	the	DET
bam-5962	147	14	neuromuscular	neuromuscular	ADJ
bam-5962	147	15	junction	junction	NOUN
bam-5962	147	16	.	.	PUNCT
bam-5962	148	1	curr	curr	PROPN
bam-5962	148	2	opin	opin	NOUN
bam-5962	148	3	neurol	neurol	PROPN
bam-5962	148	4	2012;25:523	2012;25:523	PROPN
bam-5962	148	5	-	-	SYM
bam-5962	148	6	9	9	NUM
bam-5962	148	7	.	.	NOUN
bam-5962	148	8	4	4	NUM
bam-5962	148	9	.	.	X
bam-5962	148	10	gilhus	gilhus	PROPN
bam-5962	148	11	ne	ne	PROPN
bam-5962	148	12	,	,	PUNCT
bam-5962	148	13	verschuuren	verschuuren	PROPN
bam-5962	148	14	jj	jj	PROPN
bam-5962	148	15	.	.	PROPN
bam-5962	148	16	myasthenia	myasthenia	PROPN
bam-5962	148	17	gravis	gravis	PROPN
bam-5962	148	18	:	:	PUNCT
bam-5962	148	19	subgroup	subgroup	NOUN
bam-5962	148	20	classification	classification	NOUN
bam-5962	148	21	and	and	CCONJ
bam-5962	148	22	therapeutic	therapeutic	ADJ
bam-5962	148	23	strategies	strategy	NOUN
bam-5962	148	24	.	.	PUNCT
bam-5962	149	1	lancet	lancet	PROPN
bam-5962	149	2	neurol	neurol	NOUN
bam-5962	149	3	2015;14:1023	2015;14:1023	NUM
bam-5962	149	4	-	-	SYM
bam-5962	149	5	36	36	NUM
bam-5962	149	6	.	.	PUNCT
bam-5962	149	7	5	5	X
bam-5962	149	8	.	.	X
bam-5962	150	1	querol	querol	PROPN
bam-5962	150	2	l	l	PROPN
bam-5962	150	3	,	,	PUNCT
bam-5962	150	4	illa	illa	PROPN
bam-5962	150	5	i.	i.	PROPN
bam-5962	150	6	myasthenia	myasthenia	PROPN
bam-5962	150	7	gravis	gravis	PROPN
bam-5962	150	8	and	and	CCONJ
bam-5962	150	9	the	the	DET
bam-5962	150	10	neuromuscular	neuromuscular	ADJ
bam-5962	150	11	junction	junction	NOUN
bam-5962	150	12	.	.	PUNCT
bam-5962	151	1	curr	curr	PROPN
bam-5962	151	2	opin	opin	NOUN
bam-5962	151	3	neurol	neurol	PROPN
bam-5962	151	4	2013;26:459	2013;26:459	NOUN
bam-5962	151	5	-	-	SYM
bam-5962	151	6	65	65	NUM
bam-5962	151	7	.	.	NOUN
bam-5962	152	1	6	6	NUM
bam-5962	152	2	.	.	X
bam-5962	153	1	verschuuren	verschuuren	PROPN
bam-5962	153	2	jj	jj	PROPN
bam-5962	153	3	,	,	PUNCT
bam-5962	153	4	huijbers	huijbers	PROPN
bam-5962	153	5	mg	mg	PROPN
bam-5962	153	6	,	,	PUNCT
bam-5962	153	7	plomp	plomp	PROPN
bam-5962	153	8	jj	jj	PROPN
bam-5962	153	9	,	,	PUNCT
bam-5962	153	10	et	et	PROPN
bam-5962	153	11	al	al	PROPN
bam-5962	153	12	.	.	PROPN
bam-5962	153	13	pathophysiology	pathophysiology	PROPN
bam-5962	153	14	of	of	ADP
bam-5962	153	15	myasthenia	myasthenia	NOUN
bam-5962	153	16	gravis	gravis	PROPN
bam-5962	153	17	with	with	ADP
bam-5962	153	18	antibodies	antibody	NOUN
bam-5962	153	19	to	to	ADP
bam-5962	153	20	the	the	DET
bam-5962	153	21	acetylcholine	acetylcholine	NOUN
bam-5962	153	22	receptor	receptor	NOUN
bam-5962	153	23	,	,	PUNCT
bam-5962	153	24	musclespecific	musclespecific	PROPN
bam-5962	153	25	kinase	kinase	PROPN
bam-5962	153	26	and	and	CCONJ
bam-5962	153	27	low	low	ADJ
bam-5962	153	28	-	-	PUNCT
bam-5962	153	29	density	density	NOUN
bam-5962	153	30	lipoprotein	lipoprotein	ADJ
bam-5962	153	31	receptor	receptor	NOUN
bam-5962	153	32	-	-	PUNCT
bam-5962	153	33	related	relate	VERB
bam-5962	153	34	protein	protein	NOUN
bam-5962	153	35	4	4	NUM
bam-5962	153	36	.	.	X
bam-5962	153	37	autoimmun	autoimmun	PROPN
bam-5962	153	38	rev	rev	VERB
bam-5962	153	39	2013;12:918	2013;12:918	NUM
bam-5962	153	40	-	-	SYM
bam-5962	153	41	23	23	NUM
bam-5962	153	42	.	.	PUNCT
bam-5962	154	1	7	7	X
bam-5962	154	2	.	.	X
bam-5962	154	3	gilhus	gilhus	PROPN
bam-5962	154	4	ne	ne	PROPN
bam-5962	154	5	,	,	PUNCT
bam-5962	154	6	skeie	skeie	PROPN
bam-5962	154	7	go	go	PROPN
bam-5962	154	8	,	,	PUNCT
bam-5962	154	9	romi	romi	PROPN
bam-5962	154	10	f	f	PROPN
bam-5962	154	11	,	,	PUNCT
bam-5962	154	12	et	et	PROPN
bam-5962	154	13	al	al	PROPN
bam-5962	154	14	.	.	PUNCT
bam-5962	155	1	myasthenia	myasthenia	PROPN
bam-5962	155	2	gravis	gravis	PROPN
bam-5962	155	3	autoantibody	autoantibody	VERB
bam-5962	155	4	characteristics	characteristic	NOUN
bam-5962	155	5	and	and	CCONJ
bam-5962	155	6	their	their	PRON
bam-5962	155	7	implications	implication	NOUN
bam-5962	155	8	for	for	ADP
bam-5962	155	9	therapy	therapy	NOUN
bam-5962	155	10	.	.	PUNCT
bam-5962	156	1	nat	nat	PROPN
bam-5962	156	2	rev	rev	VERB
bam-5962	156	3	neurol	neurol	PROPN
bam-5962	156	4	2016;12:259	2016;12:259	PROPN
bam-5962	156	5	-	-	SYM
bam-5962	156	6	68	68	NUM
bam-5962	156	7	.	.	NOUN
bam-5962	157	1	8	8	NUM
bam-5962	157	2	.	.	X
bam-5962	158	1	skeie	skeie	PROPN
bam-5962	158	2	go	go	PROPN
bam-5962	158	3	,	,	PUNCT
bam-5962	158	4	apostolski	apostolski	NOUN
bam-5962	158	5	s	s	PROPN
bam-5962	158	6	,	,	PUNCT
bam-5962	158	7	evoli	evoli	NOUN
bam-5962	158	8	a	a	PRON
bam-5962	158	9	,	,	PUNCT
bam-5962	158	10	et	et	PROPN
bam-5962	158	11	al	al	PROPN
bam-5962	158	12	.	.	PUNCT
bam-5962	158	13	guidelines	guideline	NOUN
bam-5962	158	14	for	for	ADP
bam-5962	158	15	treatment	treatment	NOUN
bam-5962	158	16	of	of	ADP
bam-5962	158	17	autoimmune	autoimmune	ADJ
bam-5962	158	18	neuromuscular	neuromuscular	ADJ
bam-5962	158	19	transmission	transmission	NOUN
bam-5962	158	20	disorders	disorder	NOUN
bam-5962	158	21	.	.	PUNCT
bam-5962	159	1	eur	eur	PROPN
bam-5962	159	2	j	j	PROPN
bam-5962	159	3	neurol	neurol	PROPN
bam-5962	159	4	2010;17:893902	2010;17:893902	NUM
bam-5962	159	5	.	.	PUNCT
bam-5962	159	6	9	9	NUM
bam-5962	159	7	.	.	PUNCT
bam-5962	160	1	ha	ha	INTJ
bam-5962	160	2	jc	jc	PROPN
bam-5962	160	3	,	,	PUNCT
bam-5962	160	4	richman	richman	PROPN
bam-5962	160	5	dp	dp	PROPN
bam-5962	160	6	.	.	PUNCT
bam-5962	160	7	myasthenia	myasthenia	PROPN
bam-5962	160	8	gravis	gravis	NOUN
bam-5962	160	9	and	and	CCONJ
bam-5962	160	10	related	related	ADJ
bam-5962	160	11	disorders	disorder	NOUN
bam-5962	160	12	:	:	PUNCT
bam-5962	160	13	pathology	pathology	NOUN
bam-5962	160	14	and	and	CCONJ
bam-5962	160	15	molecular	molecular	ADJ
bam-5962	160	16	pathogenesis	pathogenesis	NOUN
bam-5962	160	17	.	.	PUNCT
bam-5962	161	1	biochim	biochim	PROPN
bam-5962	161	2	biophys	biophy	NOUN
bam-5962	161	3	acta	acta	PROPN
bam-5962	161	4	2015;1852(4):651	2015;1852(4):651	X
bam-5962	161	5	-	-	PUNCT
bam-5962	161	6	7	7	NUM
bam-5962	161	7	.	.	NOUN
bam-5962	161	8	10	10	NUM
bam-5962	161	9	.	.	PUNCT
bam-5962	161	10	motomura	motomura	PROPN
bam-5962	161	11	m	m	PROPN
bam-5962	161	12	,	,	PUNCT
bam-5962	161	13	johnston	johnston	PROPN
bam-5962	161	14	i	i	PROPN
bam-5962	161	15	,	,	PUNCT
bam-5962	161	16	lang	lang	PROPN
bam-5962	161	17	b	b	PROPN
bam-5962	161	18	,	,	PUNCT
bam-5962	161	19	et	et	PROPN
bam-5962	161	20	al	al	PROPN
bam-5962	161	21	.	.	PUNCT
bam-5962	162	1	an	an	DET
bam-5962	162	2	improved	improve	VERB
bam-5962	162	3	diagnostic	diagnostic	ADJ
bam-5962	162	4	assay	assay	NOUN
bam-5962	162	5	for	for	ADP
bam-5962	162	6	lambert	lambert	PROPN
bam-5962	162	7	-	-	PUNCT
bam-5962	162	8	eaton	eaton	PROPN
bam-5962	162	9	myasthenic	myasthenic	PROPN
bam-5962	162	10	syndrome	syndrome	NOUN
bam-5962	162	11	.	.	PUNCT
bam-5962	163	1	j	j	PROPN
bam-5962	163	2	neurol	neurol	PROPN
bam-5962	163	3	neurosurg	neurosurg	PROPN
bam-5962	163	4	psychiatry	psychiatry	PROPN
bam-5962	163	5	1995;58:85	1995;58:85	NUM
bam-5962	163	6	-	-	PUNCT
bam-5962	163	7	7	7	NUM
bam-5962	163	8	.	.	NOUN
bam-5962	163	9	11	11	NUM
bam-5962	163	10	.	.	PUNCT
bam-5962	164	1	wirtz	wirtz	PROPN
bam-5962	164	2	pw	pw	PROPN
bam-5962	164	3	,	,	PUNCT
bam-5962	164	4	sotodeh	sotodeh	NOUN
bam-5962	164	5	m	m	PROPN
bam-5962	164	6	,	,	PUNCT
bam-5962	164	7	nijnuis	nijnuis	PROPN
bam-5962	164	8	m	m	PROPN
bam-5962	164	9	,	,	PUNCT
bam-5962	164	10	et	et	PROPN
bam-5962	164	11	al	al	PROPN
bam-5962	164	12	.	.	PROPN
bam-5962	164	13	difference	difference	NOUN
bam-5962	164	14	in	in	ADP
bam-5962	164	15	distribution	distribution	NOUN
bam-5962	164	16	of	of	ADP
bam-5962	164	17	muscle	muscle	NOUN
bam-5962	164	18	weakness	weakness	NOUN
bam-5962	164	19	between	between	ADP
bam-5962	164	20	myasthenia	myasthenia	NOUN
bam-5962	164	21	gravis	gravis	NOUN
bam-5962	164	22	and	and	CCONJ
bam-5962	164	23	the	the	DET
bam-5962	164	24	lambert	lambert	PROPN
bam-5962	164	25	-	-	PUNCT
bam-5962	164	26	eaton	eaton	PROPN
bam-5962	164	27	myasthenic	myasthenic	PROPN
bam-5962	164	28	syndrome	syndrome	NOUN
bam-5962	164	29	.	.	PUNCT
bam-5962	165	1	j	j	PROPN
bam-5962	165	2	neurol	neurol	PROPN
bam-5962	165	3	neurosurg	neurosurg	PROPN
bam-5962	165	4	psychiatry	psychiatry	NOUN
bam-5962	165	5	2002;73:766	2002;73:766	NOUN
bam-5962	165	6	-	-	SYM
bam-5962	165	7	8	8	NUM
bam-5962	165	8	.	.	NOUN
bam-5962	165	9	12	12	NUM
bam-5962	165	10	.	.	PUNCT
bam-5962	166	1	mcevoy	mcevoy	PROPN
bam-5962	166	2	km	km	PROPN
bam-5962	166	3	,	,	PUNCT
bam-5962	166	4	windebank	windebank	PROPN
bam-5962	166	5	aj	aj	PROPN
bam-5962	166	6	,	,	PUNCT
bam-5962	166	7	daube	daube	PROPN
bam-5962	166	8	jr	jr	PROPN
bam-5962	166	9	,	,	PUNCT
bam-5962	166	10	low	low	PROPN
bam-5962	166	11	pa	pa	PROPN
bam-5962	166	12	.	.	PROPN
bam-5962	167	1	3,4	3,4	NUM
bam-5962	167	2	-	-	PUNCT
bam-5962	167	3	diaminopyridine	diaminopyridine	NOUN
bam-5962	167	4	in	in	ADP
bam-5962	167	5	the	the	DET
bam-5962	167	6	treatment	treatment	NOUN
bam-5962	167	7	of	of	ADP
bam-5962	167	8	lamberteaton	lamberteaton	NOUN
bam-5962	167	9	myasthenic	myasthenic	ADJ
bam-5962	167	10	syndrome	syndrome	NOUN
bam-5962	167	11	.	.	PUNCT
bam-5962	168	1	n	n	PROPN
bam-5962	168	2	engl	engl	PROPN
bam-5962	168	3	j	j	PROPN
bam-5962	168	4	med	med	PROPN
bam-5962	168	5	1989;321:1567	1989;321:1567	NUM
bam-5962	168	6	-	-	SYM
bam-5962	168	7	71	71	NUM
bam-5962	168	8	.	.	NOUN
bam-5962	168	9	13	13	NUM
bam-5962	168	10	.	.	PUNCT
bam-5962	169	1	huijbers	huijbers	PROPN
bam-5962	169	2	mg	mg	PROPN
bam-5962	169	3	,	,	PUNCT
bam-5962	169	4	lipka	lipka	PROPN
bam-5962	169	5	af	af	PROPN
bam-5962	169	6	,	,	PUNCT
bam-5962	169	7	plomp	plomp	PROPN
bam-5962	169	8	jj	jj	PROPN
bam-5962	169	9	,	,	PUNCT
bam-5962	169	10	et	et	PROPN
bam-5962	169	11	al	al	PROPN
bam-5962	169	12	.	.	PROPN
bam-5962	169	13	pathogenic	pathogenic	ADJ
bam-5962	169	14	immune	immune	ADJ
bam-5962	169	15	mechanisms	mechanism	NOUN
bam-5962	169	16	at	at	ADP
bam-5962	169	17	the	the	DET
bam-5962	169	18	neuromuscular	neuromuscular	ADJ
bam-5962	169	19	synapse	synapse	NOUN
bam-5962	169	20	:	:	PUNCT
bam-5962	169	21	the	the	DET
bam-5962	169	22	role	role	NOUN
bam-5962	169	23	of	of	ADP
bam-5962	169	24	specific	specific	ADJ
bam-5962	169	25	antibody	antibody	NOUN
bam-5962	169	26	-	-	PUNCT
bam-5962	169	27	binding	bind	VERB
bam-5962	169	28	epitopes	epitope	NOUN
bam-5962	169	29	in	in	ADP
bam-5962	169	30	myasthenia	myasthenia	NOUN
bam-5962	169	31	gravis	gravis	PROPN
bam-5962	169	32	.	.	PUNCT
bam-5962	170	1	j	j	PROPN
bam-5962	170	2	intern	intern	NOUN
bam-5962	170	3	med	me	VERB
bam-5962	170	4	2014;275:12	2014;275:12	NUM
bam-5962	170	5	-	-	SYM
bam-5962	170	6	26	26	NUM
bam-5962	170	7	.	.	PUNCT
bam-5962	171	1	14	14	NUM
bam-5962	171	2	.	.	PUNCT
bam-5962	172	1	huijbers	huijbers	PROPN
bam-5962	172	2	mg	mg	PROPN
bam-5962	172	3	,	,	PUNCT
bam-5962	172	4	lipka	lipka	PROPN
bam-5962	172	5	af	af	PROPN
bam-5962	172	6	,	,	PUNCT
bam-5962	172	7	potman	potman	NOUN
bam-5962	172	8	m	m	PROPN
bam-5962	172	9	,	,	PUNCT
bam-5962	172	10	et	et	PROPN
bam-5962	172	11	al	al	PROPN
bam-5962	172	12	.	.	PROPN
bam-5962	172	13	antibodies	antibodie	VERB
bam-5962	172	14	to	to	ADP
bam-5962	172	15	active	active	ADJ
bam-5962	172	16	zone	zone	NOUN
bam-5962	172	17	protein	protein	NOUN
bam-5962	172	18	erc1	erc1	ADJ
bam-5962	172	19	in	in	ADP
bam-5962	172	20	lambert	lambert	PROPN
bam-5962	172	21	-	-	PUNCT
bam-5962	172	22	eaton	eaton	PROPN
bam-5962	172	23	myasthenic	myasthenic	PROPN
bam-5962	172	24	syndrome	syndrome	PROPN
bam-5962	172	25	.	.	PUNCT
bam-5962	173	1	hum	hum	PROPN
bam-5962	173	2	immunol	immunol	PROPN
bam-5962	173	3	2013;74:849	2013;74:849	PROPN
bam-5962	173	4	-	-	SYM
bam-5962	173	5	51	51	NUM
bam-5962	173	6	.	.	PUNCT
bam-5962	173	7	15	15	NUM
bam-5962	173	8	.	.	PUNCT
bam-5962	174	1	oh	oh	INTJ
bam-5962	174	2	sj	sj	INTJ
bam-5962	174	3	.	.	PUNCT
bam-5962	174	4	myasthenia	myasthenia	PROPN
bam-5962	174	5	gravis	gravis	PROPN
bam-5962	174	6	lambert	lambert	PROPN
bam-5962	174	7	-	-	PUNCT
bam-5962	174	8	eaton	eaton	PROPN
bam-5962	174	9	overlap	overlap	NOUN
bam-5962	174	10	syndrome	syndrome	NOUN
bam-5962	174	11	.	.	PUNCT
bam-5962	175	1	muscle	muscle	NOUN
bam-5962	175	2	nerve	nerve	NOUN
bam-5962	175	3	2016;53:20	2016;53:20	NUM
bam-5962	175	4	-	-	SYM
bam-5962	175	5	6	6	NUM
bam-5962	175	6	.	.	NOUN
bam-5962	175	7	16	16	NUM
bam-5962	175	8	.	.	PUNCT
bam-5962	176	1	frey	frey	PROPN
bam-5962	176	2	a	a	PRON
bam-5962	176	3	,	,	PUNCT
bam-5962	176	4	di	di	PROPN
bam-5962	176	5	canzio	canzio	PROPN
bam-5962	176	6	j	j	PROPN
bam-5962	176	7	,	,	PUNCT
bam-5962	176	8	zurakowski	zurakowski	PROPN
bam-5962	176	9	d.	d.	PROPN
bam-5962	176	10	a	a	DET
bam-5962	176	11	statistically	statistically	ADV
bam-5962	176	12	defined	define	VERB
bam-5962	176	13	endpoint	endpoint	NOUN
bam-5962	176	14	titer	titer	NOUN
bam-5962	176	15	determination	determination	NOUN
bam-5962	176	16	method	method	NOUN
bam-5962	176	17	for	for	ADP
bam-5962	176	18	immunoassays	immunoassay	NOUN
bam-5962	176	19	.	.	PUNCT
bam-5962	177	1	j	j	PROPN
bam-5962	177	2	immunol	immunol	NOUN
bam-5962	177	3	methods	method	NOUN
bam-5962	177	4	1998;221:3541	1998;221:3541	NUM
bam-5962	177	5	.	.	PUNCT
bam-5962	178	1	17	17	NUM
bam-5962	178	2	.	.	PUNCT
bam-5962	178	3	purroy	purroy	PROPN
bam-5962	178	4	garcia	garcia	PROPN
bam-5962	178	5	f	f	PROPN
bam-5962	178	6	,	,	PUNCT
bam-5962	178	7	comabella	comabella	PROPN
bam-5962	178	8	m	m	PROPN
bam-5962	178	9	,	,	PUNCT
bam-5962	178	10	raguer	raguer	NOUN
bam-5962	178	11	n	n	CCONJ
bam-5962	178	12	,	,	PUNCT
bam-5962	178	13	et	et	PROPN
bam-5962	178	14	al	al	PROPN
bam-5962	178	15	.	.	PUNCT
bam-5962	178	16	lambert	lambert	PROPN
bam-5962	178	17	-	-	PUNCT
bam-5962	178	18	eaton	eaton	PROPN
bam-5962	178	19	myasthenic	myasthenic	PROPN
bam-5962	178	20	syndrome	syndrome	NOUN
bam-5962	178	21	associated	associate	VERB
bam-5962	178	22	with	with	ADP
bam-5962	178	23	sarcoidosis	sarcoidosis	NOUN
bam-5962	178	24	.	.	PUNCT
bam-5962	179	1	j	j	PROPN
bam-5962	179	2	neurol	neurol	PROPN
bam-5962	179	3	2005;252:1127	2005;252:1127	NUM
bam-5962	179	4	-	-	SYM
bam-5962	179	5	8	8	NUM
bam-5962	179	6	.	.	NOUN
bam-5962	179	7	18	18	NUM
bam-5962	179	8	.	.	NOUN
bam-5962	179	9	motomura	motomura	PROPN
bam-5962	179	10	m	m	PROPN
bam-5962	179	11	,	,	PUNCT
bam-5962	179	12	lang	lang	PROPN
bam-5962	179	13	b	b	PROPN
bam-5962	179	14	,	,	PUNCT
bam-5962	179	15	johnston	johnston	PROPN
bam-5962	179	16	i	i	PROPN
bam-5962	179	17	,	,	PUNCT
bam-5962	179	18	et	et	PROPN
bam-5962	179	19	al	al	PROPN
bam-5962	179	20	.	.	PROPN
bam-5962	179	21	incidence	incidence	NOUN
bam-5962	179	22	of	of	ADP
bam-5962	179	23	serum	serum	NOUN
bam-5962	179	24	anti	anti	ADJ
bam-5962	179	25	-	-	ADJ
bam-5962	179	26	p	p	ADJ
bam-5962	179	27	/	/	SYM
bam-5962	179	28	o	o	NOUN
bam-5962	179	29	-	-	NOUN
bam-5962	179	30	type	type	NOUN
bam-5962	179	31	and	and	CCONJ
bam-5962	179	32	anti	anti	ADJ
bam-5962	179	33	-	-	ADJ
bam-5962	179	34	n	n	CCONJ
bam-5962	179	35	-	-	PUNCT
bam-5962	179	36	type	type	NOUN
bam-5962	179	37	calcium	calcium	NOUN
bam-5962	179	38	channel	channel	NOUN
bam-5962	179	39	autoantibodies	autoantibody	NOUN
bam-5962	179	40	in	in	ADP
bam-5962	179	41	the	the	DET
bam-5962	179	42	lambert	lambert	PROPN
bam-5962	179	43	-	-	PUNCT
bam-5962	179	44	eaton	eaton	PROPN
bam-5962	179	45	non	non	PROPN
bam-5962	179	46	co	co	PROPN
bam-5962	179	47	mmerc	mmerc	PROPN
bam-5962	179	48	ial	ial	PROPN
bam-5962	179	49	us	us	PROPN
bam-5962	179	50	e	e	NOUN
bam-5962	179	51	o	o	NOUN
bam-5962	180	1	nly	nly	ADV
bam-5962	180	2	clinical	clinical	ADJ
bam-5962	180	3	features	feature	NOUN
bam-5962	180	4	of	of	ADP
bam-5962	180	5	n	n	CCONJ
bam-5962	180	6	-	-	PUNCT
bam-5962	180	7	type	type	NOUN
bam-5962	180	8	vgcc	vgcc	NOUN
bam-5962	180	9	neuromuscular	neuromuscular	ADJ
bam-5962	180	10	syndromes	syndrome	NOUN
bam-5962	180	11	eur	eur	PROPN
bam-5962	180	12	j	j	PROPN
bam-5962	180	13	transl	transl	PROPN
bam-5962	180	14	myol	myol	NOUN
bam-5962	180	15	26	26	NUM
bam-5962	180	16	(	(	PUNCT
bam-5962	180	17	4	4	NUM
bam-5962	180	18	):	):	PUNCT
bam-5962	180	19	301	301	NUM
bam-5962	180	20	-	-	SYM
bam-5962	180	21	306	306	NUM
bam-5962	180	22	306	306	NUM
bam-5962	180	23	myasthenic	myasthenic	ADJ
bam-5962	180	24	syndrome	syndrome	NOUN
bam-5962	180	25	.	.	PUNCT
bam-5962	181	1	j	j	PROPN
bam-5962	181	2	neurol	neurol	PROPN
bam-5962	181	3	sci	sci	PROPN
bam-5962	181	4	1997;147:3542	1997;147:3542	NUM
bam-5962	181	5	.	.	PUNCT
bam-5962	182	1	19	19	NUM
bam-5962	182	2	.	.	PUNCT
bam-5962	183	1	oh	oh	INTJ
bam-5962	183	2	sj	sj	INTJ
bam-5962	183	3	,	,	PUNCT
bam-5962	183	4	sher	sher	PROPN
bam-5962	183	5	e.	e.	PROPN
bam-5962	183	6	mg	mg	PROPN
bam-5962	183	7	and	and	CCONJ
bam-5962	183	8	lems	lem	VERB
bam-5962	183	9	overlap	overlap	NOUN
bam-5962	183	10	syndrome	syndrome	NOUN
bam-5962	183	11	:	:	PUNCT
bam-5962	183	12	case	case	NOUN
bam-5962	183	13	report	report	NOUN
bam-5962	183	14	with	with	ADP
bam-5962	183	15	electrophysiological	electrophysiological	ADJ
bam-5962	183	16	and	and	CCONJ
bam-5962	183	17	immunological	immunological	ADJ
bam-5962	183	18	evidence	evidence	NOUN
bam-5962	183	19	.	.	PUNCT
bam-5962	184	1	clin	clin	PROPN
bam-5962	184	2	neurophysiol	neurophysiol	PROPN
bam-5962	184	3	2005;116:1167	2005;116:1167	NUM
bam-5962	184	4	-	-	SYM
bam-5962	184	5	71	71	NUM
bam-5962	184	6	.	.	NOUN
bam-5962	184	7	20	20	NUM
bam-5962	184	8	.	.	PUNCT
bam-5962	185	1	racz	racz	VERB
bam-5962	185	2	a	a	DET
bam-5962	185	3	,	,	PUNCT
bam-5962	185	4	giede	giede	NOUN
bam-5962	185	5	-	-	PUNCT
bam-5962	185	6	jeppe	jeppe	PROPN
bam-5962	185	7	a	a	PROPN
bam-5962	185	8	,	,	PUNCT
bam-5962	185	9	schramm	schramm	PROPN
bam-5962	185	10	a	a	X
bam-5962	185	11	,	,	PUNCT
bam-5962	185	12	et	et	PROPN
bam-5962	185	13	al	al	PROPN
bam-5962	185	14	.	.	PUNCT
bam-5962	185	15	lambert	lambert	PROPN
bam-5962	185	16	-	-	PUNCT
bam-5962	185	17	eaton	eaton	PROPN
bam-5962	185	18	myasthenic	myasthenic	PROPN
bam-5962	185	19	syndrome	syndrome	NOUN
bam-5962	185	20	presenting	present	VERB
bam-5962	185	21	with	with	ADP
bam-5962	185	22	a	a	DET
bam-5962	185	23	"	"	PUNCT
bam-5962	185	24	dropped	drop	VERB
bam-5962	185	25	head	head	NOUN
bam-5962	185	26	syndrome	syndrome	NOUN
bam-5962	185	27	"	"	PUNCT
bam-5962	185	28	and	and	CCONJ
bam-5962	185	29	associated	associate	VERB
bam-5962	185	30	with	with	ADP
bam-5962	185	31	antibodies	antibody	NOUN
bam-5962	185	32	against	against	ADP
bam-5962	185	33	n	n	CCONJ
bam-5962	185	34	-	-	PUNCT
bam-5962	185	35	type	type	NOUN
bam-5962	185	36	calcium	calcium	NOUN
bam-5962	185	37	channels	channel	NOUN
bam-5962	185	38	.	.	PUNCT
bam-5962	186	1	neurol	neurol	PROPN
bam-5962	186	2	sci	sci	PROPN
bam-5962	186	3	2013;34:1253	2013;34:1253	PROPN
bam-5962	186	4	-	-	SYM
bam-5962	186	5	4	4	NUM
bam-5962	186	6	.	.	NUM
bam-5962	186	7	21	21	NUM
bam-5962	186	8	.	.	PUNCT
bam-5962	187	1	ueda	ueda	PROPN
bam-5962	187	2	t	t	PROPN
bam-5962	187	3	,	,	PUNCT
bam-5962	187	4	kanda	kanda	PROPN
bam-5962	187	5	f	f	PROPN
bam-5962	187	6	,	,	PUNCT
bam-5962	187	7	kobessho	kobessho	PROPN
bam-5962	187	8	h	h	PROPN
bam-5962	187	9	,	,	PUNCT
bam-5962	187	10	et	et	PROPN
bam-5962	187	11	al	al	PROPN
bam-5962	187	12	.	.	PUNCT
bam-5962	188	1	"	"	PUNCT
bam-5962	188	2	dropped	drop	VERB
bam-5962	188	3	head	head	NOUN
bam-5962	188	4	syndrome	syndrome	NOUN
bam-5962	188	5	"	"	PUNCT
bam-5962	188	6	caused	cause	VERB
bam-5962	188	7	by	by	ADP
bam-5962	188	8	lambert	lambert	PROPN
bam-5962	188	9	-	-	PUNCT
bam-5962	188	10	eaton	eaton	PROPN
bam-5962	188	11	myasthenic	myasthenic	PROPN
bam-5962	188	12	syndrome	syndrome	PROPN
bam-5962	188	13	.	.	PUNCT
bam-5962	189	1	muscle	muscle	NOUN
bam-5962	189	2	nerve	nerve	NOUN
bam-5962	189	3	2009;40:1346	2009;40:1346	PROPN
bam-5962	189	4	.	.	PROPN
bam-5962	189	5	22	22	NUM
bam-5962	189	6	.	.	PUNCT
bam-5962	190	1	lennon	lennon	PROPN
bam-5962	190	2	va	va	PROPN
bam-5962	190	3	,	,	PUNCT
bam-5962	190	4	kryzer	kryzer	PROPN
bam-5962	190	5	tj	tj	PROPN
bam-5962	190	6	,	,	PUNCT
bam-5962	190	7	griesmann	griesmann	PROPN
bam-5962	190	8	ge	ge	PROPN
bam-5962	190	9	,	,	PUNCT
bam-5962	190	10	et	et	PROPN
bam-5962	190	11	al	al	PROPN
bam-5962	190	12	.	.	PROPN
bam-5962	190	13	calcium	calcium	NOUN
bam-5962	190	14	-	-	PUNCT
bam-5962	190	15	channel	channel	NOUN
bam-5962	190	16	antibodies	antibody	NOUN
bam-5962	190	17	in	in	ADP
bam-5962	190	18	the	the	DET
bam-5962	190	19	lambert	lambert	PROPN
bam-5962	190	20	-	-	PUNCT
bam-5962	190	21	eaton	eaton	PROPN
bam-5962	190	22	syndrome	syndrome	PROPN
bam-5962	190	23	and	and	CCONJ
bam-5962	190	24	other	other	ADJ
bam-5962	190	25	paraneoplastic	paraneoplastic	ADJ
bam-5962	190	26	syndromes	syndrome	NOUN
bam-5962	190	27	.	.	PUNCT
bam-5962	191	1	n	n	PROPN
bam-5962	191	2	engl	engl	PROPN
bam-5962	191	3	j	j	PROPN
bam-5962	191	4	med	me	VERB
bam-5962	191	5	1995;332:1467	1995;332:1467	PROPN
bam-5962	191	6	-	-	SYM
bam-5962	191	7	74	74	NUM
bam-5962	191	8	.	.	PUNCT
bam-5962	192	1	non	non	PROPN
bam-5962	192	2	co	co	PROPN
bam-5962	192	3	mmerc	mmerc	PROPN
bam-5962	192	4	ial	ial	PROPN
bam-5962	192	5	us	us	PROPN
bam-5962	193	1	e	e	NOUN
bam-5962	193	2	o	o	NOUN
bam-5962	193	3	nly	nly	ADV